BLEND LABS, INC., 10-K filed on 3/16/2026
Annual Report
v3.25.4
Cover Page - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2025
Mar. 02, 2026
Jun. 30, 2025
Document Information [Line Items]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Dec. 31, 2025    
Current Fiscal Year End Date --12-31    
Document Transition Report false    
Entity File Number 001-40599    
Entity Registrant Name BLEND LABS, INC.    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 45-5211045    
Entity Address, Address Line One 7250 Redwood Blvd.    
Entity Address, Address Line Two Suite 300    
Entity Address, City or Town Novato    
Entity Address, State or Province CA    
Entity Address, Postal Zip Code 94945    
City Area Code 650    
Local Phone Number 550-4810    
Title of 12(b) Security Class A common stock, par value $0.00001 per share    
Trading Symbol BLND    
Security Exchange Name NYSE    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Accelerated Filer    
Entity Small Business false    
Entity Emerging Growth Company true    
Entity Ex Transition Period false    
ICFR Auditor Attestation Flag false    
Document Financial Statement Error Correction Flag false    
Entity Shell Company false    
Entity Public Float     $ 696.5
Documents Incorporated by Reference
Portions of the registrant’s Definitive Proxy Statement relating to the 2026 Annual Meeting of Stockholders are incorporated by reference into Part III of this Annual Report on Form 10-K where indicated. Such Definitive Proxy Statement will be filed with the Securities and Exchange Commission within 120 days after the end of the registrant’s fiscal year ended December 31, 2025.
   
Document Fiscal Year Focus 2025    
Document Period Focus FY    
Entity Central Index Key 0001855747    
Amendment Flag false    
Class A Common Stock      
Document Information [Line Items]      
Entity Common Stock, Shares Outstanding   253,858,348  
Class B Common Stock      
Document Information [Line Items]      
Entity Common Stock, Shares Outstanding   3,256,385  
Class C Common Stock      
Document Information [Line Items]      
Entity Common Stock, Shares Outstanding   0  
v3.25.4
Audit Information
12 Months Ended
Dec. 31, 2025
Audit Information [Abstract]  
Auditor Firm ID 238
Auditor Name PricewaterhouseCoopers LLP
Auditor Location San Jose, California
v3.25.4
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 43,578 $ 38,011
Marketable securities and other investments 24,739 56,233
Trade and other receivables, net of allowance for credit losses of $112 and $50, respectively 8,786 14,656
Prepaid expenses and other current assets 15,121 16,725
Current assets held for sale from discontinued operations 5,640 9,618
Total current assets 97,864 135,243
Property and equipment, net 22,997 11,672
Operating lease right-of-use assets 1,394 339
Deferred contract costs 3,425 2,868
Other non-current assets 41,425 21,906
Non-current assets held for sale from discontinued operations 2,940 6,057
Total assets 170,045 178,085
Current liabilities:    
Accounts payable 1,826 1,620
Deferred revenue 19,385 19,240
Accrued compensation 4,555 3,315
Other current liabilities 8,872 9,740
Current liabilities held for sale from discontinued operations 4,816 5,107
Total current liabilities 39,454 39,022
Other non-current liabilities 1,415 278
Non-current liabilities held for sale from discontinued operations 154 1,103
Total liabilities 41,023 40,403
Commitments and contingencies (Note 7)
Redeemable noncontrolling interest - held for sale from discontinued operations 0 52,375
Series A redeemable convertible preferred stock, par value $0.00001 per share: 200,000 shares authorized as of December 31, 2025 and 2024, 150 shares issued and outstanding as of December 31, 2025 and 2024, respectively (Note 9) 159,495 141,663
Stockholders’ equity:    
Class A, Class B and Class C Common Stock, par value $0.00001 per share: 3,000,000 (Class A 1,800,000, Class B 600,000, Class C 600,000) shares authorized as of December 31, 2025 and 2024; 256043436 (Class A 252,787, Class B 3,256, Class C 0) and 258172720 (Class A 254426485, Class B 3,747, Class C 0) shares issued and outstanding as of December 31, 2025 and 2024, respectively 2 2
Additional paid-in capital 1,360,704 1,328,015
Accumulated other comprehensive income 597 602
Accumulated deficit (1,391,776) (1,384,975)
Total stockholders’ equity (30,473) (56,356)
Total liabilities, redeemable equity and stockholders’ equity 170,045 178,085
Series A Redeemable Convertible Preferred Stock    
Current liabilities:    
Series A redeemable convertible preferred stock, par value $0.00001 per share: 200,000 shares authorized as of December 31, 2025 and 2024, 150 shares issued and outstanding as of December 31, 2025 and 2024, respectively (Note 9) $ 159,495 $ 141,663
v3.25.4
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Accounts receivable, allowance for credit loss, current $ 112 $ 50
Temporary equity, shares outstanding (in shares) 150,000 150,000
Common stock, shares authorized (in shares) 3,000,000,000 3,000,000,000
Common stock, shares issued (in shares) 256,043,000 258,173,000
Common stock, shares outstanding (in shares) 256,043,000 258,173,000
Series A Redeemable Convertible Preferred Stock    
Temporary equity, par value (in dollars per share) $ 0.00001 $ 0.00001
Temporary equity, shares authorized (in shares) 200,000,000 200,000,000
Temporary equity, shares issued (in shares) 150,000 150,000
Temporary equity, shares outstanding (in shares) 150,000 150,000
Class A Common Stock    
Common stock, par value (in dollars per share) $ 0.00001 $ 0.00001
Common stock, shares authorized (in shares) 1,800,000,000 1,800,000,000
Common stock, shares issued (in shares) 252,787,000 254,426,000
Common stock, shares outstanding (in shares) 252,787,000 254,426,000
Class B Common Stock    
Common stock, par value (in dollars per share) $ 0.00001 $ 0.00001
Common stock, shares authorized (in shares) 600,000,000 600,000,000
Common stock, shares issued (in shares) 3,256,000 3,747,000
Common stock, shares outstanding (in shares) 3,256,000 3,747,000
Class C Common Stock    
Common stock, par value (in dollars per share) $ 0.00001 $ 0.00001
Common stock, shares authorized (in shares) 600,000,000 600,000,000
Common stock, shares issued (in shares) 0 0
Common stock, shares outstanding (in shares) 0 0
v3.25.4
Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Revenue      
Total revenue $ 123,585 $ 115,762 $ 109,549
Cost of revenue      
Total cost of revenue 32,418 32,541 33,090
Gross profit 91,167 83,221 76,459
Operating expenses:      
Research and development 32,843 46,087 81,257
Sales and marketing 29,073 34,410 57,470
General and administrative 50,115 45,687 61,284
Restructuring 871 5,882 20,056
Total operating expenses 112,902 132,066 220,067
Loss from operations (21,735) (48,845) (143,608)
Interest expense 0 (6,747) (30,811)
Other income (expense), net 20,857 12,941 7,033
Loss before income taxes (878) (42,651) (167,386)
Income tax expense (249) (109) (94)
Loss from continuing operations (1,127) (42,760) (167,480)
Loss from discontinued operations (Note 16) (5,856) (659) (12,399)
Net loss (6,983) (43,419) (179,879)
Less: Net loss attributable to noncontrolling interest included in discontinued operations 182 74 1,186
Net loss attributable to Blend Labs, Inc. (6,801) (43,345) (178,693)
Less: Accretion of redeemable noncontrolling interest to redemption value from discontinued operations (1,254) (6,259) (6,627)
Less: Accretion of Series A redeemable convertible preferred stock to redemption value (17,832) (10,879) 0
Net loss attributable to Blend Labs, Inc. common stockholders, basic (25,887) (60,483) (185,320)
Net loss attributable to Blend Labs, Inc. common stockholders, diluted $ (25,887) $ (60,483) $ (185,320)
Net loss per share attributable to Blend Labs, Inc. common stockholders - basic and diluted:      
Continuing operations, basic (in dollars per share) $ (0.07) $ (0.21) $ (0.69)
Continuing operations, diluted (in dollars per share) (0.07) (0.21) (0.69)
Discontinuing operations, basic (in dollars per share) (0.03) (0.03) (0.07)
Discontinuing operations, diluted (in dollars per share) (0.03) (0.03) (0.07)
Net loss per share attributable to Blend Labs, Inc. common stockholders, basic (in dollars per share) (0.10) (0.24) (0.76)
Net loss per share attributable to Blend Labs, Inc. common stockholders, diluted (in dollars per share) $ (0.10) $ (0.24) $ (0.76)
Weighted average shares used in calculating net loss per share:      
Basic (in shares) 258,949 253,921 245,206
Diluted (in shares) 258,949 253,921 245,206
Comprehensive loss:      
Net loss $ (6,983) $ (43,419) $ (179,879)
Unrealized (loss) gain on marketable securities (100) 87 1,030
Foreign currency translation gain 95 74 119
Comprehensive loss (6,988) (43,258) (178,730)
Less: Comprehensive loss attributable to noncontrolling interest included in discontinued operations 182 74 1,186
Comprehensive loss attributable to Blend Labs, Inc. (6,806) (43,184) (177,544)
Software platform      
Revenue      
Total revenue 114,446 106,914 101,204
Cost of revenue      
Total cost of revenue 25,312 23,107 22,025
Professional services      
Revenue      
Total revenue 9,139 8,848 8,345
Cost of revenue      
Total cost of revenue $ 7,106 $ 9,434 $ 11,065
v3.25.4
Consolidated Statements of Redeemable Noncontrolling Interest, Series A Redeemable Convertible Preferred Stock, and Stockholders’ Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Redeemable noncontrolling interest - held for sale from discontinued operations
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Series A Redeemable Convertible Preferred Stock            
Accretion of Series A redeemable convertible preferred stock to redemption value $ 0          
Ending temporary equity (in shares) at Dec. 31, 2023 0          
Ending temporary equity at Dec. 31, 2023 $ 0          
Beginning balance (in shares) at Dec. 31, 2022     240,931      
Beginning balance at Dec. 31, 2022 123,172 $ 40,749 $ 2 $ 1,286,815 $ (708) $ (1,162,937)
Stockholders’ Equity            
Issuance of common stock upon exercise of stock options, net of repurchases (in shares)     274      
Issuance of common stock upon exercise of stock options, net of repurchases 460     460    
Vesting of early exercised stock options 1,446     1,446    
Vesting of restricted stock units (in shares)     13,531      
Shares withheld related to net share settlement of equity awards (in shares)     (4,826)      
Shares withheld related to net share settlement of equity awards (6,171)     (6,171)    
Stock-based compensation 46,021     46,021    
Unrealized (loss) gain on marketable securities 1,030       1,030  
Foreign currency translation gain 119       119  
Accretion of redeemable noncontrolling interest to redemption value (6,627) 6,627   (6,627)    
Reclassification of noncontrolling interest to equity, net of noncash consideration received 0          
Net loss (178,693) (1,186)       (178,693)
Ending balance (in shares) at Dec. 31, 2023     249,910      
Ending balance at Dec. 31, 2023 $ (19,243) 46,190 $ 2 1,321,944 441 (1,341,630)
Series A Redeemable Convertible Preferred Stock            
Issuance of Series A redeemable convertible preferred stock, net of issuance costs (in shares) 150          
Issuance of Series A redeemable convertible preferred stock, net of issuance costs $ 130,784          
Accretion of Series A redeemable convertible preferred stock to redemption value $ 10,879          
Ending temporary equity (in shares) at Dec. 31, 2024 150          
Ending temporary equity at Dec. 31, 2024 $ 141,663          
Stockholders’ Equity            
Issuance of common stock upon exercise of stock options, net of repurchases (in shares)     961      
Issuance of common stock upon exercise of stock options, net of repurchases 1,658     1,658    
Vesting of early exercised stock options 363     363    
Vesting of restricted stock units (in shares)     12,107      
Shares withheld related to net share settlement of equity awards (in shares)     (4,805)      
Shares withheld related to net share settlement of equity awards (18,115)     (18,115)    
Stock-based compensation 30,192     30,192    
Unrealized (loss) gain on marketable securities 87       87  
Foreign currency translation gain 74       74  
Accretion of redeemable noncontrolling interest to redemption value (6,259) 6,259   (6,259)    
Issuance of the Haveli Warrant in connection with the Series A redeemable convertible preferred stock 9,111     9,111    
Accretion of Series A redeemable convertible preferred stock to redemption value (10,879)     (10,879)    
Reclassification of noncontrolling interest to equity, net of noncash consideration received 0          
Net loss $ (43,345) (74)       (43,345)
Ending balance (in shares) at Dec. 31, 2024 258,173   258,173      
Ending balance at Dec. 31, 2024 $ (56,356) 52,375 $ 2 1,328,015 602 (1,384,975)
Series A Redeemable Convertible Preferred Stock            
Accretion of Series A redeemable convertible preferred stock to redemption value 4,202          
Stockholders’ Equity            
Unrealized (loss) gain on marketable securities 6          
Foreign currency translation gain (43)          
Accretion of redeemable noncontrolling interest to redemption value (1,254)          
Net loss (9,517)          
Ending balance at Mar. 31, 2025 $ (17,173)          
Beginning temporary equity (in shares) at Dec. 31, 2024 150          
Beginning temporary equity at Dec. 31, 2024 $ 141,663          
Series A Redeemable Convertible Preferred Stock            
Accretion of Series A redeemable convertible preferred stock to redemption value $ 8,578          
Beginning balance (in shares) at Dec. 31, 2024 258,173   258,173      
Beginning balance at Dec. 31, 2024 $ (56,356) 52,375 $ 2 1,328,015 602 (1,384,975)
Stockholders’ Equity            
Unrealized (loss) gain on marketable securities (38)          
Foreign currency translation gain (50)          
Accretion of redeemable noncontrolling interest to redemption value (1,254)          
Net loss (16,364)          
Ending balance at Jun. 30, 2025 $ (23,054)          
Beginning temporary equity (in shares) at Dec. 31, 2024 150          
Beginning temporary equity at Dec. 31, 2024 $ 141,663          
Series A Redeemable Convertible Preferred Stock            
Accretion of Series A redeemable convertible preferred stock to redemption value $ 13,136          
Beginning balance (in shares) at Dec. 31, 2024 258,173   258,173      
Beginning balance at Dec. 31, 2024 $ (56,356) 52,375 $ 2 1,328,015 602 (1,384,975)
Stockholders’ Equity            
Unrealized (loss) gain on marketable securities (100)          
Foreign currency translation gain 53          
Accretion of redeemable noncontrolling interest to redemption value (1,254)          
Net loss (4,268)          
Ending balance at Sep. 30, 2025 $ (13,410)          
Beginning temporary equity (in shares) at Dec. 31, 2024 150          
Beginning temporary equity at Dec. 31, 2024 $ 141,663          
Series A Redeemable Convertible Preferred Stock            
Accretion of Series A redeemable convertible preferred stock to redemption value $ 17,832          
Ending temporary equity (in shares) at Dec. 31, 2025 150          
Ending temporary equity at Dec. 31, 2025 $ 159,495          
Beginning balance (in shares) at Dec. 31, 2024 258,173   258,173      
Beginning balance at Dec. 31, 2024 $ (56,356) 52,375 $ 2 1,328,015 602 (1,384,975)
Stockholders’ Equity            
Issuance of common stock upon exercise of stock options, net of repurchases (in shares)     1,146      
Issuance of common stock upon exercise of stock options, net of repurchases 1,652     1,652    
Vesting of restricted stock units (in shares)     7,430      
Shares withheld related to net share settlement of equity awards (in shares)     (2,726)      
Shares withheld related to net share settlement of equity awards (9,369)     (9,369)    
Stock-based compensation 31,687     31,687    
Unrealized (loss) gain on marketable securities (100)       (100)  
Foreign currency translation gain 95       95  
Accretion of redeemable noncontrolling interest to redemption value (1,254) 1,254   (1,254)    
Accretion of Series A redeemable convertible preferred stock to redemption value (17,832)     (17,832)    
Share repurchases (in shares)     (7,980)      
Share repurchases (24,870)     (24,870)    
Reclassification of noncontrolling interest to equity, net of noncash consideration received 52,675 (53,447)   52,675    
Net loss $ (6,801) (182)       (6,801)
Ending balance (in shares) at Dec. 31, 2025 256,043   256,043      
Ending balance at Dec. 31, 2025 $ (30,473) $ 0 $ 2 $ 1,360,704 $ 597 $ (1,391,776)
Series A Redeemable Convertible Preferred Stock            
Accretion of Series A redeemable convertible preferred stock to redemption value 4,376          
Beginning balance at Mar. 31, 2025 (17,173)          
Stockholders’ Equity            
Unrealized (loss) gain on marketable securities (44)          
Foreign currency translation gain (7)          
Accretion of redeemable noncontrolling interest to redemption value 0          
Net loss (6,847)          
Ending balance at Jun. 30, 2025 (23,054)          
Series A Redeemable Convertible Preferred Stock            
Accretion of Series A redeemable convertible preferred stock to redemption value 4,558          
Stockholders’ Equity            
Unrealized (loss) gain on marketable securities (62)          
Foreign currency translation gain 103          
Accretion of redeemable noncontrolling interest to redemption value 0          
Net loss 12,096          
Ending balance at Sep. 30, 2025 $ (13,410)          
v3.25.4
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Mar. 31, 2025
Jun. 30, 2025
Sep. 30, 2025
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Operating activities            
Net loss $ (9,699) $ (16,546) $ (4,450) $ (6,983) $ (43,419) $ (179,879)
Less: Net loss from discontinued operations (2,803) (5,801) (5,679) (5,856) (659) (12,399)
Net loss from continuing operations (6,896) (10,745) 1,229 (1,127) (42,760) (167,480)
Adjustments to reconcile net loss to net cash used in operating activities:            
Stock-based compensation 6,096 13,678 21,477 28,955 27,941 45,557
Depreciation and amortization       3,288 1,339 1,515
Amortization of deferred contract costs       1,626 1,068 2,979
Amortization of debt discount and issuance costs       0 690 2,968
Amortization of operating lease right-of-use assets       531 2,062 2,810
Accelerated amortization of right-of-use asset in connection with lease abandonment       0 2,992 0
Gain on conversion of note receivable to investment in equity securities       (825) 0 0
Gain on investment in equity securities       (16,580) (4,417) 0
Loss on extinguishment of debt       0 5,476 3,970
Gain on sale of insurance business       0 (9,213) 0
Other       (312) (1,927) (5,253)
Changes in operating assets and liabilities:            
Trade and other receivables 3,902 (506) 2,225 5,760 4,765 765
Prepaid expenses and other assets, current and non-current 864 (719) (4,291) (5,430) (432) 1,883
Deferred contract costs, non-current       (557) (415) (762)
Accounts payable       206 (291) 1,216
Deferred revenue 12,908 12,352 5,194 (627) 10,256 289
Accrued compensation       807 (2,109) (1,765)
Operating lease liabilities       (2,769) (2,922) (3,562)
Other liabilities, current and non-current 2,019 2,204 1,773 1,452 (303) (1,948)
Net cash provided by (used in) operating activities - continuing operations 19,811 14,385 11,502 14,398 (8,200) (116,818)
Net cash used in operating activities - discontinued operations       (2,886) (4,844) (10,803)
Net cash provided by (used in) operating activities 20,116 13,614 9,974 11,512 (13,044) (127,621)
Investing activities            
Purchases of marketable securities       (35,485) (102,030) (236,079)
Sale of available-for-sale securities       20,827 100,327 56,022
Maturities of marketable securities       46,727 53,150 310,450
Additions to property, equipment and internal-use software development costs (4,313) (7,912) (10,034) (11,593) (9,741) (35)
Proceeds from sale of insurance business       0 9,075 0
Cash received in connection with conversion of note receivable to investment in equity securities       2,255 0 0
Investment in non-marketable equity securities       (4,000) 0 0
Investment in note receivable       0 (5,000) (2,500)
Other       0 (283) 0
Net cash provided by investing activities - continuing operations 3,586 (7,075) 20,530 18,731 45,498 127,858
Net cash used in investing activities - discontinued operations       (195) (103) (552)
Net cash provided by investing activities 3,502 (7,195) 20,348 18,536 45,395 127,306
Financing activities            
Proceeds from exercises of stock options, including early exercises, net of repurchases       1,652 1,658 268
Taxes paid related to net share settlement of equity awards       (9,369) (18,115) (6,171)
Share repurchases       (24,870) 0 0
Repayment of long-term debt       0 (144,500) (85,055)
Net proceeds from the issuance of the Series A redeemable convertible preferred stock and the Haveli Warrant       0 149,375 0
Payment for issuance costs related to the Series A redeemable convertible preferred stock and the Haveli Warrant       0 (9,480) 0
Net cash used in financing activities - continuing operations       (32,587) (21,062) (90,958)
Effect of exchange rates on cash, cash equivalents, and restricted cash       0 (5) (31)
Net (decrease) increase in cash, cash equivalents, and restricted cash       (2,539) 11,284 (91,304)
Cash, cash equivalents, and restricted cash at beginning of period 49,537 49,537 49,537 49,537 38,253 129,557
Cash, cash equivalents, and restricted cash at end of period       46,998 49,537 38,253
Less: Cash, cash equivalents and restricted cash included in current assets held for sale from discontinued operations       3,420 6,503 9,727
Cash, cash equivalents and restricted cash, end of period, excluding current assets held for sale from discontinued operations       43,578 43,034 28,526
Reconciliation of cash, cash equivalents, and restricted cash within the consolidated balance sheets:            
Cash and cash equivalents 56,244 36,499 55,021 43,578 38,011 23,503
Restricted cash       0 5,023 5,023
Total cash, cash equivalents, and restricted cash       43,578 43,034 28,526
Cash paid for income taxes            
Total income taxes paid, net       389 76 107
Cash paid for interest       0 6,150 27,814
Supplemental disclosure of non-cash investing and financing activities:            
Conversion of note receivable to investment in equity securities       9,692 0 0
Reclassification of redeemable noncontrolling interest related to discontinued operations to equity       52,675 0 0
Vesting of early exercised stock options       0 363 1,446
Operating lease liabilities arising from obtaining new or modified right-of-use assets       1,565 1,098 327
Stock-based compensation included in capitalized internal-use software development costs       3,162 2,450 0
Accretion of redeemable noncontrolling interest related to discontinued operations to redemption value 1,254 1,254 1,254 1,254 6,259 6,627
Accretion of Series A redeemable convertible preferred stock to redemption value $ 4,202 $ 8,578 $ 13,136 17,832 10,879 0
Covered Warrant received in connection with strategic partnership and sale of insurance business       0 222 0
Capitalized internal-use software development costs included in accrued compensation       129 155 0
Texas            
Cash paid for income taxes            
State and local       64 52 41
India            
Cash paid for income taxes            
Foreign       $ 325 $ 24 $ 66
v3.25.4
Description of Business and Basis of Presentation
12 Months Ended
Dec. 31, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Description of Business and Basis of Presentation Description of Business and Basis of Presentation
Description of Business
Blend Labs, Inc. (the “Company,” “Blend,” “we,” “us,” or “our”) was incorporated on April 17, 2012. The Company offers a cloud-based software platform for financial services firms that is designed to power the end-to-end consumer journey for banking products. The Company’s solutions make the journey from application to close fast, simple, and transparent for consumers, while helping financial services firms increase productivity, deepen customer relationships, and deliver exceptional consumer experiences.
Basis of Presentation and Principles of Consolidation
The consolidated financial statements are prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) and include the accounts of Blend Labs, Inc., its subsidiaries in which the Company holds a controlling financial interest, and variable interest entities (“VIE”) in which the Company is the primary beneficiary in accordance with the consolidation accounting guidance.

Noncontrolling interest represents the minority stockholder’s share of the net income or loss and equity in a consolidated subsidiary. On February 26, 2025, the Company obtained the remaining interest previously held by the minority stockholder thereby extinguishing the noncontrolling interest.
All intercompany balances and transactions have been eliminated in consolidation.

During the first quarter of 2025, the Company classified the results of its previously reported Title segment as discontinued operations in the Company’s consolidated financial statements for all periods presented. As a result, the Company operates in a single reportable segment. For further information on the Company’s segments, refer to Note 15, Segment Information, and Note 16, Assets Held for Sale and Discontinued Operations.

Prior period information has been reclassified to conform to the current period presentation.
Use of Estimates
The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make, on an ongoing basis, estimates and assumptions that affect the amounts reported in the consolidated financial statements and the notes thereto. Actual results may differ from those estimates. Such estimates include, but are not limited to, estimates of variable consideration, evaluation of contingencies, determination of the incremental borrowing rates used in calculations of lease liabilities, determination of fair value of stock-based compensation, determination of fair value of marketable securities, determination of fair value of each of the Series A Preferred Stock and the warrant issued to Brooks Aggregator, L.P. (“Haveli”) to purchase up to 11,111,112 shares of Class A common stock, at a purchase price of $4.50 per share of Class A common stock (the “Haveli Warrant”), determination of fair values of assets transferred and performance obligations committed to under the strategic partnership agreement, assessment of expected credit losses on notes receivable, valuation of deferred tax assets, valuation of the redeemable noncontrolling interest, determination of fair value of the disposal group, determination of useful lives of tangible and intangible assets and capitalized internal-use software development costs, assessment of impairment of long-lived assets, and valuation of equity securities without readily determinable fair value.
Risks and Uncertainties
The Company has been and may continue to be affected by various macroeconomic factors, including interest rate environment, housing affordability, and worldwide political and economic conditions. The global financial markets have recently experienced extreme volatility and disruptions, including diminished liquidity and credit availability, declines in consumer confidence, declines in economic growth, rising interest rates, inflation, increases in unemployment rates and uncertainty about economic stability. The real estate environment, including interest rates and the general economic environment, typically impacts the demand for mortgage and mortgage related products. The demand for mortgage and mortgage related products continues to be sensitive to these factors, and Federal Reserve policy or any material changes in interest rates or housing supply are expected to impact overall origination activity levels during 2026. In addition, announcements of new or increased tariffs have contributed to market volatility and could potentially influence consumer confidence and interest rate expectations, which could, in turn, affect the demand for mortgage and consumer financial products.
The Company’s operations are principally funded by available liquidity from cash, cash equivalents and investments. The Company has incurred net losses in each period since inception, and its limited operating history in an evolving industry makes it difficult to accurately forecast the impact of macroeconomic or other external factors on its business and may increase the risk that the Company may not be able to achieve or maintain profitability in the future, or otherwise suffers adverse impacts on its operational and financial results.
v3.25.4
Summary of Significant Accounting Policies
12 Months Ended
Dec. 31, 2025
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies Summary of Significant Accounting Policies
Cash and Cash Equivalents
The Company places its cash with high credit quality and federally insured institutions. Cash with any one institution may be in excess of federally insured limits. The Company has not experienced any losses in such accounts and believes the exposure to credit risk is not significant. The Company considers all highly liquid investments with an original maturity date of three months or less at the time of purchase to be cash equivalents. As of December 31, 2025 and 2024, cash and cash equivalents consisted of cash, money market accounts, and highly liquid investments with original maturities less than 90 days. The carrying amounts reported in the consolidated balance sheets for cash and cash equivalents approximate fair value due to the short-term nature of the investments.
Restricted Cash
The Company has classified cash that is not available for use in its operations as restricted cash. Restricted cash consists primarily of collateral for letters of credit related to security deposits for the Company’s office facility lease arrangements. As of December 31, 2025, the Company had no restricted cash. As of December 31, 2024, the Company had restricted cash of $5.0 million, which is presented within prepaid expenses and other current assets on the consolidated balance sheets.
Trade and Other Receivables and Credit Loss Reserves
The Company reports trade and other receivables net of the allowance for credit losses, in accordance with Accounting Standards Codification (“ASC”) 326, Financial Instruments—Credit Losses. ASC 326 requires an entity to recognize an allowance that reflects the entity’s current estimate of credit losses expected to be incurred over the life of the financial instrument. The Company’s estimate of expected credit losses is determined based on expected lifetime loss rates calculated from historical data and adjusted for the impact of current and future conditions, such as the age of outstanding receivables, historical payment patterns, any known or expected changes to the customers’ ability to fulfill their payment obligations, or assessment of broader economic conditions that may impact the customers’ ability to pay the outstanding balances. As of each of December 31, 2025 and 2024, the reserve for expected credit losses was immaterial. The provision for expected credit losses and the uncollectible portion of the receivables written off against reserve for expected credit losses were immaterial for the years ended December 31, 2025 and 2024.

Marketable Securities
Marketable securities consist primarily of U.S. treasury and agency securities, commercial paper, and corporate debt securities. The Company’s policy requires investments to be investment grade, with the primary objective of minimizing the potential risk of principal loss. The Company classifies its marketable securities as available-for-sale securities at the time of purchase and reevaluates such classification at each balance sheet date. The Company has classified its investments as current based on the nature of the investments and their availability for use in current operations.

Available-for-sale securities are carried at fair value, with the change in unrealized gains and losses reported as a separate component on the consolidated statements of comprehensive income until realized. Fair value is determined based on quoted market rates when observable or utilizing data points that are observable, such as quoted prices, interest rates and yield curves. Securities with an amortized cost basis in excess of estimated fair value are assessed to determine what amount of the excess, if any, is caused by expected credit losses. Expected credit losses on securities are recognized in other income (expense), net on the consolidated statements of operations and comprehensive income (loss), and any remaining unrealized losses are included in accumulated other comprehensive loss in stockholders' equity. For the purposes of computing realized and unrealized gains and losses, the cost of securities is based on the specific-identification method. Interest on securities classified as available for sale is included as a component of investment income within other income (expense), net. The Company does not measure an
allowance for credit losses on accrued interest receivable and recognizes interest receivable write offs as a reversal of interest income.
Property and Equipment
Property and equipment are stated at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the assets as follows:
Computer and software3 years
Expenditures for maintenance and repairs are evaluated to determine whether they are capitalizable or should be expensed as incurred. Gains or losses on disposal of property and equipment are recognized in the period when the assets are sold or disposed of and the related cost and accumulated depreciation is removed from their respective accounts.
Capitalized Internal-Use Software
The Company capitalizes certain costs incurred in the development of its platform and product offerings when (i) the preliminary project stage is completed, (ii) management has authorized further funding for the completion of the project, and (iii) it is probable that the project will be completed and the software will be used to perform the function intended. These capitalized costs include personnel and related expenses, including stock-based compensation, for employees who are directly associated with and who devote time to internal-use software projects. Capitalization of these costs ceases and amortization commences once the project is substantially complete and the software is ready for its intended purpose. Costs incurred for significant upgrades and enhancements to the existing software are capitalized, while the costs incurred for minor modifications, as well as training and maintenance are expensed as incurred. The capitalized internal-use software development costs are reported in property and equipment, net, in the consolidated balance sheets. The Company does not transfer ownership of its software, license, or lease the software to third parties. Capitalized internal-use software development costs are amortized using the straight-line method through cost of revenue over an estimated useful life of the software, as the straight-line recognition method best approximates the manner in which the expected benefit will be derived as follows:
Application
3 years
Integration
4 years
Platform
5 years
Leases
The Company measures lease liabilities based on the present value of the total lease payments not yet paid discounted based on the Company’s incremental borrowing rate, which is the estimated rate the Company would be required to pay for a collateralized borrowing equal to the total lease payments over the term of the lease. The lease liability also includes expected renewal or termination options, if the option is reasonably certain to be exercised. The Company measures right-of-use assets based on the corresponding lease liability adjusted for (i) payments made to the lessor at or before the commencement date, (ii) initial direct costs the Company incurs and (iii) tenant incentives under the lease. The Company’s leases do not provide a readily determinable implicit interest rate and the Company uses its incremental borrowing rate to measure the lease liability and corresponding right-of-use asset. The incremental borrowing rate is a fully collateralized rate that considers the Company’s credit rating, market conditions, and the term of the lease. The Company accounts for all components in a lease arrangement as a single combined lease component and begins to recognize lease expense when the lessor makes the underlying asset available to the Company. For short-term leases, the Company records rent expense in the consolidated statements of operations and comprehensive income (loss) on a straight-line basis over the lease term and records variable lease payments as incurred. The Company has no finance leases.
Impairment of Long-Lived Assets
The Company evaluates the carrying value of long-lived assets, such as property and equipment and capitalized software development costs, whenever events or changes in circumstances occur that could impact the recoverability of the asset group to which the assets relate. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the asset to the future estimated undiscounted cash flows expected to be generated by the asset. If such assets are considered to
be impaired, the impairment to be recognized is measured as the amount by which the carrying amount of the asset exceeds the fair value of the asset.
Cloud Computing Arrangements
The Company capitalizes certain implementation costs incurred during the application development stage under cloud computing arrangements that are service contracts in accordance with ASC 350-40, Internal-Use Software. The capitalized costs are presented within prepaid expenses and other current assets and other non-current assets on the consolidated balance sheets and expensed over the term of the related hosting arrangement service period.
Investment in Non-Marketable Equity Securities
Investment in non-marketable equity securities without readily determinable fair values is recorded at cost, less impairment, if any, plus or minus observable price changes in orderly transactions of an identical or similar investment of the same issuer. During the years ended December 31, 2025 and 2024, the Company recognized a $16.6 million and $4.4 million gain, respectively, as the result of the adjustments to the carrying value of the non-marketable security to reflect observable price changes. The Company determined the adjustment by measuring the security at fair value using the option pricing model (“OPM”) as of the date the observable transaction occurred. Observable transactions, such as the issuance of new equity by an investee, are indicators of investee enterprise value and are used to estimate the fair value of the Company’s investment in the equity security. An OPM is utilized to allocate value to the various classes of securities of the investee, including classes owned by the Company. Such information, available to the Company from the investee entity, is supplemented with the Company’s estimates such as volatility, expected time to liquidity and the rights and obligations of the securities the Company holds. The inputs to valuation techniques used to measure fair value of the Company’s non-marketable equity security are classified as Level 3 of the fair value hierarchy due to the use of significant unobservable inputs. Refer to Note 5, Significant Balance Sheet Components, for further information.

At each reporting date, the Company performs a qualitative assessment to evaluate the investment for impairment. If the qualitative assessment indicates that the investment is impaired and the fair value of the investment is less than its carrying value, the carrying amount of the investment is reduced to its fair value. Any adjustments to carrying value based on observable price changes and impairment charges are recorded in other income (expense), net on the consolidated statements of operations and comprehensive income (loss) and the investment is presented within other non-current assets on the consolidated balance sheets.
Investment in Notes Receivable
Investment in notes receivable represents an investment in a privately-held company via convertible promissory notes that are accounted for under ASC 310, Receivables, at cost basis, less impairment. At each reporting date, the Company evaluates the collectability of the notes receivable in accordance with ASC 326, Financial Instruments—Credit Losses. The notes receivable are presented within other non-current assets on the consolidated balance sheets. Refer to Note 5, Significant Balance Sheet Components, for further information.
Equity Method Investments
Investments and ownership interests are accounted for under equity method accounting if the Company has the ability to exercise significant influence, but does not have a controlling financial interest. Significant influence generally exists when an investor owns 20% or more of the voting stock of an incorporated investee or a more than 3% to 5% interest in an unincorporated investee. Equity method investments are measured at cost minus impairment, if any, plus or minus the Company’s share of equity method investee income or loss, additional investments in the entity, and distributions. The Company’s proportionate share of the income or loss from equity method investments is typically recognized on a one-quarter lag in the Consolidated Statements of Operations due to investee reporting cycle timing. The Company assesses its investment for other-than-temporary impairment when events or changes in circumstances indicate that the carrying amount of the investment might not be recoverable and recognizes an impairment loss to adjust the investment to its then-current fair value.
Noncontrolling Interest - Held for Sale from Discontinued Operations
The Company’s 90.1% ownership of Title365 resulted in recognition of a 9.9% noncontrolling interest, which represented the minority stockholder’s share of the net income and equity in Title365. The Title365 stockholders agreement included a provision whereby the Company had a call option to purchase the 9.9% noncontrolling interest at a purchase price equal to the greater of (1) $49.5 million plus an amount of interest calculated using an interest rate of 5.0% per annum compounding annually; or (2) 4.4 multiplied by the trailing 12-month EBITDA multiplied by the noncontrolling interest ownership percentage (the “Title365 Call Option”). The Title365 Call Option became exercisable on June 30, 2023. The noncontrolling interest holder also held an option to compel the Company to purchase the remaining 9.9% noncontrolling interest at a price calculated in the same manner as the Title365 Call Option (the “Title365 Put Option”). The Title365 Put Option was exercisable beginning 5 years following the acquisition closing date. Neither the Title365 Call Option nor the Title365 Put Option had an expiration date. However, pursuant to the Title365 stockholders agreement, the Company also had certain bring-along rights that it could exercise under certain circumstances, which may have resulted in the Title365 Put Option being extinguished. As the Title365 Put Option was not solely within the Company’s control, the Company classified this interest as redeemable noncontrolling interest (“RNCI”) within the mezzanine equity section of the consolidated balance sheets. The RNCI was accreted to the redemption value under the interest method from the acquisition date through the date the Title365 Put Option became exercisable. At each balance sheet date, the RNCI was reported at the greater of the initial carrying amount adjusted for the RNCI's share of earnings or losses and other comprehensive income or loss, or its accreted redemption value. The changes in the redemption amount were recorded with corresponding adjustments against retained earnings or, in the absence of retained earnings, additional paid-in-capital. For each reporting period, the entire periodic change in the redemption amount was reflected in the computation of net income (loss) per share under the two-class method as being akin to a dividend.

On February 26, 2025, the Company entered into a multi-contract arrangement (the “Arrangement”) with the holder of the 9.9% noncontrolling interest in Title365 (the “Counterparty”), pursuant to which such holder assigned its 9.9% noncontrolling interest to Title365, and terminated the Title365 stockholders agreement with the Company. The transaction resulted in the termination of the Company’s obligations associated with the Title365 Put Option, which had a redemption amount, as if it was then-currently redeemable, of $59.2 million and $58.7 million as of February 26, 2025 and December 31, 2024, respectively. In return, the Company terminated its non-compete and non-solicit agreement with the Counterparty, allowing the Counterparty to pursue business opportunities relating to the title insurance industry. Furthermore, in conjunction with the Arrangement, the Company and the Counterparty executed an amendment to an existing revenue subscription arrangement, whereby the Counterparty committed to a certain minimum amount of consideration for access to the Company’s platform, updated pricing, and an extension of the existing arrangement’s contractual term.

The termination of the Company’s obligations associated with the Put Option resulted in a reclassification of $53.5 million from redeemable noncontrolling interest to $52.7 million of additional paid-in capital. The remaining $0.8 million represents the non-cash consideration in the Arrangement related to the assignment of the noncontrolling interest to Title365, which was recorded as deferred revenue to be recognized over the term subscription arrangement.
Series A Preferred Stock
On April 29, 2024, the Company entered into an Investment Agreement (the “Investment Agreement”) with Haveli and issued 150,000 shares of the Company’s Series A Preferred Stock. The Series A Preferred Stock is classified as mezzanine equity due to the redemption features that are not solely within the Company’s control. The Series A Preferred Stock is accreted to its maximum redemption value over the seven year term, using the effective interest method. The increases in the redemption amount are recorded with corresponding adjustments against additional paid-in capital, in the absence of retained earnings. For each reporting period, the entire periodic change in the redemption amount is reflected in the computation of net loss per share under the two-class method as being akin to a dividend, by reducing the income (or increasing the loss) attributable to common stockholders. The Series A Preferred Stock is a participating security for purposes of applying the two-class method when calculating earnings per share in periods of net income. Refer to Note 14, Net Loss per Share, for further information.
Debt and Debt Issuance Costs
The carrying value of the Company’s term loan is presented net of debt issuance costs and discount relating to the issuance of preferred stock warrant. These costs are amortized as a non-cash component of interest expense using the effective interest method over the term of the loan. Unamortized debt issuance costs that exist upon the extinguishment of debt are expensed proportionally to the amount of debt extinguished and the resulting loss on extinguishment is presented within other income (expense), net on the consolidated statement of operations and comprehensive income (loss). On April 29, 2024, in connection with the issuance of the Series A Preferred Stock, the Company paid approximately $146.1 million to repay all amounts outstanding and payable under the Credit Agreement, including the exit fee of $4.5 million, and terminated the Credit Agreement. Refer to Note 8, Debt, for further information.
Segment Information
The Company’s operating segments are defined in a manner consistent with how the Company manages its operations and how the CODM evaluates the results and allocates the Company’s resources.

During the first quarter of 2025, the Company classified the results of its previously reported Title segment as discontinued operations in its consolidated statement of operations. Refer to Note 16, Assets Held for Sale and Discontinued Operations, for additional details. As a result, the Company now operates in a single operating segment and a single reportable segment. This segment reporting change reflects a corresponding change in how the CODM reviews financial information in order to allocate resources and assess performance. The comparative prior period amounts have been reclassified to conform to current period presentation.
Consolidated Variable Interest Entity
The Company determines, at the inception of each arrangement, whether an entity in which it has made an investment or in which it has other variable interest is considered a VIE. The Company consolidates a VIE when it is deemed to be the primary beneficiary. The primary beneficiary of a VIE is the party that meets both of the following criteria: (i) has the power to direct the activities that most significantly affect the economic performance of the VIE; and (ii) has the obligation to absorb losses or the right to receive benefits that in either case could potentially be significant to the VIE. Periodically, the Company determines whether any changes in its interest or relationship with the entity impact the determination of whether the entity is still a VIE and, if so, whether the Company is the primary beneficiary. If the Company is not deemed to be the primary beneficiary of a VIE, the Company accounts for the investment or other variable interest in a VIE in accordance with applicable U.S. GAAP.
The Company has variable interest in an entity that provides certain back office support services to the Company using a cost-plus pricing model. As of December 31, 2025, the Company’s consolidated financial statements include a right-of-use asset and a corresponding lease liability, in the amount of $1.6 million and $1.5 million respectively, related to an office lease held by a VIE.

Share repurchases
All repurchased shares under the share repurchase program are retired. The retired shares are equivalent to authorized, unissued shares and are no longer considered to be outstanding or held in treasury. The excess purchase price over par value for share repurchases is recorded to additional paid-in-capital.
Assets Held for Sale and Discontinued Operations
The Company classifies assets and liabilities as held for sale (“disposal group”) when management, having the authority to approve the action, commits to a plan to sell the disposal group, the sale is probable to be completed within one year, and the disposal group is available for immediate sale in its present condition. The Company also considers whether an active program to locate a buyer has been initiated, whether the disposal group is marketed actively for sale at a price that is reasonable in relation to its current fair value, and whether actions required to complete the plan indicate that it is unlikely that significant changes to the plan will be made or that the plan will be withdrawn. The Company measures a disposal group that is classified as held for sale at the lower of its carrying amount or fair value less costs to sell. With the exception of the full impairment of the intangible assets in the amount of $2.0 million, as disclosed in Note 16, Assets Held for Sale and Discontinued Operations, there was no loss recognized related to the disposal group for the year ended December 31, 2025. Gains are not recognized until the date of sale. Assets are not depreciated or amortized while they are classified as held for sale. Upon determining that a disposal group meets the criteria to be classified as held for sale, the Company reports the assets and liabilities of the disposal group as assets held for sale and liabilities held for sale in its consolidated balance sheets.

If the disposition of a component, being an operating or reportable segment, business unit, subsidiary or asset group, represents a strategic shift that has or will have a major effect on the Company’s operations and financial results, the operating profits or losses of the component when classified as held for sale, and the gain or loss upon disposition of the component, are presented as discontinued operations in the consolidated statements of operations. As of December 31, 2025, the operations of the Company’s Title segment met the criteria to be classified as held for sale and presented as discontinued operations. Refer to Note 16, Assets Held for Sale and Discontinued Operations, for additional information.
Revenue Recognition
Overview
The Company recognizes revenue in accordance with ASC 606, Revenue from Contracts with Customers, which requires the Company to recognize revenue upon transfer of control of promised products and services to customers in an amount that reflects the consideration the Company expects to receive in exchange for those products or services. If consideration promised in a contract includes a variable amount, for example, overage fees, credits, price concessions or incentives, the Company includes an estimate of the amount it expects to receive only to the extent that it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved.

The Company determines the amount of revenue to be recognized through the application of the following five-step model:
Identification of the contract, or contracts, with a customer — A contract with a customer exists when (i) the Company enters into an enforceable contract with a customer that defines each party’s rights regarding the services to be transferred and identifies the payment terms related to these services, (ii) the contract has commercial substance, and (iii) it is determined that collection of substantially all consideration for services that are transferred is probable based on the customer’s intent and ability to pay the promised consideration when it is due.
Identification of the performance obligations in the contract — Performance obligations promised in a contract are identified based on the services that will be transferred to the customer that are both capable of being distinct, whereby the customer can benefit from the services either on their own or together with other resources that are readily available from third parties or from the Company, and are distinct within the context of the contract, whereby the transfer of the services is separately identifiable from the other promises in the contract. To the extent that a contract includes multiple promised services, the Company applies judgment to determine whether promised services are capable of being distinct and distinct within the context of the contract. If these criteria are not met, the promised services are accounted for as a combined performance obligation. The Company has concluded that promised services included in its contracts with multiple performance obligations are distinct.
Determination of the transaction price — The transaction price is determined based on the consideration to which the Company expects to be entitled in exchange for transferring services to the customer. The Company estimates and includes variable consideration in the transaction price at contract inception to the extent it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved. In estimating variable consideration in subscription arrangements, the Company considers historical experience and other external factors that may impact the expectation
of future completed transactions beyond a customer’s contracted minimum number of completed transactions. At each reporting period, the Company assesses the expected overage fees, if any, that will be earned for the duration of the contract term. Revenue is presented net of any taxes collected from customers and remitted to governmental authorities.
Allocation of the transaction price to the performance obligations in the contract — The Company allocates the transaction price to each performance obligation on a relative standalone selling price (“SSP”) basis. The SSP is the price at which the Company would sell a promised service separately to a customer. In instances where the Company does not sell or price a service separately, the Company estimates the SSP by considering available information such as market conditions, internally approved pricing guidelines, and the underlying cost of delivering the performance obligation. Judgment is required to determine the SSP for each distinct performance obligation.
Recognition of revenue when the performance obligation is satisfied — For each performance obligation identified, the Company determines at contract inception whether it satisfies the performance obligation over time or at a point in time.

The Company delivers its cloud-based software platform as a service. The Company’s arrangements do not provide the customers with a contractual right to take possession of the Company’s cloud-based software products at any point in time.

In 2023, the Company introduced a consumption-based pricing model for mortgage-related and consumer banking products to better meet the needs of its customers. With the consumption-based pricing model, customers typically enter into one to three year arrangements (“consumption-based arrangements”) that include a fixed annual commitment, which represents a portion of a customer’s expected annual usage that is consumed at specified prices for each product. Under consumption-based arrangements, the Company typically bills its customers quarterly, semi-annually, or annually in advance of their consumption. To the extent customers consume completed transactions in excess of the pre-purchased amount, they are charged for their incremental usage billed as overages monthly in arrears. Consumption-based arrangements typically permit customers to rollover any unused amount to the subsequent renewal year, generally on the commitment to pre-purchase additional consumption. Therefore, under consumption-based arrangements, the nature of the Company’s promise to customers is to provide a specified quantity of services. Consumption-based arrangements are generally non-cancelable during the contract term.

The Company also offers usage-based arrangements, in which customers pay a variable amount for completed transactions at specified prices. Under the usage-based arrangements, the Company bills its customers for completed transactions monthly in arrears. The Company recognizes revenue under these arrangements as customers consume completed transactions, such as a funded loan, new account opening, or closing transaction. Completed transaction fees for mortgage-related and consumer banking products, including ancillary products (e.g., income verification and close products), are determined by the number and type of software platform components that are needed to support each product offering. Usage-based arrangements generally can be terminated at any time by the customer.

The Company continues to recognize revenue generated from subscription arrangements where customers pay fees for the ability to access the Company’s platform. Under subscription-based arrangements, customers commit to a minimum number of completed transactions at specified prices over the contract term. For subscription-based arrangements, the Company estimates variable consideration, which takes into account historical experience and other external factors that may impact the expectation of future completed transactions beyond a customer’s contracted minimum number of completed transactions. At each reporting period, the Company assesses the expected overage fees, if any, that will be earned for the duration of the contract term. Subscription arrangements are generally non-cancelable during the contract term and do not provide the contractual right to take possession of the software at any point in time. The Company begins recognizing revenue when access to the platform is provisioned to customers for an amount that reflects the consideration the Company expects to be entitled to in exchange for those services. Access to the platform represents a series of distinct services as the Company continually provides access to the platform, fulfills its obligation to the customer over the non-cancelable contractual term, and the customer receives and consumes the benefit of the platform throughout the contract period. The series of distinct services represents a single performance obligation that is satisfied over time. Under its subscription arrangements, the Company typically bills customers for any committed amounts quarterly, semi-annually or annually in advance and for overages beyond a customer’s contracted minimum number of completed transactions on a monthly or quarterly basis in arrears. The Company recognizes fees for subscription arrangements ratably over the non-cancelable contract term of the arrangement as subscription services are provided.
Certain customer contracts also include access to Blend Builder, which provides customers with a set of low-code, drag-and-drop design tools, modular components and integrations to allow them to create and deploy their own new product offerings. The Company typically invoices customers annually in advance for access to Blend Builder and recognizes revenue allocated to Blend Builder ratably over the contract term.

Certain customer contracts include access to third-party services offered through the Company’s marketplace partner ecosystem and integrated into the Company’s platform. For these partner-provided services, the Company evaluates whether it is the principal or the agent in the arrangement and presents revenue on a gross basis when the Company controls the specified service before it is transferred to the customer, or on a net basis when the Company’s performance obligation is to arrange for the specified service to be provided by the marketplace partner. In making this determination, the Company considers whether it is primarily responsible for fulfillment of the specified service and whether it has discretion in establishing the price charged to the customer, among other factors.

The Company also generates revenue from marketplace partners through arrangements under which partners pay a combination of fixed and variable fees for access to the Company’s platform and distribution capabilities. Variable fees are typically received in arrears and fixed fees are typically billed in advance. Revenue is generally recognized ratably over the term of the arrangement.

The Company also recognized revenue, to a lesser extent, from professional services and premier support. Professional services revenue consists of fees for services related to helping customers deploy, configure, and optimize the use of the Company’s technology. These services include consulting, project management, system integration, data migration, process enhancement, and training. Professional services contracts are priced either on a fixed price basis and billed in full at the beginning of the contract term or on a time-and-materials basis and billed monthly in arrears. Professional services revenues for contracts on a fixed price basis are recognized on a proportional performance basis, which measures the service hours performed to date relative to the total expected hours to completion. Professional services revenues for contracts on a time-and-materials basis are recognized as services are delivered.

Premier support revenue consists of fees for various services provided as part of a support package, such as email and chat support, unlimited quantity of service requests, developer assist API support, VIP support escalation line, phone/web conference support, and advanced configuration support. Premier support contracts are typically billed annually in advance and recognized ratably over time as a stand-ready performance obligation.
Contract assets
The Company records a contract asset when revenue recognized on its subscription arrangements and professional services contracts exceeds billable amounts under the contract. Contract assets are included in prepaid expenses and other current assets in the Company’s consolidated balance sheets.
Deferred Revenue
Deferred revenue represents billings or payments received in advance of revenue recognition. Balances consist primarily of amounts prepaid under subscription and consumption-based arrangements and professional services not yet provided as of the balance sheet dates. Amounts that will be recognized during the succeeding 12-month period are recorded as deferred revenue, current, and the remaining portion, if any, is recorded as deferred revenue, non-current. Payment terms and conditions vary by contract type, although terms generally include a requirement of payment within 30 to 60 days. In instances where the timing of revenue recognition differs from the timing of invoicing, the Company has determined its contracts do not include a significant financing component. The primary purpose of the Company’s invoicing terms is to provide customers with simplified and predictable ways of purchasing its services, not to receive financing from its customers or to provide customers with financing.
Deferred Contract Costs
The Company capitalizes incremental and recoverable costs of obtaining contracts with customers as deferred contract costs, which consist of sales commissions paid to the Company’s sales force. The Company applies the practical expedient to expense sales commissions as incurred when the amortization period is one year or less.
Sales commissions paid to obtain renewal contracts are not considered commensurate with commissions paid for new contracts. Therefore, deferred contract costs are amortized on a straight-line basis over an estimated period of benefit of five years, which includes subsequent renewal periods. The Company determined the period of benefit by taking into consideration customer attrition and estimated technology life cycles. Amortization expense is included in sales and marketing expenses in the consolidated statements of operations and comprehensive income (loss).

The Company evaluates the period of benefit for its new revenue contracts on an annual basis, and reviews deferred contract costs for impairment as of each balance sheet date or whenever events or changes in circumstances indicate that the carrying amount may not be recoverable.
Cost of Revenue
Software-related costs of subscribed hosting, support, and costs of delivering professional services are expensed as incurred. Costs of subscribed hosting and support are comprised of third-party web hosting costs and software licenses, customer support, and other customer related activities. Costs of professional services consist primarily of personnel and related direct costs, including employee salaries, payroll taxes, business expenses (e.g., employee travel and lodging expenses for customer projects), as well as allocated overhead. Amortization of capitalized internal-use software development costs is also included within cost of revenue.
Advertising Costs
Advertising costs are expensed as incurred. The Company recorded $3.5 million, $1.8 million and $3.9 million in advertising expense for the years ended December 31, 2025, 2024 and 2023, respectively, as part of sales and marketing expenses in the consolidated statements of operations and comprehensive income (loss).
Research and Development Costs
Research and development costs within the consolidated statements of operations and comprehensive income (loss) are comprised of personnel costs, including stock-based compensation expense, associated with the Company’s product and engineering personnel responsible for the design, development, and testing of the product, depreciation of equipment used in research and development and allocated facilities and information technology costs. Research and development costs are expensed as incurred.
Stock-Based Compensation
The Company measures and recognizes its stock-based compensation in accordance with ASC 718, Stock Compensation, which requires compensation cost for the grant-date fair value of stock-based awards to be recognized over the requisite service period.

The Company primarily grants RSUs and has historically granted stock option awards to its employees that vest upon the satisfaction of a service condition. The requisite service period of the stock awards is generally the vesting period. The Company accounts for forfeitures as they occur.

Certain stock options granted to the Company’s Co-Founder and Head of Blend vest upon the satisfaction of a service condition, liquidity event-related performance condition, and performance-based market conditions. In July 2021, the first tranche of the Co-Founder and Head of Blend stock option award vested upon completion of the IPO. The remaining tranches of shares will vest dependent on performance goals tied to the Company’s stock price hurdles with specified expiration dates for each tranche.

The Company also grants restricted stock units with performance vesting conditions (“PSUs”) to certain senior executives. The PSUs will vest in four tranches upon continued service and satisfaction of certain market-based performance targets related to the Company’s stock price hurdles. The Company estimates the grant date fair value and the requisite service period of the PSUs using a Monte Carlo simulation model.
Income Taxes
The Company accounts for income taxes using an asset and liability approach. Under this method, the Company recognizes deferred income tax assets and liabilities for the expected future tax consequences of temporary differences between the tax basis of an asset or liability and its reported amount in the consolidated financial statements, as well as from net operating loss and tax credit carryforwards. Deferred tax amounts are measured using enacted statutory tax rates in effect for the year in which the differences are expected to reverse. A valuation allowance is provided against deferred tax assets that, based on all available positive and negative evidence, are not expected to be realized. Such evidence includes, but is not limited to, recent cumulative earnings or losses, expectations of future taxable income by taxing jurisdiction, the anticipated reversal or expiration dates of the deferred tax assets and tax planning strategies.

The Company recognizes tax benefits from uncertain tax positions only if it believes that it is more likely than not that the tax position will be sustained on examination by the taxing authorities based on the technical merits of the position. The benefits recognized in the consolidated financial statements from such positions are then measured based on the largest benefit that has a greater than a 50% likelihood of being sustained.
Restructuring Charges
The restructuring charges consist primarily of cash expenditures for compensation and severance payments, employee benefits, payroll taxes and related facilitation costs associated with the Company’s workforce reduction plans, as well as facilities restructuring costs. Employee termination benefits are recognized as a liability at estimated fair value, at the time of communication to employees, unless future service is required, in which case the costs are recognized ratably over the future service period. Ongoing termination benefits are recognized as a liability at estimated fair value when the amount of such benefits is probable and reasonably estimable. Charges related to facilities restructuring actions are comprised of costs related to early termination of the lease agreement and impairment of the right-of-use asset in connection with the abandonment of the property incurred in the year ended December 31, 2024.
Other Income (Expense), Net
Other income (expense), net for the year ended December 31, 2025 consists primarily of $16.6 million gain on investment on non-marketable equity securities due to an observable price change as well as income earned from the Company’s investment portfolio of $3.7 million.

Other income (expense), net for the year ended December 31, 2024 consists primarily of $9.2 million gain on sale of insurance business in connection with the strategic partnership, a $4.4 million gain on investment on non-marketable equity securities due to an observable price change, income earned from the Company’s investment portfolio of $5.4 million, offset by a $5.5 million loss on extinguishment of debt and a $0.6 million loss on transfer of the subsidiary in India.

Other income (expense), net for the year ended December 31, 2023 consists primarily of income earned from the Company’s investment portfolio of $11.4 million, offset by a loss on the partial extinguishment of debt of $4.0 million.
Employee Benefit Plan
The Company maintains a 401(k) plan that covers all eligible employees in the United States. Employer matching contributions are discretionary. The Company, at its discretion, may match a percentage of the employee contributions. The Company recognized a contribution expense of $1.4 million, $1.6 million and $2.6 million for the years ended December 31, 2025, 2024 and 2023, respectively.
Concentrations of Credit Risk and Significant Customers
Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, restricted cash, marketable securities, trade accounts receivable, and notes receivable. The Company maintains its cash equivalents primarily in money market funds and highly liquid investments that are issued or guaranteed by the United States government or its agencies. As of December 31, 2025 and 2024, cash and cash equivalents amounted to $43.6 million and $38.0 million, respectively, and included $2.0 million and $2.2 million, respectively, of cash held in a foreign jurisdiction. Collateral is not required for trade accounts receivable.
The following customers comprised 10% or more of the Company’s revenue for the following periods:

Year Ended December 31,
Customer
202520242023
A14%10%6%

The following customers comprised 10% or more of the Company’s trade and unbilled receivables:
Customer
December 31, 2025December 31, 2024
B11%8%
C1%11%
Fair Value Measurement
The Company measures its cash and cash equivalents, marketable securities, trade and other receivables, accounts payable, and other current liabilities at fair value on a recurring basis. In addition, the Company measures certain other assets, including intangible assets and investments in equity securities without readily determinable fair values, at fair value on a nonrecurring basis.

The Company reports its investments in cash equivalents and marketable securities at fair value on the consolidated balance sheets based upon the level of judgment associated with inputs used to measure their fair value. The categories are as follows:

Level 1—Observable inputs are unadjusted quoted prices in active markets for identical assets or liabilities.

Level 2—Observable inputs are quoted prices for similar assets and liabilities in active markets or inputs other than quoted prices which are observable for the assets or liabilities, either directly or indirectly through market corroboration, for substantially the full term of the financial instruments.

Level 3—Unobservable inputs which are supported by little or no market activity and which are significant to the fair value of the assets or liabilities. These inputs are based on the Company’s assumptions used to measure assets and liabilities at fair value and require significant management judgment or estimation.
The estimated fair value of trade and other receivables, accounts payable, and other current liabilities approximate their respective carrying values due to their short term nature.
JOBS Act Accounting Election
As an emerging growth company (“EGC”), the Jumpstart Our Business Startups Act (“JOBS Act”) allows the Company to delay adoption of new or revised accounting pronouncements applicable to public companies until such pronouncements are applicable to private companies (that is, those that have not had a Securities Act of 1933, as amended (the “Securities Act”), registration statement declared effective or do not have a class of securities registered under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)). The Company intends to use this extended transition period under the JOBS Act until such time as the Company is no longer considered to be an EGC. The adoption dates discussed below reflect this election.

Recently Adopted Accounting Standards
In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740) - Improvements to Income Tax Disclosures. This update improves the transparency of income tax disclosures by requiring (1) consistent categories and greater disaggregation of information in the rate reconciliation and (2) income taxes paid disaggregated by jurisdiction. The Company adopted this ASU on a prospective basis effective January 1, 2025. Refer to Note 13, Income Taxes, for the expanded disclosures required under this ASU. The adoption of this pronouncement did not have a material impact on the Company’s consolidated financial statements.
In July 2025, the FASB issued ASU No.2025-05, Financial Instruments-Credit Losses (Topic 326). This update affects the practical expedient when estimating expected credit losses on current accounts receivables and current contract assets arising from transactions under Topic 606. The guidance is effective for the Company for annual reporting periods beginning after December 15, 2025 and interim reporting periods within those annual reporting periods. The early adoption of this pronouncement did not have a material impact on the Company’s consolidated financial statements.
Recently Issued Accounting Standards Not Yet Adopted
In November 2024, the FASB issued ASU No. 2024-03, Disaggregation of Income Statement Expenses. This update improves the disclosures about a public entity’s expenses, primarily through additional disclosures of specific information about certain costs and expenses in the notes to financial statements. The guidance is effective for the Company for annual reporting periods beginning after December 15, 2026 and interim reporting periods beginning after December 15, 2027. The requirements will be applied prospectively with the option for retrospective application. Early adoption is permitted. The Company is currently evaluating the impact this ASU will have on its consolidated financial statements.

In September 2025, the FASB issued ASU No. 2025-06, Intangibles—Goodwill and Other-Internal-Use Software (Subtopic 350-40). This update removes all references to prescriptive and sequential software development stages throughout Subtopic 350-40. The guidance is effective for the Company for annual reporting periods beginning after December 15, 2027 and interim reporting periods within those annual reporting periods. Early adoption is permitted. The Company intends to early adopt this ASU as of January 1, 2026 using prospective transition method. The Company expects that the adoption of ASU 2025-06 will result in a decrease in the amount of software costs eligible for capitalization as certain agile development activities may not meet the 'probable-to-complete' threshold as early as they did under the legacy stage-based model, particularly for projects involving novel technology.

In November 2025, the FASB issued ASU No. 2025-11, Interim Reporting (Topic 270): Narrow-Scope Improvements. This amendment results in a comprehensive list of interim disclosures that are required by GAAP, which includes a disclosure principle that requires entities to disclose events since the end of the last annual reporting period that have a material impact on the entity. The guidance is effective for interim reporting periods within annual reporting periods beginning after December 15, 2027, for public business entities and for interim reporting periods within annual reporting periods beginning after December 15, 2028, for entities other than public business entities. Early adoption is permitted for all entities. The Company is currently evaluating the impact this ASU will have on its consolidated financial statements.
v3.25.4
Revenue Recognition and Contract Costs
12 Months Ended
Dec. 31, 2025
Revenue from Contract with Customer [Abstract]  
Revenue Recognition and Contract Costs Revenue Recognition and Contract Costs
Disaggregation of Revenue
The following table provides information about disaggregated revenue by service offering:

Year Ended December 31,
202520242023
(In thousands)
Blend Platform:
Mortgage Suite$69,223 $73,257 $77,574 
Consumer Banking Suite45,223 33,657 23,630 
Total software platform114,446 106,914 101,204 
Professional services9,139 8,848 8,345 
Total revenue$123,585 $115,762 $109,549 
Contract Balances
The following table provides information about contract assets and contract liabilities from contracts with customers:
Contract Accounts
Balance Sheet Line Reference
December 31, 2025December 31, 2024
(In thousands)
Contract assets—currentPrepaid expenses and other current assets$5,266 $2,539 
Contract liabilities—currentDeferred revenue, current$(19,385)$(19,240)
There were no long-term contract assets or deferred revenue as of December 31, 2025 and December 31, 2024.

During the years ended December 31, 2025 and 2024, the Company recognized $15.4 million and $7.3 million, respectively, of revenue that was included in the deferred revenue balance at the beginning of each respective period.

During the years ended December 31, 2025 and 2024, the Company recognized revenue of approximately $0.5 million and $0.3 million, respectively, related to performance obligations satisfied in previous periods. The revenue recognized from performance obligations satisfied in the prior periods primarily related to changes in the transaction price, including changes in the estimate of variable consideration.
Remaining Performance Obligations
As of December 31, 2025, the aggregate amount of the transaction price allocated to the remaining performance obligations was $189.4 million. These remaining performance obligations represent commitments in customer contracts for services expected to be provided in the future that have not been recognized as revenue. The expected timing of revenue recognition for these commitments is largely driven by the Company’s ability to deliver in accordance with relevant contract terms and when the Company’s customers utilize services, which could affect the Company’s estimate of when the Company expects to recognize revenue for these remaining performance obligations. The Company expects to recognize approximately half of the remaining performance obligations as revenue over the next 12 months. The Company expects the majority of non-current remaining performance obligations to be recognized over the next 13 to 24 months.
Deferred Contract Costs
As of December 31, 2025 and 2024, total unamortized deferred contract costs were $5.2 million and $4.2 million, respectively, of which $1.8 million and $1.3 million was recorded within prepaid expenses and other current assets and $3.4 million and $2.9 million was recorded within deferred contract costs, non-current, on the consolidated balance sheets.

The amortization of deferred contract costs was $1.6 million, $1.1 million and $3.0 million for the years ended December 31, 2025, 2024 and 2023, respectively, and is included in sales and marketing expense in the accompanying consolidated statements of operations and comprehensive income (loss).
Strategic Partnership and Sale of Insurance Business
On September 30, 2024, the Company entered into a multi-element transaction with Covered Insurance Solutions which included a strategic partnership agreement as well as the sale of the Company’s insurance business. As part of the strategic partnership agreement, the Company granted a five-year term license allowing Covered Insurance Solutions to integrate its insurance solutions into the Company’s platform for an annual fixed fee plus variable charges. The Company has determined the term license is a performance obligation under ASC 606, Revenue from Contracts with Customers.
v3.25.4
Investments and Fair Value Measurements
12 Months Ended
Dec. 31, 2025
Investments, Debt and Equity Securities [Abstract]  
Investments and Fair Value Measurements Investments and Fair Value Measurements
The carrying amount, unrealized gain and loss, and fair value of investments by major security type were as follows:
December 31, 2025
Amortized
Cost
Gross
Unrealized Gain
Fair Value
Fair Value Hierarchy
(In thousands)
Cash equivalents:  
Money market funds$29,639 $— $29,639 Level 1
Total cash equivalents29,639 — 29,639 
Marketable securities:
U.S. treasury and agency securities24,655 84 24,739 Level 2
Total marketable securities
24,655 84 24,739 
Total$54,294 $84 $54,378 

December 31, 2024
Amortized
Cost
Gross
Unrealized Gain
Fair Value
Fair Value Hierarchy
(In thousands)
Cash equivalents: 
 
 
Money market funds$7,112 $— $7,112 Level 1
Commercial paper19,162 — 19,162 Level 2
Total cash equivalents26,274 — 26,274 
Marketable securities:
U.S. treasury and agency securities31,160 92 31,252 Level 2
Commercial paper12,244 — 12,244 Level 2
Debt securities12,643 94 12,737 Level 2
Total marketable securities56,047 186 56,233 
Restricted cash, current:
Money market funds5,023 — 5,023 
Level 1
Total$87,344 $186 $87,530 

Restricted cash that is not available for use in operations consisted of $5.0 million collateral for standby letters of credit related to the Company’s office lease facilities as of December 31, 2024.

Marketable securities consist primarily of U.S. treasury and agency securities, commercial paper, and corporate debt securities. The Company classifies its marketable securities as available-for-sale securities at the time of purchase and reevaluates such classification at each balance sheet date. The Company has classified its investments as current based on the nature of the investments and their availability for use in current operations.

The fair value of the Company’s investments in money market funds classified as Level 1 of the fair value hierarchy is based on real-time quotes for transactions in active exchange markets involving identical assets. The fair value of the Company’s investments in commercial paper and marketable securities classified as Level 2 of the fair value hierarchy is based on quoted market prices for similar instruments.

The following table summarizes the stated maturities of the Company’s marketable securities and other investments:
December 31, 2025December 31, 2024
(In thousands)
Amortized
Cost
Fair Value
Amortized
Cost
Fair Value
Due within one year$10,446 $10,470 $35,422 $35,477 
Due after one year through two years14,209 14,269 20,625 20,756 
Total marketable securities and other investments
$24,655 $24,739 $56,047 $56,233 
The Company evaluates marketable securities in unrealized loss positions to determine whether the impairment is due to credit-related factors or other factors. The Company considers the extent to which the fair value is less than cost, the financial condition and near-term prospects of the security issuer, and the intent and ability of the Company to retain its investment in the security for a period of time sufficient to allow for any anticipated recovery in fair value.

The Company does not have an intent to sell any of these securities prior to maturity and believes that it is more likely than not that the Company will not have to sell any such securities before a recovery of cost. The fair value is expected to recover as the securities approach their maturity date. Accordingly, the Company believes that generally the unrealized losses are due to noncredit-related factors, including changes in interest rates and other market conditions, and therefore no impairment charges or allowance for credit losses have been recognized in the Company’s consolidated statements of operations for the years ended December 31, 2025 and 2024. As of December 31, 2025 and 2024, the Company had no securities in an unrealized loss position, nor any securities in a continuous unrealized loss position for twelve months or greater. The Company determines realized gains or losses on the sale of marketable securities based on a specific identification method.

The Company recognized interest income from its investment portfolio of $3.7 million, $5.3 million and $11.4 million for the years ended December 31, 2025, 2024 and 2023, respectively. Accrued interest receivable related to marketable securities is $0.3 million and $0.4 million, as of December 31, 2025 and 2024, respectively, and is presented within prepaid expenses and other current assets on the consolidated balance sheets. The Company does not measure an allowance for credit losses on accrued interest receivable and recognizes interest receivable write offs as a reversal of interest income. No accrued interest was written off during the years ended December 31, 2025, 2024 and 2023.
v3.25.4
Significant Balance Sheet Components
12 Months Ended
Dec. 31, 2025
Supplemental Balance Sheet Information [Abstract]  
Significant Balance Sheet Components Significant Balance Sheet Components
Prepaid Expenses and Other Current Assets
Prepaid expenses and other current assets consisted of the following:
December 31, 2025December 31, 2024
(In thousands)
Contract assets$5,266 $2,539 
Deferred contract costs1,812 1,277 
Prepaid software3,985 2,831 
Prepaid insurance1,289 1,291 
Prepaid other1,574 2,229 
Restricted cash
— 5,023 
Other current assets1,195 1,535 
Total prepaid expenses and other current assets$15,121 $16,725 
Property and Equipment, Net
Property and equipment, net, consisted of the following:
December 31, 2025December 31, 2024
(In thousands)
Computer and software$1,367 $783 
Capitalized internal-use software26,059 12,041 
Total property and equipment, gross27,426 12,824 
Accumulated depreciation and amortization(4,429)(1,152)
Total property and equipment, net$22,997 $11,672 
Depreciation expense for the years ended December 31, 2025, 2024 and 2023 was $0.2 million, $0.8 million and $1.5 million, respectively.

Amortization of capitalized internal use software development costs for years ended December 31, 2025 and 2024 was $3.1 million and $0.5 million, respectively. There was no amortization of capitalized internal use software development costs for the year ended December 31, 2023.

Impairment of capitalized internal use software was immaterial for the year ended December 31, 2025. There was no impairment for the years ended December 31, 2024 and 2023.
Other Non-Current Assets
Other non-current assets consisted of the following:
December 31, 2025December 31, 2024
(In thousands)
Investments in non-marketable equity securities
$30,380 $9,801 
Notes receivable
— 10,500 
Equity method investment9,692 — 
Other non-current assets
1,353 1,605 
Total non-current assets
$41,425 $21,906 
Investments in Non-Marketable Equity Securities
The Company holds 103,611 shares of Series Growth 1a Preferred Stock received in exchange for an investment of cash in a privately-held company. This investment in the equity securities without readily determinable fair value is measured at cost, less impairment, if any, plus or minus observable price changes in orderly transactions of an identical or similar investment of the same issuer.

As of December 31, 2025, the carrying value of this investment was $26.4 million, inclusive of a cumulative upward adjustment of $23.9 million, of which $16.6 million was recognized as a gain in 2025 to reflect observable price changes. As of December 31, 2024, the carrying value of the investment was $9.8 million, inclusive of a cumulative upward adjustment of $7.3 million, of which $4.4 million was recognized in 2024 to reflect observable price changes.

The gain resulting from the adjustment to the carrying value of the non-marketable security is presented within other income (expense) in the consolidated statements of operations and comprehensive income (loss). There were no impairments for the years ended December 31, 2025, 2024 and 2023.

During the year ended December 31, 2025, the Company made a cash investment in exchange for Series A Preferred Units in a privately-held company. The investment in the equity securities without readily determinable fair value is measured at cost, less impairment, if any, plus or minus observable price changes in orderly transactions of an identical or similar instrument of the same issuer. As of December 31, 2025, the carrying value of this investment was $4.0 million. No observable price changes have been identified for this investment to date.
Notes Receivable and Equity Method Investment
In 2021, the Company made a $3.0 million investment in a privately-held company via a convertible promissory note (“2021 Note”). In 2023, the Company made an additional $2.5 million investment into the issuer via another convertible promissory note (“2023 Note”). In 2024, the Company made an additional $5.0 million investment into the issuer via a third convertible promissory note (“2024 Note”). Interest accrues at 2% per annum for the 2021 Note and 2023 Note, and 4% per annum for the 2024 Note, and outstanding principal and accrued interest is due and payable at the earliest of (i) 60 months from the execution of each note, respectively, (ii) an initial public offering, or (iii) change in control, unless otherwise converted to shares of the issuer. The outstanding principal and unpaid accrued interest on the notes is convertible into 4,500,000 shares of the issuer’s Series Seed Preferred Stock, 2,192,308 shares of the issuer’s Series A Preferred Stock and 4,384,615 shares of the issuer’s Voting Series B Preferred Stock, respectively, at the option of the issuer, upon a change in control, upon the issuer’s initial public offering, or upon a qualified equity financing. The conversion options are not bifurcated from the promissory notes as the options do not meet the net settlement criteria of a derivative instrument due to the options not being readily convertible to cash. The Company also has a call option to merge the issuer with the Company for aggregate consideration of $1.0 billion if exercised prior to November 18, 2029 or 11 times the issuer’s last 12 months of aggregate gross revenue if exercised on or after November 18, 2029. The value of the call option was determined to be inconsequential.

During the fourth quarter of 2025, the entire balance of the promissory note plus all accrued interest were converted into 1,846,153 Class A and 9,230,770 Class B units of the privately-held company. Subsequent to the conversion, all Class A units were sold to a third party for $2.3 million in cash, and the Company recognized a $9.7 million equity method investment based on the fair value of retained Class B units. The conversion resulted in a gain of $0.8 million which is presented within other income (expense), net in the accompanying consolidated statements of operations and comprehensive income (loss). After these transactions, Company holds a fully-diluted equity interest of 19% in the privately-held company as of December 31, 2025. The carrying value of the equity method investment exceeded the Company’s share of the investee’s underlying net assets by approximately $6.7 million at December 31, 2025. This basis difference is primarily related to goodwill and is not amortized.
Cloud Computing Arrangements
The Company capitalizes certain implementation costs incurred during the application development stage under cloud computing arrangements that are service contracts. The carrying value of the capitalized costs was $0.2 million as of December 31, 2025 and 2024, of which $0.1 million is presented within prepaid expenses and other current assets, and $0.1 million is presented within other non-current assets on the consolidated balance sheets for each period. Amortization of capitalized implementation costs is recognized on a straight-line basis over the term of the associated hosting arrangement when it is ready for its intended use. Costs related to preliminary project activities and post-implementation activities are expensed as incurred.
Other Current Liabilities
Other current liabilities consisted of the following:
December 31, 2025December 31, 2024
(In thousands)
Accrued expenses$2,835 $2,116 
Accrued professional fees1,5711,392
Accrued connectivity fees3,9513,489
Operating lease liabilities, current portion2542,660
Other
261 83 
Total other current liabilities$8,872 $9,740 
Other Non-Current Liabilities
Other non-current liabilities consisted of the following:
December 31, 2025December 31, 2024
(In thousands)
Operating lease liabilities, non-current
$1,223 $— 
Other192278
Total other non-current liabilities
$1,415 $278 
v3.25.4
Leases
12 Months Ended
Dec. 31, 2025
Leases [Abstract]  
Leases Leases
The Company leases its facilities under non-cancelable operating leases with various expiration dates. Leases may contain escalating payments.

The Company’s total operating lease costs were $2.0 million, $4.9 million and $5.4 million for the years ended December 31, 2025, 2024 and 2023, respectively. For the year ended December 31, 2024, the Company incurred an additional $1.2 million net charge related to an early termination of one of its leases. Refer to Note 12, Restructuring, for details.

The Company’s total operating lease costs included variable costs in the amount of $1.3 million, $2.1 million and $1.9 million for the years ended December 31, 2025, 2024 and 2023, respectively. Variable lease costs are primarily comprised of maintenance costs and are determined based on the actual costs incurred during the period. Variable lease payments are expensed in the period incurred and not included in the measurement of lease assets and liabilities. The Company’s total operating lease costs also include short-term lease costs in the amount of $0.8 million, $0.1 million and $0.2 million for the years ended December 31, 2025, 2024 and 2023.

As of December 31, 2025 and 2024, the weighted average remaining operating lease term was 4.3 years and 0.8 years, respectively. The weighted average discount rate used to estimate operating lease liabilities for leases that existed as of December 31, 2025 and 2024 was 10.8% and 6.8%, respectively. Cash paid for amounts included in the measurement of operating lease liabilities was $3.3 million, $4.2 million and $4.3 million for the years ended December 31, 2025, 2024 and 2023, respectively. For the year ended December 31, 2024, the Company made an additional $1.4 million cash payment related to an early termination fee. Refer to Note 12, Restructuring, for details.
As of December 31, 2025, maturities of operating lease liabilities were as follows:
(In thousands)
2026$396 
2027417 
2028437 
2029458 
2030142 
Thereafter— 
Total lease payments1,850 
Less: imputed interest(373)
Total operating lease liabilities$1,477 
v3.25.4
Commitments and Contingencies
12 Months Ended
Dec. 31, 2025
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
Purchase Commitments
The Company has future minimum purchase obligations under arrangements with third parties who provide hosting infrastructure services, cloud services, and software as a service (“SaaS”) solutions to support our business operations.

The future non-cancelable purchase obligations, which were not recognized on the Company’s consolidated balance sheet as of December 31, 2025, were as follows:

Year ending December 31,
(In thousands)
2026$2,042 
20271,349 
2028154 
2029— 
2030— 
Total$3,545 
Contingencies
From time to time and in the normal course of business, the Company may be subject to various legal matters, such as threatened or pending claims or proceedings. The litigation contingencies, if realized, could have a material negative impact on the Company’s financial condition, results of operations, and cash flows. The Company recognizes a provision for litigation losses when a contingent liability is probable and the amount thereof is estimable. Costs associated with the Company's involvement in legal proceedings are expensed as incurred. Amounts accrued for litigation contingencies are based on the Company’s best estimates, assessments of the likelihood of damages, and the advice of counsel and often result from a series of judgments about future events and uncertainties that rely heavily on estimates and assumptions, therefore the actual settlement amounts could differ from the estimated contingency accrual and result in additional charges or reversals in future periods. There was no litigation contingency accrual as of December 31, 2025. The Company had a litigation contingency accrual of $0.3 million as of December 31, 2024.
Warranties, Indemnifications, and Contingent Obligations
The Company’s platform, products, and services are generally warranted to perform substantially as described in the associated documentation and to satisfy defined levels of uptime reliability. The service-level agreements that provide for defined levels of uptime reliability and performance permit the customers to receive credits or to terminate their agreements in the event that the Company fails to meet those levels. To date, the Company has not experienced any significant failures to meet defined levels of reliability and performance as a result of those agreements and historically the Company has not incurred any material costs associated with warranties. Accordingly, the Company has not accrued any liabilities related to these agreements in the consolidated financial statements as of December 31, 2025 or December 31, 2024.

The Company enters into indemnification provisions under (i) its agreements with other companies in the ordinary course of business, typically with business partners, contractors, customers, and landlords and (ii) its agreements with investors. Under these provisions, the Company generally indemnifies and holds harmless the indemnified party for losses suffered or incurred by the indemnified party as a result of the Company’s activities or, in some cases, as a result of the indemnified party’s activities under the agreement. These indemnification provisions often include indemnifications relating to representations made by the Company with regard to intellectual property rights. These indemnification provisions generally survive termination of the underlying agreement. The maximum potential amount of future payments the Company could be required to make under these indemnification provisions is unlimited. The Company has not incurred material costs to defend lawsuits or settle claims related to these indemnification agreements. Accordingly, the Company has no liabilities recorded for these agreements as of December 31, 2025 or December 31, 2024.

The Company has agreed to indemnify its officers and directors to the fullest extent permitted by its amended and restated bylaws and the General Corporation Law of the State of Delaware for certain events or occurrences arising as a result of the officers or directors serving in such capacity. The coverage applies only to acts that occurred during the tenure of the officer or director and has an unlimited term. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is unlimited.
v3.25.4
Debt
12 Months Ended
Dec. 31, 2025
Debt Disclosure [Abstract]  
Debt Debt
As of December 31, 2025 and 2024, the Company had no outstanding debt.

On June 30, 2021, in connection with the closing of the acquisition of Title365, the Company entered into a credit agreement, as amended from time to time (the “Credit Agreement”), which provided for a $225.0 million senior secured term loan (the “Term Loan”) and a $25.0 million senior secured revolving credit facility (the “Revolving Facility”). The Revolving Facility included $10.0 million sublimit for the issuance of letters of credit. The Revolving Facility also included a swingline sub-facility (the “Swingline Facility”) that accommodated same-day borrowing of base rate loans. The sublimit for the Swingline Facility was $5.0 million.

The Term Loan was fully drawn at closing to provide, in part, the cash consideration paid in connection with the acquisition of Title365. The Term Loan was funded and the cash consideration was transferred on July 1, 2021. The Term Loan maturity date was June 30, 2026, and the full principal amount was due at maturity. No amortization payments were required with respect to the Term Loan.

The borrowings under the Term Loan accrued interest at a floating rate which were, at the Company’s option, either (i) an adjusted Term SOFR rate for a specified interest period plus an applicable margin of 7.50% or (ii) a base rate plus an applicable margin of 6.50%. The Term SOFR rate applicable to the Term Loan was subject to a floor of 1.00%, and the base rate was subject to a floor of 2.00%. The base rate for any day was a fluctuating rate per annum equal to the highest of (i) the federal funds effective rate in effect on such day, plus 0.50%, (ii) the rate of interest for such day as published in the Wall Street Journal as the “prime rate,” and (iii) the adjusted Term SOFR rate for a one-month interest period, plus 1.00%. Interest was payable in arrears for the elected specified interest period.

Under the Revolving Facility, the Company was required to pay a commitment fee of 0.50% per annum of the unused commitments.

The Company was also required to pay letter of credit fees, customary fronting fees, and other customary documentary fees in connection with the issuance of letters of credit.
The Company incurred approximately $5.7 million of debt issuance costs in connection with the Term Loan, which had been deferred, and the remaining unamortized portion of these costs was presented as a reduction of long-term debt on the consolidated balance sheet as of December 31, 2023.

In connection with the Credit Agreement, the Company issued a Series G preferred stock warrant to purchase 598,431 shares of Class A common stock at an exercise price per share of $13.827822 (the “Series G Warrant"). The terms of the warrant agreement for the Series G Warrant provide the holder with an option to net settle if the fair value of Class A common stock is greater than the exercise price. The net shares to be issued in a cashless exercise will be based on the fair value of the Company’s Class A common stock at the time the Series G Warrant is exercised. As of December 31, 2025 and 2024, the Series G Warrant has not been exercised. The Series G Warrant will expire 10 years from the issue date. The proceeds from the issuance of debt were allocated between the Term Loan and the Series G Warrant based on their relative fair values, resulting in a debt discount of approximately $6.8 million for the amount allocated to the Series G Warrant and accounted for as paid-in capital.

In October 2022, the Company entered into the First Amendment (the “Amendment”) to the Credit Agreement. The Amendment replaced the reference rate from LIBOR to SOFR as a result of the expected cessation of LIBOR and in accordance with the Credit Agreement.

On November 27, 2023, the Company entered into the Second Amendment to the Credit Agreement (the “Second Amendment”), which amended the Credit Agreement to, among other things, (i) terminate the Revolving Facility and (ii) amend the maturity date of the Term Loan to provide for a springing maturity extension to June 30, 2027, in the event that certain conditions were satisfied. These conditions had not been met as of the date of the termination of the Credit Agreement. In connection with the Second Amendment, the Company voluntarily prepaid outstanding Term Loan under the Credit Agreement in an aggregate principal amount of $85.0 million.

For the year ended December 31, 2023, in connection with prepayment made under the Second Amendment, the Company recognized approximately $4.0 million loss, consisting of the proportionate write-off of unamortized debt issuance costs and debt discounts due to the partial extinguishment of the Term Loan and the write off of unamortized portion of debt issuance costs related to the termination of the Revolving Facility.

On April 29, 2024, in connection with the issuance of the Series A Preferred Stock, the Company paid approximately $146.1 million to repay all amounts outstanding and payable under the Credit Agreement, including the exit fee of $4.5 million, and terminated the Credit Agreement.

For the year ended December 31, 2024, in connection with the full repayment of amounts outstanding and payable under the Credit Agreement and the termination of the Credit Agreement, the Company recognized approximately a $5.5 million loss consisting of the full write-off of unamortized debt issuance costs and debt discounts due to the full extinguishment of the Term Loan. The loss is presented within other income (expense), net in the accompanying consolidated statements of operations and comprehensive income (loss).

Including the impact of the deferred debt issuance costs and the debt discounts resulting from the exit fee and the Series G Warrant, the effective interest rate on the Term Loan was approximately 14.55% as of April 29, 2024. Debt issuance costs, debt discounts, and the Revolving Facility issuance costs were being amortized as interest expense over the term of the Credit Agreement.
v3.25.4
Redeemable Preferred Stock
12 Months Ended
Dec. 31, 2025
Temporary Equity Disclosure [Abstract]  
Redeemable Preferred Stock Redeemable Preferred Stock
On April 29, 2024, the Company entered into the Investment Agreement with Haveli and issued 150,000 shares of Series A Preferred Stock, for an aggregate purchase price of $150.0 million. The Company incurred $10.1 million of issuance costs. Net proceeds from the transaction in the amount of $139.9 million were used to repay in full the amounts outstanding under the Credit Agreement.

The Series A Preferred Stock has the following rights:
Conversion Rights

Each share of the Series A Preferred Stock is convertible into Class A common stock at the option of the holders thereof at any time at an initial conversion rate of 307.6923 shares of Class A common stock per $1,000 principal amount (equivalent to an initial conversion price of approximately $3.25 per share).
Redemption Rights
The Series A Preferred Stock includes the following redemption provisions:

At any time following the fifth anniversary of issuance, a majority of the holders of the Series A Preferred Stock have the right to cause the Company to redeem in whole, but not in part the shares of Series A Preferred Stock for cash. The per share amount of such redemption will equal the then-current liquidation preference multiplied by (i) 150% if the redemption occurs on or after the fifth anniversary and prior to the sixth anniversary of the Issuance Date, (ii) 175% if the redemption occurs on or after the sixth anniversary and before the seventh anniversary of the Issuance Date, and (iii) 200% if the redemption occurs on or after the seventh anniversary of the Issuance Date.

At any time following the seventh anniversary of issuance, the Company may redeem in whole, but not in part all of the Series A Preferred Stock in cash for a per share amount equal to the then-current liquidation preference multiplied by 200%.

Upon notice of a change of control, holders of Series A Preferred Stock may elect to convert the shares into Class A common stock. If the holder does not elect to convert shares, the Company will be required to redeem the Series A Preferred Stock in cash for a price per share equal to the greater of (i) the amount of cash and the fair market value of any other property that the holder would have received on an as-converted basis at the then-current conversion price and (ii) 200% of the then-current liquidation preference.

Dividend Rights
The holders of the Series A Preferred Stock are entitled to receive any dividends paid and distributions made to the holders of the Class A common stock to the same extent in kind and amount of consideration that would be payable on an as-converted basis as of the same record date and payment date of any dividend paid or distribution made to the holders of the Class A common stock. Dividends do not accrue on the Series A Preferred Stock.

Voting & Consent Rights
The holders of the Series A Preferred Stock are entitled to vote, as a single class, with the holders of the Class A common stock and the holders of any other class or series of capital stock of the Company then entitled to vote with the Class A common stock on all matters submitted to a vote of the holders of Class A common stock (and, if applicable, holders of any other class or series of capital stock of the Company). The Company requires the affirmative approval of the holders of a majority of the Series A Preferred Stock then outstanding, voting as a single class, in connection with certain corporate actions or events of the Company that may have a material effect on the value of the Series A Preferred Stock.

Governance Rights
So long as Haveli, together with the other permitted transferees, beneficially owns at least 33% of the shares of Series A Preferred Stock purchased by Haveli in connection with the Investment Agreement on an as-converted basis, Haveli will have the right to designate a director nominee for election to the Company’s board of directors.

Liquidation Preference
The Series A Preferred Stock has a liquidation preference of $1,000 per share and ranks senior to the Class A common stock with respect to rights on the distribution of assets on any voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Company. As of December 31, 2025, the Series A Preferred Stock has a liquidation preference of $150.0 million.

The Series A Preferred Stock is not mandatorily redeemable and as such is not required to be classified as a liability. The Series A Preferred Stock is redeemable at the option of the holder starting with the 5-year anniversary of issuance, or redeemable upon
notice of change of control. As the redemption of the Series A Preferred Stock is not solely within the Company’s control, it is classified as mezzanine equity in the consolidated balance sheets.

As of December 31, 2025, the Series A Preferred Stock has a maximum redemption value of $300.0 million. The carrying value of the Series A Preferred Stock is accreted to its maximum redemption value over the seven year term, using the effective interest method. The increases in the redemption amount are recorded with corresponding adjustments against additional paid-in capital, in the absence of retained earnings. For each reporting period, the entire periodic change in the redemption amount is reflected in the computation of net income (loss) per share under the two-class method as being akin to a dividend, by reducing the income (or increasing the loss) attributable to common stockholders.

In connection with the issuance of the Series A Preferred Stock, the Company issued the Haveli Warrant to Haveli to purchase up to 11,111,112 shares of Class A common stock, at a purchase price of $4.50 per share. The number of shares and exercise price are subject to anti-dilution adjustments for splits, dividends, capital reorganizations, reclassifications and similar transactions. The Haveli Warrant is exercisable for a period of 24 months from issuance, subject to the expiration or early termination of the applicable waiting period under the Hart Scott Rodino Antitrust Improvements Act of 1976, as amended. The Haveli Warrant has not been exercised as of December 31, 2025. The net proceeds were allocated to the Series A Preferred Stock and the Haveli Warrant based on their relative fair values as of the issuance date, in the amount of $130.8 million and $9.1 million, respectively. The proceeds allocated to Haveli Warrant were accounted for as paid-in capital.

The Series A Preferred Stock does not contain any embedded features that are required to be bifurcated.
v3.25.4
Stockholders’ Equity
12 Months Ended
Dec. 31, 2025
Equity [Abstract]  
Stockholders’ Equity Stockholders’ Equity
The following is a summary of the rights of the holders of the Company’s capital stock:
Common Stock
The Company has three classes of authorized common stock: Class A common stock, Class B common stock, and Class C common stock. The rights of the holders of Class A common stock, Class B common stock, and Class C common stock are identical, except with respect to voting and conversion. No shares of Class C common stock are issued or outstanding.

Dividend Rights
Subject to preferences that may apply to any shares of preferred stock outstanding at the time, the holders of the Company’s common stock will be entitled to receive dividends out of funds legally available if the Company’s board of directors, in its discretion, determines to issue dividends and then only at the times and in the amounts that the Company’s board of directors may determine.

Voting Rights
Holders of the Class A common stock are entitled to one vote for each share held on all matters submitted to a vote of stockholders, holders of the Class B common stock are entitled to 40 votes for each share held on all matters submitted to a vote of stockholders, and holders of the Class C common stock are not entitled to vote on any matter that is submitted to a vote of stockholders, except as otherwise required by law. The holders of the Class A common stock and Class B common stock will vote together as a single class, unless otherwise required by law. At the completion of the IPO, the Co-Founder and Head of Blend held all of the issued and outstanding shares of the Company’s Class B common stock.

No Preemptive or Similar Rights
The Company’s common stock is not entitled to preemptive rights and is not subject to conversion, redemption, or sinking fund provisions.

Right to Receive Liquidation Distributions
If the Company becomes subject to a liquidation, dissolution, or winding-up, the assets legally available for distribution to the Company’s stockholders would be distributable ratably among the holders of the Company’s common stock and any participating preferred stock outstanding at that time, subject to prior satisfaction of all outstanding debt and liabilities and the preferential rights of and the payment of liquidation preferences, if any, on any outstanding shares of preferred stock.
Conversion of Class B Common Stock
Each share of Class B common stock is convertible at any time at the option of the holder into one share of Class A common stock. Shares of Class B common stock will automatically convert into shares of Class A common stock upon sale or transfer except for certain transfers described in the Amended and Restated Certificate of Incorporation, such as certain transfers effected for estate planning or charitable purposes.

Conversion of Class C Common Stock
After the conversion or exchange of all outstanding shares of the Company’s Class B common stock into shares of Class A common stock, all outstanding shares of Class C common stock will convert automatically into Class A common stock, on a share-for-share basis, on the date or time specified by the holders of a majority of the outstanding shares of Class A common stock, voting as a separate class.
Preferred Stock
Subject to the protective provisions afforded to the holders of the Series A Preferred Stock, the Company’s board of directors has the authority to issue preferred stock in one or more series, to establish from time to time the number of shares to be included in each series and to fix the designation, powers, preferences, and rights of the shares of each series and any of its qualifications, limitations, or restrictions, in each case without further vote or action by the Company’s stockholders. As of December 31, 2025, the Company had 200,000,000 shares authorized and 150,000 shares of preferred stock issued and outstanding.
Share Repurchase Program
In August 2024, the Company's board of directors authorized the repurchase of up to $25.0 million of the Company’s Class A common stock. Repurchases may be made from time to time through open market repurchases or through privately negotiated transactions subject to market conditions, applicable legal requirements and other relevant factors. The repurchase program does not obligate the Company to acquire any particular amount of its Class A common stock, and it may be suspended at any time at the Company’s discretion. The timing and actual number of shares repurchased may depend on a variety of factors, including price, general business and market conditions, and alternative investment opportunities. The share repurchase program has no set expiration date.
During the year ended December 31, 2025, the Company repurchased and retired 7,979,247 shares of the Company’s Class A common stock for $25.0 million, which completed its share repurchase program. The Company did not make any share repurchases under the repurchase program during the year ended December 31, 2024.
v3.25.4
Stock-Based Compensation
12 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation Stock-Based Compensation
2012 Stock Option Plan
Effective May 1, 2012, the Company adopted the 2012 Stock Plan (the “2012 Plan”). Options granted under the 2012 Plan may be either incentive stock options or nonqualified stock options. Incentive stock options (“ISOs”), within the meaning of Section 422 of the Internal Revenue Code of 1986, as amended (the “Code”) may be granted only to employees (including officers and directors). Non-qualified stock options (“NSOs”) may be granted to employees and consultants. The exercise price of ISOs and NSOs shall not be less than 100% of the estimated fair value of the common shares on the date of grant, respectively, as determined by the Company’s board of directors. The exercise price of an ISO granted to a 10% or greater stockholder shall not be less than 110% of the estimated fair value of the common shares on the date of grant. Options generally vest over a period of four years. No further grants may be made under the 2012 Plan.
2021 Equity Incentive Plan
In July 2021, the Company’s board of directors adopted, and the Company’s stockholders approved, the 2021 Equity Incentive Plan (the “2021 Plan”), which became effective on July 14, 2021. The Company’s prior plan, 2012 Plan, was terminated immediately prior to the effectiveness of the 2021 Plan with respect to the grant of future awards.
The 2021 Plan provides for the grant of ISOs, to the Company’s employees and any parent and subsidiary corporations’ employees, and for the grant of NSOs, stock appreciation rights, restricted stock, restricted stock units (“RSUs”), and performance awards, including performance stock units (“PSUs”) to the Company’s employees, directors, and consultants and the Company’s parent and subsidiary corporations’ employees and consultants.

Subject to the adjustment provisions of and the automatic increase described in the 2021 Plan, a total of 23,000,000 shares of the Company’s Class A common stock were reserved for issuance pursuant to the 2021 Plan, plus 36,101,718 shares of the Company’s Class A common stock reserved for future issuance under the 2012 Plan. Subject to the adjustment provisions of the 2021 Plan, the number of shares available for issuance under the 2021 Plan also includes an annual increase on the first day of each fiscal year beginning on January 1, 2022, equal to the least of (a) 34,500,000 shares of Class A common stock, (b) 5% of the total number of shares of all classes of the Company’s common stock outstanding on the last day of the immediately preceding fiscal year, or (c) such other amount as the Company’s board of directors (or its committee) may determine. Options granted under the 2021 Plan generally vest over periods ranging from one to four years.
A summary of the stock option activity is as follows:
Number of
options
Weighted
average
exercise
price
Weighted
average
remaining
contractual
life
Aggregate
intrinsic
value
(In thousands)(In years)(In thousands)
Balance as of December 31, 202417,300 $4.20 4.69$31,282 
Exercised(1,146)$1.44 
 
$2,309 
Canceled and forfeited(984)$10.17 
 
 
Balance as of December 31, 202515,170 $4.02 3.99$14,414 
Vested and exercisable as of December 31, 202514,427 $4.11 3.99$13,872 

No options were granted during the years ended December 31, 2025, 2024 and 2023.

The number of options unvested as of December 31, 2025 and 2024 was 742 and 1,552, respectively. The weighted average grant-date fair value of these unvested options was $1.18 and $1.58 per share as of December 31, 2025 and 2024, respectively.

The total fair value of options vested during the years ended December 31, 2025, 2024 and 2023 was $1.5 million, $4.5 million and $11.4 million, respectively.

The aggregate intrinsic value of options exercised during the years ended December 31, 2025, 2024 and 2023 was $2.3 million, $1.8 million and $0.2 million, respectively.

As of December 31, 2025, the total unrecognized stock-based compensation expense for stock options was approximately $0.8 million, which is expected to be recognized over a weighted average period of 1.0 years.
Restricted Stock Units
A summary of the Company’s RSU activity and related information is as follows:
Number of RSUs
Weighted
average
grant date fair value per share
(In thousands)
Balance as of December 31, 202413,770 $1.75 
Granted12,077 $3.44 
Vested(7,430)$2.13 
Forfeited
(5,678)$2.39 
Balance as of December 31, 202512,739 $2.84 
As of December 31, 2025, there was $32.4 million of unrecognized stock-based compensation expense related to unvested RSUs, which is expected to be recognized over a weighted average period of 2.5 years. RSUs granted under the 2021 Plan generally vest quarterly over a period of two to four years from the grant date.

The total fair value of RSUs vested during the years ended December 31, 2025, 2024 and 2023 was $15.8 million, $17.5 million and $33.6 million, respectively.

During the year ended December 31, 2025, 1,093,750 RSUs were cancelled and 218,750 RSUs were modified in connection with the departure of a legacy senior executive. The net impact of the modification resulted in an incremental stock-based compensation cost of $0.3 million.
Performance Stock Units
A summary of the Company’s PSU activity and related information is as follows:
Number of PSUs
Weighted
average
grant date fair value per share
(In thousands)
Balance as of December 31, 20243,525 $0.67 
Granted8,260 $1.98 
Vested— $— 
Forfeited
(4,525)$0.81 
Balance as of December 31, 20257,260 $2.06 

In the first quarter of 2025, the Company’s board of directors granted 1,300,000 PSUs to a recently hired senior executive, 4,200,000 PSUs to the Co-Founder and Head of Blend and 250,000 PSUs to another senior executive. The PSUs will vest in four tranches upon continued service and satisfaction of certain market-based performance targets related to the Company’s stock price hurdles.
Executive PSU Standardization
In 2023, the Company’s board of directors granted PSUs (the “2023 PSU Awards”) to two senior executives (the “legacy senior executives”), covering a total of 1,200,000 PSUs and 800,000 PSUs, respectively. The 2023 PSU Awards were scheduled to vest in four tranches upon continued service and satisfaction of certain market-based performance targets related to the Company’s stock price hurdles. In December 2024, the first performance target related to the Company’s stock price was satisfied and 25% of the PSUs subject to each 2023 PSU Award vested.

On March 13, 2025, the Company’s compensation committee elected to standardize the performance goals applicable to all outstanding PSUs for the legacy senior executives so that the Company’s executives would have the same incentives and work towards the same objectives, thus creating a more cohesive and effective leadership team. In connection with this
determination, the outstanding 2023 PSU Awards were cancelled and on the same date, the Company’s compensation committee granted new PSUs (the “New PSUs”) to each of the legacy senior executives, covering a total of 1,300,000 PSUs and 800,000 PSUs, respectively. The New PSUs are scheduled to vest in four tranches upon continued service and satisfaction of certain market-based performance targets related to the Company’s stock price hurdles. The cancellation and concurrent replacement of these awards was accounted for as a modification. As the modification relates to unvested awards, the Company will recognize, on a prospective basis over the remaining requisite service period, the incremental cost associated with the modified PSUs, inclusive of any previously unrecognized compensation cost for the original awards. As of the modification date, the total incremental cost associated with the modified PSUs was $2.8 million, which included $0.2 million of unrecognized compensation costs.

The estimated weighted-average grant date fair value of all the awards issued during the first quarter of 2025 was $2.07 per share, which was determined using a Monte Carlo simulation model. The significant assumptions in the Monte Carlo simulation model include the risk-free interest rate, expected volatility of the Company’s stock price, and expected life of the award.

Fair value of common stock
$3.49 - $3.89
Remaining contractual term (years)
4.81 - 4.92
Expected volatility
90%
Risk-free interest rate
4.01% - 4.35%
Expected dividend yield

The total stock-based compensation expense recognized for PSUs for the years ended December 31, 2025, 2024 and 2023 was $8.0 million, $1.8 million and $0.6 million, respectively.

The total unrecognized compensation expense related to outstanding PSUs was $5.8 million as of December 31, 2025, which will be recognized over an estimated weighted average remaining period of 1.5 years.
Non-Plan Co-Founder and Head of Blend Options
In March 2021, the Company’s board of directors granted to its Co-Founder and Head of Blend a stand-alone stock option issued outside of the 2012 Plan covering a maximum of 26,057,181 shares of Class B common stock with an exercise price of $8.58 per share. The award has a 15-year term (subject to earlier termination when shares subject to the award are no longer eligible to vest) and vests upon the satisfaction of a service condition, liquidity event-related performance condition, and performance-based market conditions.

The terms of the award stipulated that if an IPO is completed within 15 months of the date of grant, the first tranche of 1,954,289 shares will vest. The remaining tranches of shares will vest dependent on performance goals tied to the Company’s stock price hurdles with specified expiration dates for each tranche. In July 2021, the first tranche of the Co-Founder and Head of Blend stock option award vested upon completion of the IPO.

The remaining tranches were valued using a Monte Carlo simulation model. The weighted average estimated fair value of the remaining tranches was $3.80 per share based on the following assumptions:

Fair value of common stock$18.00
Remaining contractual term (years)14.75
Expected volatility40.00%
Risk-free interest rate1.71%
Expected dividend yield

During the year ended December 31, 2025, the second tranche of the Co-Founder and Head of Blend stock option award expired, resulting in a forfeiture of 5,862,866 shares.
The total stock-based compensation expense recognized for this award for the years ended December 31, 2025, 2024 and 2023 was $3.4 million, $5.8 million and $12.3 million, respectively.

The total unrecognized compensation expense related to the award was $4.8 million as of December 31, 2025, which will be recognized over an estimated weighted average remaining period of 2.6 years.
Stock-Based Compensation Expense
The Company’s stock-based compensation expense was as follows:

Year Ended December 31,
202520242023
Cost of revenue$543 $510 $987 
Research and development(1)
6,292 9,870 19,046 
Sales and marketing2,864 3,546 7,035 
General and administrative19,256 14,015 18,489 
Total$28,955$27,941$45,557
____________
(1) Net of $3.2 million and $2.5 million of additions to capitalized internal-use software for the years ended December 31, 2025 and 2024, respectively, and none for the year ended December 31, 2023.
v3.25.4
Restructuring
12 Months Ended
Dec. 31, 2025
Restructuring and Related Activities [Abstract]  
Restructuring Restructuring
Workforce Reduction Plans
Between 2023 and 2024, the Company executed several strategic workforce reductions, including two initiatives in 2023 and two additional plans initiated in January and September 2024 (the “January 2024 Plan” and “September 2024 Plan,” respectively). In 2025, the Company implemented a new reduction plan (the “2025 Plan”), resulting in the elimination of 24 positions. The execution of the 2025 Plan was finalized in the fourth quarter of 2025.

The Company executed these initiatives as part of its broader efforts to improve cost efficiency and better align its operating structure with its strategic objectives, focusing on streamlining operations and general and administrative functions.

The restructuring charges attributable to the workforce reduction plans were $0.9 million, $2.5 million and $18.9 million for the years ended December 31, 2025, 2024 and 2023, respectively. The restructuring charges for workforce reduction plans consisted primarily of cash expenditures for compensation, severance, and transition payments, employee benefits, payroll taxes and related facilitation costs. The restructuring charges attributable to one of the 2023 plans also include an accelerated expense of $2.1 million consisting of prepaid cash bonuses issued earlier that year to certain employees in lieu of previously committed equity-based awards.

The component classified as discontinued operations incurred an additional $1.2 million, $0.4 million, and $4.9 million for the years ended December 31, 2025, 2024 and 2023, respectively. Refer to Note 16, Assets Held for Sale and Discontinued Operations.
Lease Termination and Abandonment
During the year ended December 31, 2024, the Company entered into an agreement to terminate one of its leases incurring a net $1.2 million restructuring charge primarily related to the early termination fee, and abandoned another leased facility, incurring a $3.3 million restructuring charge primarily related to accelerated amortization of the right-of-use asset and disposal of the accompanying leasehold improvements. The $2.6 million lease liability related to the abandoned lease facility is presented under other current liabilities as of December 31, 2024, and there was no balance outstanding as of December 31, 2025.
Executive Transition Costs
During year ended December 31, 2023, the Company recognized $1.1 million in restructuring charges related to the transition of its former executives. These charges primarily consisted of one-time severance and retention payments, all of which were settled in 2023. There were no restructuring charges attributable to the executive transition costs for the year ended December 31, 2024. The Company recognized $0.7 million of executive transition costs for the year ended December 31, 2025.

The reconciliation of the restructuring liability balances is as follows:
(In thousands)
Restructuring liability as of December 31, 2023
$31 
January 2024 Plan charge
1,086 
September 2024 Plan charge
1,442 
Settlements(2,484)
Restructuring liability as of December 31, 2024
$75 
2025 Plan charge
871 
Settlements(934)
Restructuring liability as of December 31, 2025
$12 
v3.25.4
Income Taxes
12 Months Ended
Dec. 31, 2025
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
The total provision for income taxes consisted of the following:

Year Ended December 31,
202520242023
(in thousands)
Current:
Federal$— $— $— 
State79 64 41 
Foreign170 11 87 
Total current249 75 128 
Deferred:
Federal$— $— $— 
State— — — 
Foreign— 34 (34)
Total deferred— 34 (34)
Total provision for income taxes$249 $109 $94 

The following table summarizes the differences between the income tax provision recorded by the Company and the amount computed by applying the statutory federal income tax rate of 21% to loss before income tax for the year ended December 31, 2025:
2025
Amount
Rate
(in thousands)
US federal statutory tax rate
$(185)21 %
State and local income taxes, net of federal income tax effect(1)
79 (9)%
Foreign tax effects
India398 (45)%
Tax credits
— — %
Changes in valuation allowances
(2,820)321 %
Nontaxable or nondeductible items
Section 162(m) adjustment
2,657 (302)%
Stock-based compensation
(2,248)256 %
Meals and entertainment45 (5)%
Gifts19 (2)%
Other
(1)%
Other reconciling items
Section 162(m)1,284 (146)%
Stock-based compensation993 (113)%
Other deferred adjustments163 (19)%
Deferred true-up
(142)16 %
Other reconciling items(1)— %
Total Tax Expense$249 (28)%

(1) The only state and local jurisdiction that contributes to the majority (greater than 50%) of the tax effect in this category is Texas.

The following table summarizes the differences between the income tax provision recorded by the Company and the amount computed by applying the statutory federal income tax rate of 21% to loss before income tax for the years ended December 31, 2024 and 2023.

Year Ended December 31
20242023
(in thousands)
Tax benefit at federal statutory rate$(8,957)$(35,151)
State income taxes, net of federal benefit(127)481 
Research and other credits(2,771)(3,774)
Change in valuation allowance8,898 26,519 
Section 162(m) adjustment 4,830 2,836 
Stock-based compensation(2,009)9,380 
Other245 (197)
Total provision for income taxes$109 $94 

Deferred income taxes reflect the net tax effects of loss and credit carryforwards and temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company’s deferred tax assets and liabilities are as follows:
December 31, 2025December 31, 2024
(in thousands)
Deferred tax assets:
Net operating loss carryforwards$156,822 $152,665 
Lease liabilities— 642 
Research and other credits25,808 25,296 
Accruals and reserves1,150 265 
Interest expense limitation14,497 15,023 
Stock-based compensation6,665 6,513 
Fixed assets1,195 1,469 
Capitalized research and development costs25,782 37,428 
Other deferred tax assets28 100 
Gross deferred tax assets231,947 239,401 
Less: valuation allowance(223,684)(235,540)
Total deferred tax assets$8,263 $3,861 
Deferred tax liabilities:
Right-of-use assets$— $(75)
Deferred contract costs(1,303)(1,016)
ASC 606 adjustments(3)(3)
Investments(5,936)(1,782)
Other deferred tax liabilities(383)(240)
Amortization(638)(745)
Gross deferred tax liabilities(8,263)(3,861)
Total net deferred tax assets$— $— 

As of December 31, 2025, the Company believes that, based on available evidence, both positive and negative, it is more likely than not that the net deferred tax assets will not be utilized.

As of December 31, 2025, the Company had a valuation allowance of $223.7 million. The valuation allowance decrease of $11.8 million during 2025 is primarily attributable to a decrease in deferred tax assets resulting from Section 174 cost amortization.

As of December 31, 2025, the Company had net operating loss (“NOL”) carryforwards for federal and state income tax purposes of approximately $636.3 million and $434.5 million, respectively, available to reduce future taxable income. The federal net operating losses generated before 2018 will begin to expire in 2028. The federal net operating losses generated in and after 2018 may be carried forward indefinitely. The state NOL carryforwards vary by state and begin to expire in 2026.

As of December 31, 2025, the Company had $25.7 million of federal research credit carryforwards which will begin to expire in 2033 and state research credit carryforwards of $14.1 million which have no expiration date.

Utilization of the net operating loss and tax credit carryforwards may be subject to annual limitations due to the ownership change limitation provided by the Internal Revenue Code of 1986, as amended, and similar state provisions. Events which may cause limitations in the amount of the NOLs that the Company may use in any one year include, but are not limited to, a cumulative ownership change of more than 50% over a three-year period. Any annual limitations may result in the expiration of NOL and credits before they are able to be utilized.

As of December 31, 2025, the Company had $12.0 million of unrecognized tax benefits, none of which, if recognized, would impact the effective tax rate. The Company’s policy is to include interest and penalties related to unrecognized tax benefits within the provision for income taxes. Interest and penalties were not significant during the years ended December 31, 2025, 2024 and 2023. The Company does not expect any material changes to its unrecognized tax benefits within the next twelve months.
The following table reflects the changes in the Company’s unrecognized tax benefits:

Year Ended December 31,
202520242023
(in thousands)
Beginning Balance$11,677 $10,040 $8,228 
Gross increases—tax positions in prior periods35 275 191 
Gross increases—tax positions in current periods240 1,362 1,621 
Ending balance$11,952 $11,677 $10,040 

The Company files income tax returns in the U.S. federal, various state jurisdictions, and India. The Company is currently not under income tax examinations by the U.S. federal or state tax authorities.

In 2025, the Indian tax authorities concluded their examination of the Company’s 2022 tax year and issued an assessment. The Company has filed a formal appeal with the appropriate appellate authorities. As of December 31, 2025, management believes that its tax positions are well‑supported by the technical merits of the relevant tax law. Accordingly, under the more‑likely‑than‑not recognition threshold required by ASC 740‑10, the Company has determined that recognition of any tax liability is not warranted, and no provision for an uncertain tax position has been recorded. The Company is undergoing income tax examination in India for the 2023 tax year.

Since the Company has net operating losses and credits carried forward in federal and various state jurisdictions, certain items attributable to closed tax years are still subject to adjustment by applicable taxing authorities through an adjustment to tax attributes carried forward to open years. All tax returns will remain open for examination by the federal and most state taxing authorities for three years and four years, respectively, from the date of utilization of any net operating loss carryforwards or research and development credits.
v3.25.4
Net Income (Loss) Per Share
12 Months Ended
Dec. 31, 2025
Earnings Per Share [Abstract]  
Net Income (Loss) Per Share Net Income (Loss) Per Share
The Company has three classes of authorized common stock for which voting rights differ by class. The Company computes net income (loss) per share using the two-class method required for multiple classes of common stock. The Company’s Series A Preferred Stock is considered a participating security for purposes of applying the two-class method when calculating earnings per share in periods of net income. Under the two-class method, net income (loss) attributable to common stockholders for the period is allocated between shares of common stock and participating securities based upon their respective rights to receive dividends as if all earnings for the period had been distributed.

Basic net income (loss) per share is computed by dividing net loss attributable to common stockholders by the weighted average number of shares of stock outstanding during the period, adjusted for options early exercised and subject to repurchase.

Diluted income (loss) per share is computed using the weighted-average number of shares and the effect of potentially dilutive securities, including awards issued under the Company’s equity compensation plans or other contracts to issue common stock, as if the securities were exercised or converted into common stock or resulted in the issuance of common stock (net of any assumed repurchases) that then shared in the earnings of the Company. During the periods of net losses, the net loss is reduced for amounts allocated to participating securities only if the security has a right to participate in the earnings of the entity and an objectively determinable contractual obligation to share in the net losses of the entity. The Company’s participating securities are not allocated any share of the net loss, as the participating securities do not have a contractual obligation to share in the net losses of the Company. Diluted net income (loss) per share attributable to the Company is computed by dividing the net income (loss) attributable to common stockholders by the weighted average number of fully diluted common shares outstanding.

The following table presents the calculation of basic and diluted net loss per share for Class A and Class B common stock. No shares of Class C common stock were issued and outstanding during the periods presented.
Year Ended December 31,
202520242023
Class A
Common
Class B
Common
Class A
Common
Class B
Common
Class A
Common
Class B
Common
(In thousands, except per share data)
Numerator:
Loss from continuing operations
$(1,111)$(16)$(41,686)$(1,074)$(160,519)$(6,961)
Less: Accretion of Series A Preferred Stock to redemption value(17,583)(249)(10,606)(273)— — 
Net loss attributable to Blend Labs, Inc common stockholders from continuing operations(18,694)(265)(52,292)(1,347)(160,519)(6,961)
Net loss from discontinued operations(5,774)(82)(642)(17)(11,884)(515)
Less: Accretion of RNCI to redemption value from discontinued operations
(1,236)(18)(6,102)(157)(6,352)(275)
Less: Net loss attributable to noncontrolling interest included in discontinued operations
179 72 1,137 49 
Net loss attributable to Blend Labs, Inc common stockholders from discontinued operations(6,831)(97)(6,672)(172)(17,099)(741)
Net loss attributable to Blend Labs, Inc common stockholders$(25,525)$(362)$(58,964)$(1,519)$(177,618)$(7,702)
Denominator:
Weighted average common stock outstanding, basic and diluted255,330 3,619 247,546 6,375 235,015 10,191 
Net loss per share from continuing operations
Basic and diluted$(0.07)$(0.07)$(0.21)$(0.21)$(0.69)$(0.69)
Net loss per share from discontinued operations
Basic and diluted$(0.03)$(0.03)$(0.03)$(0.03)$(0.07)$(0.07)
Net loss per share attributable to Blend Labs, Inc.:
Basic and diluted$(0.10)$(0.10)$(0.24)$(0.24)$(0.76)$(0.76)

The following potential shares of common stock were excluded from the computation of diluted net earnings per share for the years ended December 31, 2025, 2024 and 2023 because including them would have been antidilutive as the Company has reported net loss for each of the periods:

As of December 31,
202520242023
(In thousands)
Outstanding stock options15,170 17,300 19,946 
Early exercised options subject to repurchase— — 124 
Non-plan Co-Founder and Head of Blend options20,194 26,057 26,057 
Unvested restricted stock units12,739 13,770 20,137 
Unvested performance stock awards(1)
7,260 3,525 5,500 
Series G Warrant598 598 598 
Haveli Warrant11,111 11,111 — 
Series A redeemable convertible preferred stock46,154 46,154 — 
Total anti-dilutive securities113,226 118,515 72,362 
____________
(1) Performance conditions were not satisfied for the unvested performance stock awards as of December 31, 2025.
v3.25.4
Segment Information
12 Months Ended
Dec. 31, 2025
Segment Reporting [Abstract]  
Segment Information Segment Information
The Company’s CODM is the chief executive officer. The Company’s operating segments are defined in a manner consistent with how the Company manages its operations and how the CODM evaluates the results and allocates the Company’s resources. In the year ended December 31, 2025, the Company classified the results of its previously reported Title segment as discontinued operations in its consolidated statement of operations. Refer to Note 16, Assets Held for Sale and Discontinued Operations, for additional details. As a result, the Company now operates in a single operating segment and a single reportable segment. The CODM assesses the segment performance by using net loss from continuing operations as a measure of segment profitability. The CODM uses revenue and net loss from continuing operations for purposes of making operating decisions, allocation of resources, and evaluation of financial performance, primarily by monitoring actual to budget results as well as by reviewing year-over-year performance.

The CODM also reviews significant segment expenses for the single reportable segment. Significant segment expenses include cost of revenue, research and development expenses, sales and marketing expenses, and general and administrative expenses, all of which are presented in our consolidated statements of operations and comprehensive income (loss). Other segment items include restructuring expenses, interest expense, other income (expense), net and income tax (expense) benefit, which are also presented in our consolidated statements of operations and comprehensive income (loss).

The Company does not evaluate performance or allocate resources based on segment assets, and therefore, such information is not presented.

The Company’s reported measure of segment profit or loss is as follows:
Year Ended December 31,
202520242023
(In thousands)
Loss from continuing operations$(1,127)$(42,760)$(167,480)

The Company does not generate revenue from external customers in foreign countries. The Company’s long-lived assets, which consist of property and equipment, net and operating lease right-of-use assets, by geographic location are as follows:

As of December 31,
20252024
(in thousands)
Long-lived assets:
United States$22,595 $11,924 
India1,746 — 
Mexico
50 87 
Total$24,391 $12,011 
v3.25.4
Assets Held for Sale and Discontinued Operations
12 Months Ended
Dec. 31, 2025
Discontinued Operations and Disposal Groups [Abstract]  
Assets Held for Sale and Discontinued Operations Assets Held for Sale and Discontinued Operations
In the first quarter of 2025 the Company initiated a process to exit the title business, and on June 9, 2025, the Company entered into a definitive agreement to sell its title insurance business to a third party. The transaction closed on March 1, 2026. The divestiture is part of the Company’s strategic shift to transform into a platform-first company along with the further expansion of partner ecosystem.

The Company determined that all the criteria required for held-for-sale presentation were met as of March 31, 2025. As a result, the Company reported the assets and the liabilities of the disposal group as held for sale on the consolidated balance sheets and the operations of the disposal group as discontinued operations starting in the first quarter of 2025. Disposal group net assets are recorded at the lower of their carrying amount or estimated fair value less the costs to sell. Prior period amounts have been reclassified to conform to current period presentation.
Upon the execution of the definitive agreement, the Company recorded an impairment charge in the amount of $2.0 million related to the indefinite-lived intangible assets held within discontinued operations as the value was deemed to be not recoverable. With the exception of this impairment charge, there was no loss recognized related to the disposal group for the year ended December 31, 2025.

The following table is a summary of the assets and liabilities held for sale from discontinued operations:
December 31, 2025December 31, 2024
(In thousands)
Cash and cash equivalents$1,483 $4,232 
Trade and other receivables, net of allowance for credit losses
3,346 2,782 
Prepaid expenses and other current assets811 2,604 
Current assets held for sale from discontinued operations$5,640 $9,618 
Property and equipment, net$652 $649 
Operating lease right-of-use assets349 1,130 
Intangible assets, net— 2,000 
Other non-current assets(1)
1,939 2,278 
Non-current assets held for sale from discontinued operations$2,940 $6,057 
Accounts payable$343 $797 
Accrued compensation438 661 
Other current liabilities4,035 3,649 
Current liabilities held for sale from discontinued operations$4,816 $5,107 
Operating lease liabilities, non-current$— $801 
Other non-current liabilities154 302 
Non-current liabilities held for sale from discontinued operations$154 $1,103 
____________
(1) Other non-current assets includes $1.9 million of restricted cash related to collateral for surety bonds.
Operating results from the disposal group for the years ended December 31, 2025, 2024 and 2023 are reported as Loss from discontinued operations, on the consolidated statements of operations and comprehensive income (loss), as follows:
Year Ended December 31,
202520242023
(in thousands)
Revenue$33,396 $46,257 $47,297 
Cost of revenue29,643 38,934 42,621 
Operating expenses:
Research and development
— — 334 
Sales and marketing1,365 1,639 2,660 
General and administrative5,402 4,870 9,404 
Impairment of intangible asset2,000 — — 
Restructuring1,205 1,589 4,892 
Loss from operations
(6,219)(775)(12,614)
Other income (expense), net363 116 215 
Loss before income taxes
(5,856)(659)(12,399)
Income tax benefit
— — — 
Loss from discontinued operations
$(5,856)$(659)$(12,399)
v3.25.4
Revision of Previously Issued Quarterly Information (Unaudited)
12 Months Ended
Dec. 31, 2025
Accounting Changes and Error Corrections [Abstract]  
Revision of Previously Issued Quarterly Information (Unaudited) Revision of Previously Issued Quarterly Information (Unaudited)
In connection with the preparation of the financial statements for the year ended December 31, 2025, the Company identified errors in its consolidated financial statements for the first three quarters within fiscal year 2025. The Company assessed the effect of the errors on prior periods under the guidance of Securities and Exchange Commission (“SEC”) Staff Accounting Bulletin No. 99, “Materiality,” codified in ASC 250, Accounting Changes and Error Corrections (“ASC 250”). Based on its assessment, the Company determined that the errors were not material, individually or in the aggregate, to any previously issued financial statements.

While these errors were immaterial to prior quarters, correcting them all during the three months ended December 31, 2025, would have been material to the results for the fourth quarter. Therefore, the Company is revising the previously issued financial statements for those periods to correct the following identified misstatements: (i) improperly capitalizing costs relating to a specific internal use software project, (ii) not accruing timely for certain legal expenses, (iii) under-accruing for costs related to certain third party platform connectivity services, and (iv) several other previously identified immaterial errors, certain of which had been previously corrected in prior periods within 2025, and are also being revised.

The following tables present selected unaudited condensed consolidated statements of operations and comprehensive income (loss), condensed consolidated statements of cash flows, and condensed consolidated balance sheets for the periods indicated, as well as information about the impact of the revision adjustments on the previously reported amounts for those periods (in thousands, except per share data). The below revisions to the 2025 interim periods will be reflected as applicable in the Company’s 2026 quarterly reports to be filed on Form 10-Q.
Blend Labs, Inc.
Condensed Consolidated Balance Sheets
(In thousands, except per share amounts)
(Unaudited)

As of March 31, 2025
As Reported
Adjustments
As Revised
Assets
Current assets:
Cash and cash equivalents$56,244 $— $56,244 
Marketable securities and other investments48,574 — 48,574 
Trade and other receivables10,692 10,696 
Prepaid expenses and other current assets15,916 (475)15,441 
Current assets held for sale from discontinued operations8,518 — 8,518 
Total current assets139,944 (471)139,473 
Property and equipment, net16,993 (322)16,671 
Operating lease right-of-use assets262 — 262 
Intangible assets, net77 — 77 
Deferred contract costs3,221 — 3,221 
Other non-current assets21,930 — 21,930 
Non-current assets held for sale from discontinued operations5,839 — 5,839 
Total assets$188,266 $(793)$187,473 
Liabilities, redeemable equity and stockholders’ equity
Current liabilities:
Accounts payable$2,666 $— $2,666 
Deferred revenue33,266 (346)32,920 
Accrued compensation3,901 — 3,901 
Other current liabilities11,467 (160)11,307 
Current liabilities held for sale from discontinued operations6,793 — 6,793 
Total current liabilities58,093 (506)57,587 
Other non-current liabilities291 — 291 
Non-current liabilities held for sale from discontinued operations903 — 903 
Total liabilities59,287 (506)58,781 
Commitments and contingencies
Series A redeemable convertible preferred stock145,865 — 145,865 
Stockholders’ equity:
Common Stock— 
Additional paid-in capital1,376,752 — 1,376,752 
Accumulated other comprehensive income565 — 565 
Accumulated deficit(1,394,205)(287)(1,394,492)
Total stockholders’ equity(16,886)(287)(17,173)
Total liabilities, redeemable equity and stockholders’ equity$188,266 $(793)$187,473 
Blend Labs, Inc.
Condensed Consolidated Balance Sheets
(In thousands, except per share amounts)
(Unaudited)

As of June 30, 2025
As Reported
AdjustmentsAs Revised
Assets
Current assets:
Cash and cash equivalents$36,499 $— $36,499 
Marketable securities and other investments51,801 — 51,801 
Trade and other receivables14,962 142 15,104 
Prepaid expenses and other current assets17,128 (543)16,585 
Current assets held for sale from discontinued operations6,440 — 6,440 
Total current assets126,830 (401)126,429 
Property and equipment, net21,179 (476)20,703 
Operating lease right-of-use assets1,780 — 1,780 
Intangible assets, net73 — 73 
Deferred contract costs3,399 — 3,399 
Other non-current assets25,938 — 25,938 
Non-current assets held for sale from discontinued operations3,873 — 3,873 
Total assets$183,072 $(877)$182,195 
Liabilities, redeemable equity and stockholders’ equity
Current liabilities:
Accounts payable$1,201 $— $1,201 
Deferred revenue32,746 (382)32,364 
Accrued compensation2,854 — 2,854 
Other current liabilities10,152 (6)10,146 
Current liabilities held for sale from discontinued operations5,790 — 5,790 
Total current liabilities52,743 (388)52,355 
Other non-current liabilities1,795 — 1,795 
Non-current liabilities held for sale from discontinued operations858 — 858 
Total liabilities55,396 (388)55,008 
Commitments and contingencies
Series A redeemable convertible preferred stock150,241 — 150,241 
Stockholders’ equity:
Common Stock— 
Additional paid-in capital1,377,769 — 1,377,769 
Accumulated other comprehensive income514 — 514 
Accumulated deficit(1,400,850)(489)(1,401,339)
Total stockholders’ equity(22,565)(489)(23,054)
Total liabilities, redeemable equity and stockholders’ equity$183,072 $(877)$182,195 
Blend Labs, Inc.
Consolidated Balance Sheets
(In thousands, except per share amounts)
(Unaudited)

As of September 30, 2025
As Reported
AdjustmentsAs Revised
Assets
Current assets:
Cash and cash equivalents$55,021 $— $55,021 
Marketable securities and other investments22,234 — 22,234 
Trade and other receivables12,201 120 12,321 
Prepaid expenses and other current assets20,105 (418)19,687 
Current assets held for sale from discontinued operations6,427 — 6,427 
Total current assets115,988 (298)115,690 
Property and equipment, net22,978 (659)22,319 
Operating lease right-of-use assets1,573 — 1,573 
Intangible assets, net69 — 69 
Deferred contract costs3,136 — 3,136 
Other non-current assets42,559 — 42,559 
Non-current assets held for sale from discontinued operations3,263 — 3,263 
Total assets$189,566 $(957)$188,609 
Liabilities, redeemable equity and stockholders’ equity
Current liabilities:
Accounts payable$772 $— $772 
Deferred revenue25,325 (119)25,206 
Accrued compensation4,596 — 4,596 
Other current liabilities9,235 87 9,322 
Current liabilities held for sale from discontinued operations5,744 — 5,744 
Total current liabilities45,672 (32)45,640 
Operating lease liabilities, non-current— — — 
Other non-current liabilities1,420 — 1,420 
Debt, non-current, net— — — 
Non-current liabilities held for sale from discontinued operations160 — 160 
Total liabilities47,252 (32)47,220 
Commitments and contingencies
Series A redeemable convertible preferred stock154,799 — 154,799 
Stockholders’ equity:
Common Stock— 
Additional paid-in capital1,375,276 — 1,375,276 
Accumulated other comprehensive income555 — 555 
Accumulated deficit(1,388,318)(925)(1,389,243)
Total stockholders’ equity(12,485)(925)(13,410)
Total liabilities, redeemable equity and stockholders’ equity$189,566 $(957)$188,609 
Blend Labs, Inc.
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)
(In thousands, except per share amounts)
(Unaudited)

Three months ended March 31, 2025
As Reported
AdjustmentsAs Revised
Revenue
Software platform$24,260 $42 $24,302 
Professional services2,510 33 2,543 
Total revenue26,770 75 26,845 
Cost of revenue
Software platform5,865 33 5,898 
Professional services1,947 — 1,947 
Total cost of revenue7,812 33 7,845 
Gross profit18,958 42 19,000 
Operating expenses:
Research and development7,520 322 7,842 
Sales and marketing7,188 — 7,188 
General and administrative11,224 11,231 
Restructuring719 — 719 
Total operating expenses26,651 329 26,980 
Loss from operations(7,693)(287)(7,980)
Other income (expense), net1,114 — 1,114 
Loss before income taxes(6,579)(287)(6,866)
Income tax expense(30)— (30)
Loss from continuing operations(6,609)(287)(6,896)
Loss from discontinued operations (Note 16)(2,803)— (2,803)
Net loss
(9,412)(287)(9,699)
Less: Net loss attributable to noncontrolling interest included in discontinued operations182 — 182 
Net loss attributable to Blend Labs, Inc.(9,230)(287)(9,517)
Less: Accretion of redeemable noncontrolling interest to redemption value from discontinued operations(1,254)— (1,254)
Less: Accretion of Series A redeemable convertible preferred stock to redemption value(4,202)— (4,202)
Net loss attributable to Blend Labs, Inc. common stockholders$(14,686)$(287)$(14,973)
Net loss per share attributable to Blend Labs, Inc. common stockholders - basic and diluted:
Continuing operations$(0.04)$— $(0.04)
Discontinued operations$(0.01)$— $(0.01)
Weighted average shares used in calculating net loss per share:
Basic and diluted258,832 — $258,832 
Comprehensive loss:
Net loss$(9,412)$(287)$(9,699)
Unrealized gain on marketable securities
— 
Foreign currency translation loss
(43)— (43)
Comprehensive loss(9,449)(287)(9,736)
Less: Comprehensive loss attributable to noncontrolling interest182 — 182 
Comprehensive loss attributable to Blend Labs, Inc.$(9,267)$(287)$(9,554)
Blend Labs, Inc.
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)
(In thousands, except per share amounts)
(Unaudited)

Three months ended June 30, 2025
As ReportedAdjustmentsAs Revised
Revenue
Software platform$29,391 $74 $29,465 
Professional services2,132 32 2,164 
Total revenue31,523 106 31,629 
Cost of revenue
Software platform6,505 55 6,560 
Professional services1,713 — 1,713 
Total cost of revenue8,218 55 8,273 
Gross profit23,305 51 23,356 
Operating expenses:
Research and development7,332 154 7,486 
Sales and marketing6,950 — 6,950 
General and administrative13,619 99 13,718 
Restructuring28 — 28 
Total operating expenses27,929 253 28,182 
Loss from operations(4,624)(202)(4,826)
Other income (expense), net1,018 — 1,018 
Loss before income taxes(3,606)(202)(3,808)
Income tax expense(41)— (41)
Loss from continuing operations(3,647)(202)(3,849)
Loss from discontinued operations (Note 16)(2,998)— (2,998)
Net loss(6,645)(202)(6,847)
Less: Net loss attributable to noncontrolling interest included in discontinued operations— — — 
Net loss attributable to Blend Labs, Inc.(6,645)(202)(6,847)
Less: Accretion of redeemable noncontrolling interest to redemption value from discontinued operations— — — 
Less: Accretion of Series A redeemable convertible preferred stock to redemption value(4,376)— (4,376)
Net loss attributable to Blend Labs, Inc. common stockholders$(11,021)$(202)$(11,223)
Net loss per share attributable to Blend Labs, Inc. common stockholders - basic and diluted:
Continuing operations$(0.03)$— $(0.03)
Discontinued operations$(0.01)$— $(0.01)
Weighted average shares used in calculating net loss per share:
Basic and diluted259,211 — 259,211 
Comprehensive loss:
Net loss$(6,645)$(202)$(6,847)
Unrealized loss on marketable securities(44)— (44)
Foreign currency translation loss(7)— (7)
Comprehensive loss(6,696)(202)(6,898)
Less: Comprehensive loss attributable to noncontrolling interest— — — 
Comprehensive loss attributable to Blend Labs, Inc.$(6,696)$(202)$(6,898)
Blend Labs, Inc.
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)
(In thousands, except per share amounts)
(Unaudited)

Three months ended September 30, 2025
As ReportedAdjustmentsAs Revised
Revenue
Software platform$30,459 $(97)$30,362 
Professional services2,401 (68)2,333 
Total revenue32,860 (165)32,695 
Cost of revenue
Software platform6,624 13 6,637 
Professional services1,780 — 1,780 
Total cost of revenue8,404 13 8,417 
Gross profit24,456 (178)24,278 
Operating expenses:
Research and development8,522 183 8,705 
Sales and marketing7,873 — 7,873 
General and administrative12,879 75 12,954 
Restructuring93 — 93 
Total operating expenses29,367 258 29,625 
Loss from operations(4,911)(436)(5,347)
Other income (expense), net17,348 — 17,348 
Income before income taxes12,437 (436)12,001 
Income tax expense(27)— (27)
Income from continuing operations12,410 (436)11,974 
Income from discontinued operations (Note 16)122 — 122 
Net income12,532 (436)12,096 
Less: Net income attributable to noncontrolling interest included in discontinued operations— — — 
Net income attributable to Blend Labs, Inc.12,532 (436)12,096 
Less: Accretion of redeemable noncontrolling interest to redemption value from discontinued operations— — — 
Less: Accretion of Series A redeemable convertible preferred stock to redemption value(4,558)— (4,558)
Net income attributable to Blend Labs, Inc. common stockholders$7,974 $(436)$7,538 
Net income per share attributable to Blend Labs, Inc. common stockholders - basic and diluted:
Basic
Continuing operations$0.03 $(0.01)$0.02 
Discontinued operations$— $— $— 
Net income per share attributable to Blend Labs, Inc. common stockholders$0.03 $(0.01)$0.02 
Diluted
Continuing operations$0.02 $— $0.02 
Discontinued operations$— $— $— 
Net income per share attributable to Blend Labs, Inc. common stockholders$0.02 $— $0.02 
Weighted average shares used in calculating net income per share:
Basic259,631 — 259,631 
Diluted268,719 — 268,719 
Comprehensive income:
Net income$12,532 $(436)$12,096 
Unrealized loss on marketable securities(62)— (62)
Foreign currency translation gain103 — 103 
Comprehensive income12,573 (436)12,137 
Less: Comprehensive loss attributable to noncontrolling interest— — — 
Comprehensive income attributable to Blend Labs, Inc.$12,573 $(436)$12,137 
Blend Labs, Inc.
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)
(In thousands, except per share amounts)
(Unaudited)

Six months ended June 30, 2025
As ReportedAdjustmentsAs Revised
Revenue
Software platform$53,651 $116 $53,767 
Professional services4,642 65 4,707 
Total revenue58,293 181 58,474 
Cost of revenue
Software platform12,369 88 12,457 
Professional services3,660 — 3,660 
Total cost of revenue16,029 88 16,117 
Gross profit42,264 93 42,357 
Operating expenses:
Research and development14,853 476 15,329 
Sales and marketing14,137 — 14,137 
General and administrative24,844 106 24,950 
Restructuring747 — 747 
Total operating expenses54,581 582 55,163 
Loss from operations(12,317)(489)(12,806)
Other income (expense), net2,132 — 2,132 
Loss before income taxes(10,185)(489)(10,674)
Income tax expense(71)— (71)
Loss from continuing operations(10,256)(489)(10,745)
Loss from discontinued operations (Note 16)(5,801)— (5,801)
Net loss(16,057)(489)(16,546)
Less: Net loss attributable to noncontrolling interest included in discontinued operations182 — 182 
Net loss attributable to Blend Labs, Inc.(15,875)(489)(16,364)
Less: Accretion of redeemable noncontrolling interest to redemption value from discontinued operations(1,254)— (1,254)
Less: Accretion of Series A redeemable convertible preferred stock to redemption value(8,578)— (8,578)
Net loss attributable to Blend Labs, Inc. common stockholders$(25,707)$(489)$(26,196)
Net loss per share attributable to Blend Labs, Inc. common stockholders - basic and diluted:
Continuing operations$(0.07)$— $(0.07)
Discontinued operations$(0.03)$— $(0.03)
Weighted average shares used in calculating net income (loss) per share:
Basic and diluted259,004 — 259,004 
Comprehensive loss:
Net loss$(16,057)$(489)$(16,546)
Unrealized loss on marketable securities(38)— (38)
Foreign currency translation loss(50)— (50)
Comprehensive loss(16,145)(489)(16,634)
Less: Comprehensive loss attributable to noncontrolling interest182 — 182 
Comprehensive loss attributable to Blend Labs, Inc.$(15,963)$(489)$(16,452)
Blend Labs, Inc.
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)
(In thousands, except per share amounts)
(Unaudited)

Nine months ended September 30, 2025
As ReportedAdjustmentsAs Revised
Revenue
Software platform$84,110 $19 $84,129 
Professional services7,043 (3)7,040 
Total revenue91,153 16 91,169 
Cost of revenue
Software platform18,993 101 19,094 
Professional services5,440 — 5,440 
Total cost of revenue24,433 101 24,534 
Gross profit66,720 (85)66,635 
Operating expenses:
Research and development23,375 659 24,034 
Sales and marketing22,010 — 22,010 
General and administrative37,723 181 37,904 
Restructuring840 — 840 
Total operating expenses83,948 840 84,788 
Loss from operations(17,228)(925)(18,153)
Other income (expense), net19,480 — 19,480 
Income before income taxes2,252 (925)1,327 
Income tax expense(98)— (98)
Income from continuing operations2,154 (925)1,229 
Loss from discontinued operations (Note 16)(5,679)— (5,679)
Net loss(3,525)(925)(4,450)
Less: Net loss attributable to noncontrolling interest included in discontinued operations182 — 182 
Net loss attributable to Blend Labs, Inc.(3,343)(925)(4,268)
Less: Accretion of redeemable noncontrolling interest to redemption value from discontinued operations(1,254)— (1,254)
Less: Accretion of Series A redeemable convertible preferred stock to redemption value(13,136)— (13,136)
Net loss attributable to Blend Labs, Inc. common stockholders$(17,733)$(925)$(18,658)
Net loss per share attributable to Blend Labs, Inc. common stockholders - basic and diluted:
Basic:
Continuing operations$(0.04)$— $(0.04)
Discontinued operations$(0.03)$— $(0.03)
Weighted average shares used in calculating net loss per share:
Basic and diluted
259,228 — 259,228 
Comprehensive loss:
Net loss$(3,525)$(925)$(4,450)
Unrealized loss on marketable securities(100)— (100)
Foreign currency translation gain53 — 53 
Comprehensive loss(3,572)(925)(4,497)
Less: Comprehensive loss attributable to noncontrolling interest182 — 182 
Comprehensive loss attributable to Blend Labs, Inc.$(3,390)$(925)$(4,315)
Blend Labs, Inc.
Condensed Consolidated Statements of Cash Flows
(In thousands)
(Unaudited)

Three months ended March 31, 2025
As ReportedAdjustmentsAs Revised
Operating activities
Net loss$(9,412)$(287)$(9,699)
Net loss from continuing operations(6,609)(287)(6,896)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation6,048 48 6,096 
Changes in operating assets and liabilities:
Trade and other receivables3,906 (4)3,902 
Prepaid expenses and other assets, current and non-current389 475 864 
Deferred revenue13,254 (346)12,908 
Other liabilities, current and non-current2,179 (160)2,019 
Net cash provided by operating activities - continuing operations20,085 (274)19,811 
Net cash provided by operating activities20,390 (274)20,116 
Additions to property, equipment and internal-use software development costs(4,587)274 (4,313)
Net cash provided by investing activities - continuing operations3,312 274 3,586 
Net cash provided by investing activities3,228 274 3,502 
Blend Labs, Inc.
Condensed Consolidated Statements of Cash Flows
(In thousands)
(Unaudited)

Six months ended June 30, 2025
As ReportedAdjustmentsAs Revised
Operating activities
Net loss$(16,057)$(489)$(16,546)
Net loss from continuing operations(10,256)(489)(10,745)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation13,610 68 13,678 
Changes in operating assets and liabilities:
Trade and other receivables(364)(142)(506)
Prepaid expenses and other assets, current and non-current(1,262)543 (719)
Deferred revenue12,734 (382)12,352 
Other liabilities, current and non-current2,210 (6)2,204 
Net cash provided by operating activities - continuing operations
14,793 (408)14,385 
Net cash provided by operating activities
14,022 (408)13,614 
Additions to property, equipment and internal-use software development costs(8,320)408 (7,912)
Net cash used in investing activities - continuing operations(7,483)408 (7,075)
Net cash used in investing activities(7,603)408 (7,195)
Blend Labs, Inc.
Condensed Consolidated Statements of Cash Flows
(In thousands)
(Unaudited)

Nine months ended September 30, 2025
As ReportedAdjustmentsAs Revised
Operating activities
Net loss$(3,525)$(925)$(4,450)
Net income from continuing operations2,154 (925)1,229 
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation21,376 101 21,477 
Changes in operating assets and liabilities:
Trade and other receivables2,345 (120)2,225 
Prepaid expenses and other assets, current and non-current(4,709)418 (4,291)
Deferred revenue5,313 (119)5,194 
Other liabilities, current and non-current1,686 87 1,773 
Net cash provided by operating activities - continuing operations
12,060 (558)11,502 
Net cash provided by operating activities
10,532 (558)9,974 
Additions to property, equipment and internal-use software development costs(10,592)558 (10,034)
Net cash provided by investing activities - continuing operations19,972 558 20,530 
Net cash provided by investing activities19,790 558 20,348 

The impact of the revisions on the Condensed Consolidated Statements of Redeemable Noncontrolling Interest, Series A Redeemable Convertible Preferred Stock, and Stockholders' Equity was solely within net (loss) income for errors impacting accumulated deficit as presented above.
v3.25.4
Subsequent Events
12 Months Ended
Dec. 31, 2025
Subsequent Events [Abstract]  
Subsequent Events Subsequent Events
On March 1, 2026, the Company completed the sale of substantially all the assets and liabilities of its title insurance business to a third party.

On March 10, 2026, the Company's board of directors authorized the repurchase of up to $50.0 million of the Company’s Class A common stock. Repurchases may be made from time to time through open market repurchases or through privately negotiated transactions subject to market conditions, applicable legal requirements and other relevant factors. The repurchase program does not obligate the Company to acquire any particular amount of its Class A common stock, and it may be suspended at any time at the Company’s discretion. The timing and actual number of shares repurchased may depend on a variety of factors, including price, general business and market conditions, and alternative investment opportunities. The share repurchase program has no set expiration date.
v3.25.4
Insider Trading Arrangements
3 Months Ended
Dec. 31, 2025
Trading Arrangements, by Individual  
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
Nima Ghamsari [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
On December 16, 2025, Nima Ghamsari, our Head of Blend, entered into a Rule 10b5-1 trading arrangement that provides for the sale from time to time of shares of our Class A Common Stock, intended to generate an aggregate of approximately a maximum dollar amount of $650,000, with the exact number of shares to be sold pursuant to Mr. Ghamsari’s trading arrangement to be determined based on market prices of our Class A Common Stock. The plan will expire on June 11, 2026,
subject to early termination for certain specified events as set forth in the plan. The plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Name Nima Ghamsari
Title Head of Blend
Rule 10b5-1 Arrangement Adopted true
Adoption Date December 16, 2025
Expiration Date June 11, 2026
Arrangement Duration 177 days
v3.25.4
Insider Trading Policies and Procedures
12 Months Ended
Dec. 31, 2025
Insider Trading Policies and Procedures [Line Items]  
Insider Trading Policies and Procedures Adopted true
v3.25.4
Cybersecurity Risk Management and Strategy Disclosure
12 Months Ended
Dec. 31, 2025
Cybersecurity Risk Management, Strategy, and Governance [Line Items]  
Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]
We have established processes and policies for assessing, identifying, and managing material risks arising from cybersecurity threats and have integrated these processes into our overall risk management systems and processes. We routinely assess material risks from cybersecurity threats, including any potential unauthorized occurrence on, or conducted through, our information systems that may result in adverse effects on the confidentiality, integrity, or availability of our information systems or any information residing therein.

We conduct annual risk assessments to identify cybersecurity threats, as well as assessments in the event of a material change in our business practices that may affect information systems that are vulnerable to such cybersecurity threats. These risk assessments include identification of reasonably foreseeable internal and external risks, the likelihood and potential damage that could result from such risks, and the sufficiency of existing policies, procedures, systems, and safeguards in place to manage such risks. We also utilize threat modeling to evaluate changes to our applications or environments for new threats or risks, and our cybersecurity team monitors the threat landscape regularly using security industry sources and external threat intelligence information. Blend conducts daily vulnerability assessments, prioritizes remediation, and engages in routine system and application patching as well as other proactive measures, where deemed appropriate, to mitigate reasonably foreseeable risks.

Blend maintains an incident response plan that is designed to contain and address any suspected security incident identified by the Company. This plan is tested at least annually. Our security operations team triages issues and invokes the incident response plan when deemed necessary. This plan includes provisions for notifications of internal and external parties, including Blend leadership and the Audit Committee as required.

Following these risk assessments, or when we otherwise identify cybersecurity risks through the processes described in this “Risk Management and Strategy” section, we evaluate whether and how to re-design, implement, and maintain reasonable safeguards to minimize identified risks and reasonably address any identified gaps in existing safeguards. We devote significant resources and designate high-level personnel, including our Information Security Officer, who reports to our Head of Finance and Administration, to manage the risk assessment and mitigation process.
As part of our overall risk management system, we monitor and test our safeguards and train our employees on these safeguards, in collaboration with our human resources and information technology functional groups. Personnel at all levels and departments are made aware of our cybersecurity policies through training. Specific training is required for users of higher-risk systems or individuals associated with specific security processes such as incident response.

Our cybersecurity program includes processes for identifying and managing risks from third parties and is integrated into our overall risk management framework. Our program defines key risk objectives and if cybersecurity risk exceeds defined thresholds, such risks are documented and escalated into the enterprise risk program and Blend’s internal audit team. We contractually obligate third-party service providers with access to our systems or processing sensitive data on our behalf to align with our cybersecurity objectives and adhere to industry best practices. We re-evaluate each such service provider at least annually and when the role or purpose of a service provider changes, and have processes to require service providers maintaining sensitive data on our behalf to delete such data upon contract termination.

We engage assessors or other third-party service providers in connection with our risk assessment and cybersecurity assessment or audit processes. These service providers assist us to evaluate risks and identify where our current security program may be improved. We consult with these service providers as required to verify mitigation approaches, to compare Blend’s security posture against industry peers, and to provide overall feedback for the security program. Additionally, we utilize outside service providers, as well as a bug bounty program, to penetration test our network infrastructure and applications and provide prioritized security vulnerability findings reports. Some Blend customers also perform annual security testing on Blend’s infrastructure and applications.

Like other technology companies, we have experienced cybersecurity incidents in the past. We have not, however, been materially impacted by any previous cybersecurity incidents. For additional information regarding whether any risks from cybersecurity threats, including as a result of any previous cybersecurity incidents, have materially affected or are reasonably likely to materially affect our company, including our business strategy, results of operations, or financial condition, please refer to Item 1A, “Risk Factors,” in this Annual Report on Form 10-K,including the risk factors entitled “Risks Related to Our Business and Operations: A cyberattack, security breach, or incident affecting us or the third parties we rely on or partner with could expose us or our customers and consumers to a risk of loss or misuse of confidential information and have an adverse effect on our reputation, brand, business, financial condition, and results of operations.”
Cybersecurity Risk Management Processes Integrated [Flag] true
Cybersecurity Risk Management Processes Integrated [Text Block]
We have established processes and policies for assessing, identifying, and managing material risks arising from cybersecurity threats and have integrated these processes into our overall risk management systems and processes. We routinely assess material risks from cybersecurity threats, including any potential unauthorized occurrence on, or conducted through, our information systems that may result in adverse effects on the confidentiality, integrity, or availability of our information systems or any information residing therein.

We conduct annual risk assessments to identify cybersecurity threats, as well as assessments in the event of a material change in our business practices that may affect information systems that are vulnerable to such cybersecurity threats. These risk assessments include identification of reasonably foreseeable internal and external risks, the likelihood and potential damage that could result from such risks, and the sufficiency of existing policies, procedures, systems, and safeguards in place to manage such risks. We also utilize threat modeling to evaluate changes to our applications or environments for new threats or risks, and our cybersecurity team monitors the threat landscape regularly using security industry sources and external threat intelligence information. Blend conducts daily vulnerability assessments, prioritizes remediation, and engages in routine system and application patching as well as other proactive measures, where deemed appropriate, to mitigate reasonably foreseeable risks.

Blend maintains an incident response plan that is designed to contain and address any suspected security incident identified by the Company. This plan is tested at least annually. Our security operations team triages issues and invokes the incident response plan when deemed necessary. This plan includes provisions for notifications of internal and external parties, including Blend leadership and the Audit Committee as required.

Following these risk assessments, or when we otherwise identify cybersecurity risks through the processes described in this “Risk Management and Strategy” section, we evaluate whether and how to re-design, implement, and maintain reasonable safeguards to minimize identified risks and reasonably address any identified gaps in existing safeguards. We devote significant resources and designate high-level personnel, including our Information Security Officer, who reports to our Head of Finance and Administration, to manage the risk assessment and mitigation process.
As part of our overall risk management system, we monitor and test our safeguards and train our employees on these safeguards, in collaboration with our human resources and information technology functional groups. Personnel at all levels and departments are made aware of our cybersecurity policies through training. Specific training is required for users of higher-risk systems or individuals associated with specific security processes such as incident response.
Cybersecurity Risk Management Third Party Engaged [Flag] true
Cybersecurity Risk Third Party Oversight and Identification Processes [Flag] true
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag] false
Cybersecurity Risk Board of Directors Oversight [Text Block]
One of the key functions of our board of directors is informed oversight of our risk management process, including risks from cybersecurity threats. Our board of directors is responsible for monitoring and assessing strategic risk exposure, and our executive officers are responsible for the day-to-day management of the material risks we face. Our board of directors administers its cybersecurity risk oversight function through the Audit Committee.
Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block] Our board of directors administers its cybersecurity risk oversight function through the Audit Committee.
Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block] In the event of a significant cybersecurity incident that is identified by the Company, Blend leadership and the Audit Committee are informed by the Information Security Officer or our manager of security operations to support swift and informed decision-making.
Our Information Security Officer provides quarterly briefings to the Audit Committee regarding our cybersecurity risks and activities, including our progress on mitigating threats identified by external cybersecurity risk audits, any recent cybersecurity incidents and related responses, cybersecurity systems testing, activities of third parties, and the like, in each case as applicable. Our Audit Committee provides regular updates to the board of directors on such reports.
Cybersecurity Risk Role of Management [Text Block]
Our Information Security Officer and our cybersecurity team (which consists of our security policy manager, security operations manager, and red team lead) are primarily responsible for assessing and managing our material risks from cybersecurity threats. Our Information Security Officer has over 20 years of expertise within the cybersecurity field, and manages an experienced team with expertise in relevant security practices such as penetration testing, security operations, and policy.

Our Information Security Officer and our cybersecurity team oversee our cybersecurity policies and processes, including those described in “Risk Management and Strategy” above. The processes by which our Information Security Officer and our cybersecurity team are informed about and monitor the prevention, detection, mitigation, and remediation of cybersecurity incidents include monitoring of network, system and application logs, review of vulnerability scans and penetration test results, review of industry sources for vulnerability and threat indicators, and use of third-party service providers for audit or assessment purposes. In the event of a significant cybersecurity incident that is identified by the Company, Blend leadership and the Audit Committee are informed by the Information Security Officer or our manager of security operations to support swift and informed decision-making.

Our Information Security Officer provides quarterly briefings to the Audit Committee regarding our cybersecurity risks and activities, including our progress on mitigating threats identified by external cybersecurity risk audits, any recent cybersecurity incidents and related responses, cybersecurity systems testing, activities of third parties, and the like, in each case as applicable. Our Audit Committee provides regular updates to the board of directors on such reports.
Cybersecurity Risk Management Positions or Committees Responsible [Flag] true
Cybersecurity Risk Management Positions or Committees Responsible [Text Block]
One of the key functions of our board of directors is informed oversight of our risk management process, including risks from cybersecurity threats. Our board of directors is responsible for monitoring and assessing strategic risk exposure, and our executive officers are responsible for the day-to-day management of the material risks we face. Our board of directors administers its cybersecurity risk oversight function through the Audit Committee.

Our Information Security Officer and our cybersecurity team (which consists of our security policy manager, security operations manager, and red team lead) are primarily responsible for assessing and managing our material risks from cybersecurity threats. Our Information Security Officer has over 20 years of expertise within the cybersecurity field, and manages an experienced team with expertise in relevant security practices such as penetration testing, security operations, and policy.

Our Information Security Officer and our cybersecurity team oversee our cybersecurity policies and processes, including those described in “Risk Management and Strategy” above. The processes by which our Information Security Officer and our cybersecurity team are informed about and monitor the prevention, detection, mitigation, and remediation of cybersecurity incidents include monitoring of network, system and application logs, review of vulnerability scans and penetration test results, review of industry sources for vulnerability and threat indicators, and use of third-party service providers for audit or assessment purposes. In the event of a significant cybersecurity incident that is identified by the Company, Blend leadership and the Audit Committee are informed by the Information Security Officer or our manager of security operations to support swift and informed decision-making.

Our Information Security Officer provides quarterly briefings to the Audit Committee regarding our cybersecurity risks and activities, including our progress on mitigating threats identified by external cybersecurity risk audits, any recent cybersecurity incidents and related responses, cybersecurity systems testing, activities of third parties, and the like, in each case as applicable. Our Audit Committee provides regular updates to the board of directors on such reports.
Cybersecurity Risk Management Expertise of Management Responsible [Text Block] Our Information Security Officer has over 20 years of expertise within the cybersecurity field, and manages an experienced team with expertise in relevant security practices such as penetration testing, security operations, and policy.
Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]
Our Information Security Officer and our cybersecurity team oversee our cybersecurity policies and processes, including those described in “Risk Management and Strategy” above. The processes by which our Information Security Officer and our cybersecurity team are informed about and monitor the prevention, detection, mitigation, and remediation of cybersecurity incidents include monitoring of network, system and application logs, review of vulnerability scans and penetration test results, review of industry sources for vulnerability and threat indicators, and use of third-party service providers for audit or assessment purposes. In the event of a significant cybersecurity incident that is identified by the Company, Blend leadership and the Audit Committee are informed by the Information Security Officer or our manager of security operations to support swift and informed decision-making.

Our Information Security Officer provides quarterly briefings to the Audit Committee regarding our cybersecurity risks and activities, including our progress on mitigating threats identified by external cybersecurity risk audits, any recent cybersecurity incidents and related responses, cybersecurity systems testing, activities of third parties, and the like, in each case as applicable. Our Audit Committee provides regular updates to the board of directors on such reports.
Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag] true
v3.25.4
Summary of Significant Accounting Policies (Policies)
12 Months Ended
Dec. 31, 2025
Accounting Policies [Abstract]  
Basis of Presentation
Basis of Presentation and Principles of Consolidation
The consolidated financial statements are prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) and include the accounts of Blend Labs, Inc., its subsidiaries in which the Company holds a controlling financial interest, and variable interest entities (“VIE”) in which the Company is the primary beneficiary in accordance with the consolidation accounting guidance.

Noncontrolling interest represents the minority stockholder’s share of the net income or loss and equity in a consolidated subsidiary. On February 26, 2025, the Company obtained the remaining interest previously held by the minority stockholder thereby extinguishing the noncontrolling interest.
All intercompany balances and transactions have been eliminated in consolidation.
Principles of Consolidation and Consolidated Variable Interest Entity
Basis of Presentation and Principles of Consolidation
The consolidated financial statements are prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) and include the accounts of Blend Labs, Inc., its subsidiaries in which the Company holds a controlling financial interest, and variable interest entities (“VIE”) in which the Company is the primary beneficiary in accordance with the consolidation accounting guidance.

Noncontrolling interest represents the minority stockholder’s share of the net income or loss and equity in a consolidated subsidiary. On February 26, 2025, the Company obtained the remaining interest previously held by the minority stockholder thereby extinguishing the noncontrolling interest.
All intercompany balances and transactions have been eliminated in consolidation.
Consolidated Variable Interest Entity
The Company determines, at the inception of each arrangement, whether an entity in which it has made an investment or in which it has other variable interest is considered a VIE. The Company consolidates a VIE when it is deemed to be the primary beneficiary. The primary beneficiary of a VIE is the party that meets both of the following criteria: (i) has the power to direct the activities that most significantly affect the economic performance of the VIE; and (ii) has the obligation to absorb losses or the right to receive benefits that in either case could potentially be significant to the VIE. Periodically, the Company determines whether any changes in its interest or relationship with the entity impact the determination of whether the entity is still a VIE and, if so, whether the Company is the primary beneficiary. If the Company is not deemed to be the primary beneficiary of a VIE, the Company accounts for the investment or other variable interest in a VIE in accordance with applicable U.S. GAAP.
Reclassification
During the first quarter of 2025, the Company classified the results of its previously reported Title segment as discontinued operations in the Company’s consolidated financial statements for all periods presented. As a result, the Company operates in a single reportable segment. For further information on the Company’s segments, refer to Note 15, Segment Information, and Note 16, Assets Held for Sale and Discontinued Operations.

Prior period information has been reclassified to conform to the current period presentation.
Use of Estimates
Use of Estimates
The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make, on an ongoing basis, estimates and assumptions that affect the amounts reported in the consolidated financial statements and the notes thereto. Actual results may differ from those estimates. Such estimates include, but are not limited to, estimates of variable consideration, evaluation of contingencies, determination of the incremental borrowing rates used in calculations of lease liabilities, determination of fair value of stock-based compensation, determination of fair value of marketable securities, determination of fair value of each of the Series A Preferred Stock and the warrant issued to Brooks Aggregator, L.P. (“Haveli”) to purchase up to 11,111,112 shares of Class A common stock, at a purchase price of $4.50 per share of Class A common stock (the “Haveli Warrant”), determination of fair values of assets transferred and performance obligations committed to under the strategic partnership agreement, assessment of expected credit losses on notes receivable, valuation of deferred tax assets, valuation of the redeemable noncontrolling interest, determination of fair value of the disposal group, determination of useful lives of tangible and intangible assets and capitalized internal-use software development costs, assessment of impairment of long-lived assets, and valuation of equity securities without readily determinable fair value.
Risks and Uncertainties
Risks and Uncertainties
The Company has been and may continue to be affected by various macroeconomic factors, including interest rate environment, housing affordability, and worldwide political and economic conditions. The global financial markets have recently experienced extreme volatility and disruptions, including diminished liquidity and credit availability, declines in consumer confidence, declines in economic growth, rising interest rates, inflation, increases in unemployment rates and uncertainty about economic stability. The real estate environment, including interest rates and the general economic environment, typically impacts the demand for mortgage and mortgage related products. The demand for mortgage and mortgage related products continues to be sensitive to these factors, and Federal Reserve policy or any material changes in interest rates or housing supply are expected to impact overall origination activity levels during 2026. In addition, announcements of new or increased tariffs have contributed to market volatility and could potentially influence consumer confidence and interest rate expectations, which could, in turn, affect the demand for mortgage and consumer financial products.
The Company’s operations are principally funded by available liquidity from cash, cash equivalents and investments. The Company has incurred net losses in each period since inception, and its limited operating history in an evolving industry makes it difficult to accurately forecast the impact of macroeconomic or other external factors on its business and may increase the risk that the Company may not be able to achieve or maintain profitability in the future, or otherwise suffers adverse impacts on its operational and financial results.
Cash and Cash Equivalents
Cash and Cash Equivalents
The Company places its cash with high credit quality and federally insured institutions. Cash with any one institution may be in excess of federally insured limits. The Company has not experienced any losses in such accounts and believes the exposure to credit risk is not significant. The Company considers all highly liquid investments with an original maturity date of three months or less at the time of purchase to be cash equivalents. As of December 31, 2025 and 2024, cash and cash equivalents consisted of cash, money market accounts, and highly liquid investments with original maturities less than 90 days. The carrying amounts reported in the consolidated balance sheets for cash and cash equivalents approximate fair value due to the short-term nature of the investments.
Restricted Cash
Restricted Cash
The Company has classified cash that is not available for use in its operations as restricted cash. Restricted cash consists primarily of collateral for letters of credit related to security deposits for the Company’s office facility lease arrangements. As of December 31, 2025, the Company had no restricted cash. As of December 31, 2024, the Company had restricted cash of $5.0 million, which is presented within prepaid expenses and other current assets on the consolidated balance sheets.
Trade and Other Receivables and Credit Loss Reserves and Investment in Notes Receivable
Trade and Other Receivables and Credit Loss Reserves
The Company reports trade and other receivables net of the allowance for credit losses, in accordance with Accounting Standards Codification (“ASC”) 326, Financial Instruments—Credit Losses. ASC 326 requires an entity to recognize an allowance that reflects the entity’s current estimate of credit losses expected to be incurred over the life of the financial instrument. The Company’s estimate of expected credit losses is determined based on expected lifetime loss rates calculated from historical data and adjusted for the impact of current and future conditions, such as the age of outstanding receivables, historical payment patterns, any known or expected changes to the customers’ ability to fulfill their payment obligations, or assessment of broader economic conditions that may impact the customers’ ability to pay the outstanding balances. As of each of December 31, 2025 and 2024, the reserve for expected credit losses was immaterial. The provision for expected credit losses and the uncollectible portion of the receivables written off against reserve for expected credit losses were immaterial for the years ended December 31, 2025 and 2024.
Investment in Notes Receivable
Investment in notes receivable represents an investment in a privately-held company via convertible promissory notes that are accounted for under ASC 310, Receivables, at cost basis, less impairment. At each reporting date, the Company evaluates the collectability of the notes receivable in accordance with ASC 326, Financial Instruments—Credit Losses. The notes receivable are presented within other non-current assets on the consolidated balance sheets. Refer to Note 5, Significant Balance Sheet Components, for further information.
Marketable Securities
Marketable Securities
Marketable securities consist primarily of U.S. treasury and agency securities, commercial paper, and corporate debt securities. The Company’s policy requires investments to be investment grade, with the primary objective of minimizing the potential risk of principal loss. The Company classifies its marketable securities as available-for-sale securities at the time of purchase and reevaluates such classification at each balance sheet date. The Company has classified its investments as current based on the nature of the investments and their availability for use in current operations.

Available-for-sale securities are carried at fair value, with the change in unrealized gains and losses reported as a separate component on the consolidated statements of comprehensive income until realized. Fair value is determined based on quoted market rates when observable or utilizing data points that are observable, such as quoted prices, interest rates and yield curves. Securities with an amortized cost basis in excess of estimated fair value are assessed to determine what amount of the excess, if any, is caused by expected credit losses. Expected credit losses on securities are recognized in other income (expense), net on the consolidated statements of operations and comprehensive income (loss), and any remaining unrealized losses are included in accumulated other comprehensive loss in stockholders' equity. For the purposes of computing realized and unrealized gains and losses, the cost of securities is based on the specific-identification method. Interest on securities classified as available for sale is included as a component of investment income within other income (expense), net. The Company does not measure an
allowance for credit losses on accrued interest receivable and recognizes interest receivable write offs as a reversal of interest income.
Property and Equipment
Property and Equipment
Property and equipment are stated at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the assets as follows:
Computer and software3 years
Expenditures for maintenance and repairs are evaluated to determine whether they are capitalizable or should be expensed as incurred. Gains or losses on disposal of property and equipment are recognized in the period when the assets are sold or disposed of and the related cost and accumulated depreciation is removed from their respective accounts.
Capitalized Internal-Use Software
Capitalized Internal-Use Software
The Company capitalizes certain costs incurred in the development of its platform and product offerings when (i) the preliminary project stage is completed, (ii) management has authorized further funding for the completion of the project, and (iii) it is probable that the project will be completed and the software will be used to perform the function intended. These capitalized costs include personnel and related expenses, including stock-based compensation, for employees who are directly associated with and who devote time to internal-use software projects. Capitalization of these costs ceases and amortization commences once the project is substantially complete and the software is ready for its intended purpose. Costs incurred for significant upgrades and enhancements to the existing software are capitalized, while the costs incurred for minor modifications, as well as training and maintenance are expensed as incurred. The capitalized internal-use software development costs are reported in property and equipment, net, in the consolidated balance sheets. The Company does not transfer ownership of its software, license, or lease the software to third parties.
Leases
Leases
The Company measures lease liabilities based on the present value of the total lease payments not yet paid discounted based on the Company’s incremental borrowing rate, which is the estimated rate the Company would be required to pay for a collateralized borrowing equal to the total lease payments over the term of the lease. The lease liability also includes expected renewal or termination options, if the option is reasonably certain to be exercised. The Company measures right-of-use assets based on the corresponding lease liability adjusted for (i) payments made to the lessor at or before the commencement date, (ii) initial direct costs the Company incurs and (iii) tenant incentives under the lease. The Company’s leases do not provide a readily determinable implicit interest rate and the Company uses its incremental borrowing rate to measure the lease liability and corresponding right-of-use asset. The incremental borrowing rate is a fully collateralized rate that considers the Company’s credit rating, market conditions, and the term of the lease. The Company accounts for all components in a lease arrangement as a single combined lease component and begins to recognize lease expense when the lessor makes the underlying asset available to the Company. For short-term leases, the Company records rent expense in the consolidated statements of operations and comprehensive income (loss) on a straight-line basis over the lease term and records variable lease payments as incurred. The Company has no finance leases.
Impairment of Long-Lived Assets
Impairment of Long-Lived Assets
The Company evaluates the carrying value of long-lived assets, such as property and equipment and capitalized software development costs, whenever events or changes in circumstances occur that could impact the recoverability of the asset group to which the assets relate. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the asset to the future estimated undiscounted cash flows expected to be generated by the asset. If such assets are considered to
be impaired, the impairment to be recognized is measured as the amount by which the carrying amount of the asset exceeds the fair value of the asset.
Cloud Computing Arrangements
Cloud Computing Arrangements
The Company capitalizes certain implementation costs incurred during the application development stage under cloud computing arrangements that are service contracts in accordance with ASC 350-40, Internal-Use Software. The capitalized costs are presented within prepaid expenses and other current assets and other non-current assets on the consolidated balance sheets and expensed over the term of the related hosting arrangement service period.
Cloud Computing Arrangements
The Company capitalizes certain implementation costs incurred during the application development stage under cloud computing arrangements that are service contracts. The carrying value of the capitalized costs was $0.2 million as of December 31, 2025 and 2024, of which $0.1 million is presented within prepaid expenses and other current assets, and $0.1 million is presented within other non-current assets on the consolidated balance sheets for each period. Amortization of capitalized implementation costs is recognized on a straight-line basis over the term of the associated hosting arrangement when it is ready for its intended use. Costs related to preliminary project activities and post-implementation activities are expensed as incurred.
Investment in Non-Marketable Equity Securities and Equity Method Investments
Investment in Non-Marketable Equity Securities
Investment in non-marketable equity securities without readily determinable fair values is recorded at cost, less impairment, if any, plus or minus observable price changes in orderly transactions of an identical or similar investment of the same issuer. During the years ended December 31, 2025 and 2024, the Company recognized a $16.6 million and $4.4 million gain, respectively, as the result of the adjustments to the carrying value of the non-marketable security to reflect observable price changes. The Company determined the adjustment by measuring the security at fair value using the option pricing model (“OPM”) as of the date the observable transaction occurred. Observable transactions, such as the issuance of new equity by an investee, are indicators of investee enterprise value and are used to estimate the fair value of the Company’s investment in the equity security. An OPM is utilized to allocate value to the various classes of securities of the investee, including classes owned by the Company. Such information, available to the Company from the investee entity, is supplemented with the Company’s estimates such as volatility, expected time to liquidity and the rights and obligations of the securities the Company holds. The inputs to valuation techniques used to measure fair value of the Company’s non-marketable equity security are classified as Level 3 of the fair value hierarchy due to the use of significant unobservable inputs. Refer to Note 5, Significant Balance Sheet Components, for further information.

At each reporting date, the Company performs a qualitative assessment to evaluate the investment for impairment. If the qualitative assessment indicates that the investment is impaired and the fair value of the investment is less than its carrying value, the carrying amount of the investment is reduced to its fair value. Any adjustments to carrying value based on observable price changes and impairment charges are recorded in other income (expense), net on the consolidated statements of operations and comprehensive income (loss) and the investment is presented within other non-current assets on the consolidated balance sheets.
Equity Method Investments
Investments and ownership interests are accounted for under equity method accounting if the Company has the ability to exercise significant influence, but does not have a controlling financial interest. Significant influence generally exists when an investor owns 20% or more of the voting stock of an incorporated investee or a more than 3% to 5% interest in an unincorporated investee. Equity method investments are measured at cost minus impairment, if any, plus or minus the Company’s share of equity method investee income or loss, additional investments in the entity, and distributions. The Company’s proportionate share of the income or loss from equity method investments is typically recognized on a one-quarter lag in the Consolidated Statements of Operations due to investee reporting cycle timing. The Company assesses its investment for other-than-temporary impairment when events or changes in circumstances indicate that the carrying amount of the investment might not be recoverable and recognizes an impairment loss to adjust the investment to its then-current fair value.
Investments in Non-Marketable Equity Securities
The Company holds 103,611 shares of Series Growth 1a Preferred Stock received in exchange for an investment of cash in a privately-held company. This investment in the equity securities without readily determinable fair value is measured at cost, less impairment, if any, plus or minus observable price changes in orderly transactions of an identical or similar investment of the same issuer.

As of December 31, 2025, the carrying value of this investment was $26.4 million, inclusive of a cumulative upward adjustment of $23.9 million, of which $16.6 million was recognized as a gain in 2025 to reflect observable price changes. As of December 31, 2024, the carrying value of the investment was $9.8 million, inclusive of a cumulative upward adjustment of $7.3 million, of which $4.4 million was recognized in 2024 to reflect observable price changes.

The gain resulting from the adjustment to the carrying value of the non-marketable security is presented within other income (expense) in the consolidated statements of operations and comprehensive income (loss). There were no impairments for the years ended December 31, 2025, 2024 and 2023.
During the year ended December 31, 2025, the Company made a cash investment in exchange for Series A Preferred Units in a privately-held company. The investment in the equity securities without readily determinable fair value is measured at cost, less impairment, if any, plus or minus observable price changes in orderly transactions of an identical or similar instrument of the same issuer. As of December 31, 2025, the carrying value of this investment was $4.0 million. No observable price changes have been identified for this investment to date.
Noncontrolling Interest - Held for Sale from Discontinued Operations
Noncontrolling Interest - Held for Sale from Discontinued Operations
The Company’s 90.1% ownership of Title365 resulted in recognition of a 9.9% noncontrolling interest, which represented the minority stockholder’s share of the net income and equity in Title365. The Title365 stockholders agreement included a provision whereby the Company had a call option to purchase the 9.9% noncontrolling interest at a purchase price equal to the greater of (1) $49.5 million plus an amount of interest calculated using an interest rate of 5.0% per annum compounding annually; or (2) 4.4 multiplied by the trailing 12-month EBITDA multiplied by the noncontrolling interest ownership percentage (the “Title365 Call Option”). The Title365 Call Option became exercisable on June 30, 2023. The noncontrolling interest holder also held an option to compel the Company to purchase the remaining 9.9% noncontrolling interest at a price calculated in the same manner as the Title365 Call Option (the “Title365 Put Option”). The Title365 Put Option was exercisable beginning 5 years following the acquisition closing date. Neither the Title365 Call Option nor the Title365 Put Option had an expiration date. However, pursuant to the Title365 stockholders agreement, the Company also had certain bring-along rights that it could exercise under certain circumstances, which may have resulted in the Title365 Put Option being extinguished. As the Title365 Put Option was not solely within the Company’s control, the Company classified this interest as redeemable noncontrolling interest (“RNCI”) within the mezzanine equity section of the consolidated balance sheets. The RNCI was accreted to the redemption value under the interest method from the acquisition date through the date the Title365 Put Option became exercisable. At each balance sheet date, the RNCI was reported at the greater of the initial carrying amount adjusted for the RNCI's share of earnings or losses and other comprehensive income or loss, or its accreted redemption value. The changes in the redemption amount were recorded with corresponding adjustments against retained earnings or, in the absence of retained earnings, additional paid-in-capital. For each reporting period, the entire periodic change in the redemption amount was reflected in the computation of net income (loss) per share under the two-class method as being akin to a dividend.

On February 26, 2025, the Company entered into a multi-contract arrangement (the “Arrangement”) with the holder of the 9.9% noncontrolling interest in Title365 (the “Counterparty”), pursuant to which such holder assigned its 9.9% noncontrolling interest to Title365, and terminated the Title365 stockholders agreement with the Company. The transaction resulted in the termination of the Company’s obligations associated with the Title365 Put Option, which had a redemption amount, as if it was then-currently redeemable, of $59.2 million and $58.7 million as of February 26, 2025 and December 31, 2024, respectively. In return, the Company terminated its non-compete and non-solicit agreement with the Counterparty, allowing the Counterparty to pursue business opportunities relating to the title insurance industry. Furthermore, in conjunction with the Arrangement, the Company and the Counterparty executed an amendment to an existing revenue subscription arrangement, whereby the Counterparty committed to a certain minimum amount of consideration for access to the Company’s platform, updated pricing, and an extension of the existing arrangement’s contractual term.

The termination of the Company’s obligations associated with the Put Option resulted in a reclassification of $53.5 million from redeemable noncontrolling interest to $52.7 million of additional paid-in capital. The remaining $0.8 million represents the non-cash consideration in the Arrangement related to the assignment of the noncontrolling interest to Title365, which was recorded as deferred revenue to be recognized over the term subscription arrangement.
Series A Preferred Stock
Series A Preferred Stock
On April 29, 2024, the Company entered into an Investment Agreement (the “Investment Agreement”) with Haveli and issued 150,000 shares of the Company’s Series A Preferred Stock. The Series A Preferred Stock is classified as mezzanine equity due to the redemption features that are not solely within the Company’s control. The Series A Preferred Stock is accreted to its maximum redemption value over the seven year term, using the effective interest method. The increases in the redemption amount are recorded with corresponding adjustments against additional paid-in capital, in the absence of retained earnings. For each reporting period, the entire periodic change in the redemption amount is reflected in the computation of net loss per share under the two-class method as being akin to a dividend, by reducing the income (or increasing the loss) attributable to common stockholders. The Series A Preferred Stock is a participating security for purposes of applying the two-class method when calculating earnings per share in periods of net income. Refer to Note 14, Net Loss per Share, for further information.
Debt and Debt Issuance Costs
Debt and Debt Issuance Costs
The carrying value of the Company’s term loan is presented net of debt issuance costs and discount relating to the issuance of preferred stock warrant. These costs are amortized as a non-cash component of interest expense using the effective interest method over the term of the loan. Unamortized debt issuance costs that exist upon the extinguishment of debt are expensed proportionally to the amount of debt extinguished and the resulting loss on extinguishment is presented within other income (expense), net on the consolidated statement of operations and comprehensive income (loss). On April 29, 2024, in connection with the issuance of the Series A Preferred Stock, the Company paid approximately $146.1 million to repay all amounts outstanding and payable under the Credit Agreement, including the exit fee of $4.5 million, and terminated the Credit Agreement. Refer to Note 8, Debt, for further information.
Segment Information
Segment Information
The Company’s operating segments are defined in a manner consistent with how the Company manages its operations and how the CODM evaluates the results and allocates the Company’s resources.

During the first quarter of 2025, the Company classified the results of its previously reported Title segment as discontinued operations in its consolidated statement of operations. Refer to Note 16, Assets Held for Sale and Discontinued Operations, for additional details. As a result, the Company now operates in a single operating segment and a single reportable segment. This segment reporting change reflects a corresponding change in how the CODM reviews financial information in order to allocate resources and assess performance. The comparative prior period amounts have been reclassified to conform to current period presentation.
As a result, the Company now operates in a single operating segment and a single reportable segment. The CODM assesses the segment performance by using net loss from continuing operations as a measure of segment profitability. The CODM uses revenue and net loss from continuing operations for purposes of making operating decisions, allocation of resources, and evaluation of financial performance, primarily by monitoring actual to budget results as well as by reviewing year-over-year performance.
The CODM also reviews significant segment expenses for the single reportable segment. Significant segment expenses include cost of revenue, research and development expenses, sales and marketing expenses, and general and administrative expenses, all of which are presented in our consolidated statements of operations and comprehensive income (loss). Other segment items include restructuring expenses, interest expense, other income (expense), net and income tax (expense) benefit, which are also presented in our consolidated statements of operations and comprehensive income (loss).
Share repurchases
Share repurchases
All repurchased shares under the share repurchase program are retired. The retired shares are equivalent to authorized, unissued shares and are no longer considered to be outstanding or held in treasury. The excess purchase price over par value for share repurchases is recorded to additional paid-in-capital.
Assets Held for Sale
Assets Held for Sale and Discontinued Operations
The Company classifies assets and liabilities as held for sale (“disposal group”) when management, having the authority to approve the action, commits to a plan to sell the disposal group, the sale is probable to be completed within one year, and the disposal group is available for immediate sale in its present condition. The Company also considers whether an active program to locate a buyer has been initiated, whether the disposal group is marketed actively for sale at a price that is reasonable in relation to its current fair value, and whether actions required to complete the plan indicate that it is unlikely that significant changes to the plan will be made or that the plan will be withdrawn. The Company measures a disposal group that is classified as held for sale at the lower of its carrying amount or fair value less costs to sell. With the exception of the full impairment of the intangible assets in the amount of $2.0 million, as disclosed in Note 16, Assets Held for Sale and Discontinued Operations, there was no loss recognized related to the disposal group for the year ended December 31, 2025. Gains are not recognized until the date of sale. Assets are not depreciated or amortized while they are classified as held for sale. Upon determining that a disposal group meets the criteria to be classified as held for sale, the Company reports the assets and liabilities of the disposal group as assets held for sale and liabilities held for sale in its consolidated balance sheets.
Discontinued Operations If the disposition of a component, being an operating or reportable segment, business unit, subsidiary or asset group, represents a strategic shift that has or will have a major effect on the Company’s operations and financial results, the operating profits or losses of the component when classified as held for sale, and the gain or loss upon disposition of the component, are presented as discontinued operations in the consolidated statements of operations. As of December 31, 2025, the operations of the Company’s Title segment met the criteria to be classified as held for sale and presented as discontinued operations. Refer to Note 16, Assets Held for Sale and Discontinued Operations, for additional information.
Revenue Recognition
Revenue Recognition
Overview
The Company recognizes revenue in accordance with ASC 606, Revenue from Contracts with Customers, which requires the Company to recognize revenue upon transfer of control of promised products and services to customers in an amount that reflects the consideration the Company expects to receive in exchange for those products or services. If consideration promised in a contract includes a variable amount, for example, overage fees, credits, price concessions or incentives, the Company includes an estimate of the amount it expects to receive only to the extent that it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved.

The Company determines the amount of revenue to be recognized through the application of the following five-step model:
Identification of the contract, or contracts, with a customer — A contract with a customer exists when (i) the Company enters into an enforceable contract with a customer that defines each party’s rights regarding the services to be transferred and identifies the payment terms related to these services, (ii) the contract has commercial substance, and (iii) it is determined that collection of substantially all consideration for services that are transferred is probable based on the customer’s intent and ability to pay the promised consideration when it is due.
Identification of the performance obligations in the contract — Performance obligations promised in a contract are identified based on the services that will be transferred to the customer that are both capable of being distinct, whereby the customer can benefit from the services either on their own or together with other resources that are readily available from third parties or from the Company, and are distinct within the context of the contract, whereby the transfer of the services is separately identifiable from the other promises in the contract. To the extent that a contract includes multiple promised services, the Company applies judgment to determine whether promised services are capable of being distinct and distinct within the context of the contract. If these criteria are not met, the promised services are accounted for as a combined performance obligation. The Company has concluded that promised services included in its contracts with multiple performance obligations are distinct.
Determination of the transaction price — The transaction price is determined based on the consideration to which the Company expects to be entitled in exchange for transferring services to the customer. The Company estimates and includes variable consideration in the transaction price at contract inception to the extent it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved. In estimating variable consideration in subscription arrangements, the Company considers historical experience and other external factors that may impact the expectation
of future completed transactions beyond a customer’s contracted minimum number of completed transactions. At each reporting period, the Company assesses the expected overage fees, if any, that will be earned for the duration of the contract term. Revenue is presented net of any taxes collected from customers and remitted to governmental authorities.
Allocation of the transaction price to the performance obligations in the contract — The Company allocates the transaction price to each performance obligation on a relative standalone selling price (“SSP”) basis. The SSP is the price at which the Company would sell a promised service separately to a customer. In instances where the Company does not sell or price a service separately, the Company estimates the SSP by considering available information such as market conditions, internally approved pricing guidelines, and the underlying cost of delivering the performance obligation. Judgment is required to determine the SSP for each distinct performance obligation.
Recognition of revenue when the performance obligation is satisfied — For each performance obligation identified, the Company determines at contract inception whether it satisfies the performance obligation over time or at a point in time.

The Company delivers its cloud-based software platform as a service. The Company’s arrangements do not provide the customers with a contractual right to take possession of the Company’s cloud-based software products at any point in time.

In 2023, the Company introduced a consumption-based pricing model for mortgage-related and consumer banking products to better meet the needs of its customers. With the consumption-based pricing model, customers typically enter into one to three year arrangements (“consumption-based arrangements”) that include a fixed annual commitment, which represents a portion of a customer’s expected annual usage that is consumed at specified prices for each product. Under consumption-based arrangements, the Company typically bills its customers quarterly, semi-annually, or annually in advance of their consumption. To the extent customers consume completed transactions in excess of the pre-purchased amount, they are charged for their incremental usage billed as overages monthly in arrears. Consumption-based arrangements typically permit customers to rollover any unused amount to the subsequent renewal year, generally on the commitment to pre-purchase additional consumption. Therefore, under consumption-based arrangements, the nature of the Company’s promise to customers is to provide a specified quantity of services. Consumption-based arrangements are generally non-cancelable during the contract term.

The Company also offers usage-based arrangements, in which customers pay a variable amount for completed transactions at specified prices. Under the usage-based arrangements, the Company bills its customers for completed transactions monthly in arrears. The Company recognizes revenue under these arrangements as customers consume completed transactions, such as a funded loan, new account opening, or closing transaction. Completed transaction fees for mortgage-related and consumer banking products, including ancillary products (e.g., income verification and close products), are determined by the number and type of software platform components that are needed to support each product offering. Usage-based arrangements generally can be terminated at any time by the customer.

The Company continues to recognize revenue generated from subscription arrangements where customers pay fees for the ability to access the Company’s platform. Under subscription-based arrangements, customers commit to a minimum number of completed transactions at specified prices over the contract term. For subscription-based arrangements, the Company estimates variable consideration, which takes into account historical experience and other external factors that may impact the expectation of future completed transactions beyond a customer’s contracted minimum number of completed transactions. At each reporting period, the Company assesses the expected overage fees, if any, that will be earned for the duration of the contract term. Subscription arrangements are generally non-cancelable during the contract term and do not provide the contractual right to take possession of the software at any point in time. The Company begins recognizing revenue when access to the platform is provisioned to customers for an amount that reflects the consideration the Company expects to be entitled to in exchange for those services. Access to the platform represents a series of distinct services as the Company continually provides access to the platform, fulfills its obligation to the customer over the non-cancelable contractual term, and the customer receives and consumes the benefit of the platform throughout the contract period. The series of distinct services represents a single performance obligation that is satisfied over time. Under its subscription arrangements, the Company typically bills customers for any committed amounts quarterly, semi-annually or annually in advance and for overages beyond a customer’s contracted minimum number of completed transactions on a monthly or quarterly basis in arrears. The Company recognizes fees for subscription arrangements ratably over the non-cancelable contract term of the arrangement as subscription services are provided.
Certain customer contracts also include access to Blend Builder, which provides customers with a set of low-code, drag-and-drop design tools, modular components and integrations to allow them to create and deploy their own new product offerings. The Company typically invoices customers annually in advance for access to Blend Builder and recognizes revenue allocated to Blend Builder ratably over the contract term.

Certain customer contracts include access to third-party services offered through the Company’s marketplace partner ecosystem and integrated into the Company’s platform. For these partner-provided services, the Company evaluates whether it is the principal or the agent in the arrangement and presents revenue on a gross basis when the Company controls the specified service before it is transferred to the customer, or on a net basis when the Company’s performance obligation is to arrange for the specified service to be provided by the marketplace partner. In making this determination, the Company considers whether it is primarily responsible for fulfillment of the specified service and whether it has discretion in establishing the price charged to the customer, among other factors.

The Company also generates revenue from marketplace partners through arrangements under which partners pay a combination of fixed and variable fees for access to the Company’s platform and distribution capabilities. Variable fees are typically received in arrears and fixed fees are typically billed in advance. Revenue is generally recognized ratably over the term of the arrangement.

The Company also recognized revenue, to a lesser extent, from professional services and premier support. Professional services revenue consists of fees for services related to helping customers deploy, configure, and optimize the use of the Company’s technology. These services include consulting, project management, system integration, data migration, process enhancement, and training. Professional services contracts are priced either on a fixed price basis and billed in full at the beginning of the contract term or on a time-and-materials basis and billed monthly in arrears. Professional services revenues for contracts on a fixed price basis are recognized on a proportional performance basis, which measures the service hours performed to date relative to the total expected hours to completion. Professional services revenues for contracts on a time-and-materials basis are recognized as services are delivered.

Premier support revenue consists of fees for various services provided as part of a support package, such as email and chat support, unlimited quantity of service requests, developer assist API support, VIP support escalation line, phone/web conference support, and advanced configuration support. Premier support contracts are typically billed annually in advance and recognized ratably over time as a stand-ready performance obligation.
Contract assets
The Company records a contract asset when revenue recognized on its subscription arrangements and professional services contracts exceeds billable amounts under the contract. Contract assets are included in prepaid expenses and other current assets in the Company’s consolidated balance sheets.
Deferred Revenue
Deferred revenue represents billings or payments received in advance of revenue recognition. Balances consist primarily of amounts prepaid under subscription and consumption-based arrangements and professional services not yet provided as of the balance sheet dates. Amounts that will be recognized during the succeeding 12-month period are recorded as deferred revenue, current, and the remaining portion, if any, is recorded as deferred revenue, non-current. Payment terms and conditions vary by contract type, although terms generally include a requirement of payment within 30 to 60 days. In instances where the timing of revenue recognition differs from the timing of invoicing, the Company has determined its contracts do not include a significant financing component. The primary purpose of the Company’s invoicing terms is to provide customers with simplified and predictable ways of purchasing its services, not to receive financing from its customers or to provide customers with financing.
Deferred Contract Costs
The Company capitalizes incremental and recoverable costs of obtaining contracts with customers as deferred contract costs, which consist of sales commissions paid to the Company’s sales force. The Company applies the practical expedient to expense sales commissions as incurred when the amortization period is one year or less.
Sales commissions paid to obtain renewal contracts are not considered commensurate with commissions paid for new contracts. Therefore, deferred contract costs are amortized on a straight-line basis over an estimated period of benefit of five years, which includes subsequent renewal periods. The Company determined the period of benefit by taking into consideration customer attrition and estimated technology life cycles. Amortization expense is included in sales and marketing expenses in the consolidated statements of operations and comprehensive income (loss).

The Company evaluates the period of benefit for its new revenue contracts on an annual basis, and reviews deferred contract costs for impairment as of each balance sheet date or whenever events or changes in circumstances indicate that the carrying amount may not be recoverable.
Cost of Revenue
Cost of Revenue
Software-related costs of subscribed hosting, support, and costs of delivering professional services are expensed as incurred. Costs of subscribed hosting and support are comprised of third-party web hosting costs and software licenses, customer support, and other customer related activities. Costs of professional services consist primarily of personnel and related direct costs, including employee salaries, payroll taxes, business expenses (e.g., employee travel and lodging expenses for customer projects), as well as allocated overhead. Amortization of capitalized internal-use software development costs is also included within cost of revenue.
Advertising Costs
Advertising Costs
Advertising costs are expensed as incurred.
Research and Development Costs
Research and Development Costs
Research and development costs within the consolidated statements of operations and comprehensive income (loss) are comprised of personnel costs, including stock-based compensation expense, associated with the Company’s product and engineering personnel responsible for the design, development, and testing of the product, depreciation of equipment used in research and development and allocated facilities and information technology costs. Research and development costs are expensed as incurred.
Stock-Based Compensation
Stock-Based Compensation
The Company measures and recognizes its stock-based compensation in accordance with ASC 718, Stock Compensation, which requires compensation cost for the grant-date fair value of stock-based awards to be recognized over the requisite service period.

The Company primarily grants RSUs and has historically granted stock option awards to its employees that vest upon the satisfaction of a service condition. The requisite service period of the stock awards is generally the vesting period. The Company accounts for forfeitures as they occur.

Certain stock options granted to the Company’s Co-Founder and Head of Blend vest upon the satisfaction of a service condition, liquidity event-related performance condition, and performance-based market conditions. In July 2021, the first tranche of the Co-Founder and Head of Blend stock option award vested upon completion of the IPO. The remaining tranches of shares will vest dependent on performance goals tied to the Company’s stock price hurdles with specified expiration dates for each tranche.
The Company also grants restricted stock units with performance vesting conditions (“PSUs”) to certain senior executives. The PSUs will vest in four tranches upon continued service and satisfaction of certain market-based performance targets related to the Company’s stock price hurdles. The Company estimates the grant date fair value and the requisite service period of the PSUs using a Monte Carlo simulation model.
Income Taxes
Income Taxes
The Company accounts for income taxes using an asset and liability approach. Under this method, the Company recognizes deferred income tax assets and liabilities for the expected future tax consequences of temporary differences between the tax basis of an asset or liability and its reported amount in the consolidated financial statements, as well as from net operating loss and tax credit carryforwards. Deferred tax amounts are measured using enacted statutory tax rates in effect for the year in which the differences are expected to reverse. A valuation allowance is provided against deferred tax assets that, based on all available positive and negative evidence, are not expected to be realized. Such evidence includes, but is not limited to, recent cumulative earnings or losses, expectations of future taxable income by taxing jurisdiction, the anticipated reversal or expiration dates of the deferred tax assets and tax planning strategies.

The Company recognizes tax benefits from uncertain tax positions only if it believes that it is more likely than not that the tax position will be sustained on examination by the taxing authorities based on the technical merits of the position. The benefits recognized in the consolidated financial statements from such positions are then measured based on the largest benefit that has a greater than a 50% likelihood of being sustained.
Restructuring Charges
Restructuring Charges
The restructuring charges consist primarily of cash expenditures for compensation and severance payments, employee benefits, payroll taxes and related facilitation costs associated with the Company’s workforce reduction plans, as well as facilities restructuring costs. Employee termination benefits are recognized as a liability at estimated fair value, at the time of communication to employees, unless future service is required, in which case the costs are recognized ratably over the future service period. Ongoing termination benefits are recognized as a liability at estimated fair value when the amount of such benefits is probable and reasonably estimable. Charges related to facilities restructuring actions are comprised of costs related to early termination of the lease agreement and impairment of the right-of-use asset in connection with the abandonment of the property incurred in the year ended December 31, 2024.
Other Income (Expense), Net
Other Income (Expense), Net
Other income (expense), net for the year ended December 31, 2025 consists primarily of $16.6 million gain on investment on non-marketable equity securities due to an observable price change as well as income earned from the Company’s investment portfolio of $3.7 million.

Other income (expense), net for the year ended December 31, 2024 consists primarily of $9.2 million gain on sale of insurance business in connection with the strategic partnership, a $4.4 million gain on investment on non-marketable equity securities due to an observable price change, income earned from the Company’s investment portfolio of $5.4 million, offset by a $5.5 million loss on extinguishment of debt and a $0.6 million loss on transfer of the subsidiary in India.
Other income (expense), net for the year ended December 31, 2023 consists primarily of income earned from the Company’s investment portfolio of $11.4 million, offset by a loss on the partial extinguishment of debt of $4.0 million.
Employee Benefit Plan
Employee Benefit Plan
The Company maintains a 401(k) plan that covers all eligible employees in the United States. Employer matching contributions are discretionary. The Company, at its discretion, may match a percentage of the employee contributions. The Company recognized a contribution expense of $1.4 million, $1.6 million and $2.6 million for the years ended December 31, 2025, 2024 and 2023, respectively.
Concentrations of Credit Risk and Significant Customers
Concentrations of Credit Risk and Significant Customers
Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, restricted cash, marketable securities, trade accounts receivable, and notes receivable. The Company maintains its cash equivalents primarily in money market funds and highly liquid investments that are issued or guaranteed by the United States government or its agencies. As of December 31, 2025 and 2024, cash and cash equivalents amounted to $43.6 million and $38.0 million, respectively, and included $2.0 million and $2.2 million, respectively, of cash held in a foreign jurisdiction. Collateral is not required for trade accounts receivable.
Fair Value Measurement
Fair Value Measurement
The Company measures its cash and cash equivalents, marketable securities, trade and other receivables, accounts payable, and other current liabilities at fair value on a recurring basis. In addition, the Company measures certain other assets, including intangible assets and investments in equity securities without readily determinable fair values, at fair value on a nonrecurring basis.

The Company reports its investments in cash equivalents and marketable securities at fair value on the consolidated balance sheets based upon the level of judgment associated with inputs used to measure their fair value. The categories are as follows:

Level 1—Observable inputs are unadjusted quoted prices in active markets for identical assets or liabilities.

Level 2—Observable inputs are quoted prices for similar assets and liabilities in active markets or inputs other than quoted prices which are observable for the assets or liabilities, either directly or indirectly through market corroboration, for substantially the full term of the financial instruments.

Level 3—Unobservable inputs which are supported by little or no market activity and which are significant to the fair value of the assets or liabilities. These inputs are based on the Company’s assumptions used to measure assets and liabilities at fair value and require significant management judgment or estimation.
The estimated fair value of trade and other receivables, accounts payable, and other current liabilities approximate their respective carrying values due to their short term nature.
Recently Adopted Accounting Standards and Recently Issued Accounting Standards Not Yet Adopted
Recently Adopted Accounting Standards
In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740) - Improvements to Income Tax Disclosures. This update improves the transparency of income tax disclosures by requiring (1) consistent categories and greater disaggregation of information in the rate reconciliation and (2) income taxes paid disaggregated by jurisdiction. The Company adopted this ASU on a prospective basis effective January 1, 2025. Refer to Note 13, Income Taxes, for the expanded disclosures required under this ASU. The adoption of this pronouncement did not have a material impact on the Company’s consolidated financial statements.
In July 2025, the FASB issued ASU No.2025-05, Financial Instruments-Credit Losses (Topic 326). This update affects the practical expedient when estimating expected credit losses on current accounts receivables and current contract assets arising from transactions under Topic 606. The guidance is effective for the Company for annual reporting periods beginning after December 15, 2025 and interim reporting periods within those annual reporting periods. The early adoption of this pronouncement did not have a material impact on the Company’s consolidated financial statements.
Recently Issued Accounting Standards Not Yet Adopted
In November 2024, the FASB issued ASU No. 2024-03, Disaggregation of Income Statement Expenses. This update improves the disclosures about a public entity’s expenses, primarily through additional disclosures of specific information about certain costs and expenses in the notes to financial statements. The guidance is effective for the Company for annual reporting periods beginning after December 15, 2026 and interim reporting periods beginning after December 15, 2027. The requirements will be applied prospectively with the option for retrospective application. Early adoption is permitted. The Company is currently evaluating the impact this ASU will have on its consolidated financial statements.

In September 2025, the FASB issued ASU No. 2025-06, Intangibles—Goodwill and Other-Internal-Use Software (Subtopic 350-40). This update removes all references to prescriptive and sequential software development stages throughout Subtopic 350-40. The guidance is effective for the Company for annual reporting periods beginning after December 15, 2027 and interim reporting periods within those annual reporting periods. Early adoption is permitted. The Company intends to early adopt this ASU as of January 1, 2026 using prospective transition method. The Company expects that the adoption of ASU 2025-06 will result in a decrease in the amount of software costs eligible for capitalization as certain agile development activities may not meet the 'probable-to-complete' threshold as early as they did under the legacy stage-based model, particularly for projects involving novel technology.

In November 2025, the FASB issued ASU No. 2025-11, Interim Reporting (Topic 270): Narrow-Scope Improvements. This amendment results in a comprehensive list of interim disclosures that are required by GAAP, which includes a disclosure principle that requires entities to disclose events since the end of the last annual reporting period that have a material impact on the entity. The guidance is effective for interim reporting periods within annual reporting periods beginning after December 15, 2027, for public business entities and for interim reporting periods within annual reporting periods beginning after December 15, 2028, for entities other than public business entities. Early adoption is permitted for all entities. The Company is currently evaluating the impact this ASU will have on its consolidated financial statements.
v3.25.4
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2025
Accounting Policies [Abstract]  
Schedule of Property and Equipment
Property and equipment are stated at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the assets as follows:
Computer and software3 years
Property and equipment, net, consisted of the following:
December 31, 2025December 31, 2024
(In thousands)
Computer and software$1,367 $783 
Capitalized internal-use software26,059 12,041 
Total property and equipment, gross27,426 12,824 
Accumulated depreciation and amortization(4,429)(1,152)
Total property and equipment, net$22,997 $11,672 
Schedule of Capitalized Internal-Use Capitalized internal-use software development costs are amortized using the straight-line method through cost of revenue over an estimated useful life of the software, as the straight-line recognition method best approximates the manner in which the expected benefit will be derived as follows:
Application
3 years
Integration
4 years
Platform
5 years
Schedule of Concentration of Credit Risk
The following customers comprised 10% or more of the Company’s revenue for the following periods:

Year Ended December 31,
Customer
202520242023
A14%10%6%

The following customers comprised 10% or more of the Company’s trade and unbilled receivables:
Customer
December 31, 2025December 31, 2024
B11%8%
C1%11%
v3.25.4
Revenue Recognition and Contract Costs (Tables)
12 Months Ended
Dec. 31, 2025
Revenue from Contract with Customer [Abstract]  
Schedule of Disaggregation of Revenue
The following table provides information about disaggregated revenue by service offering:

Year Ended December 31,
202520242023
(In thousands)
Blend Platform:
Mortgage Suite$69,223 $73,257 $77,574 
Consumer Banking Suite45,223 33,657 23,630 
Total software platform114,446 106,914 101,204 
Professional services9,139 8,848 8,345 
Total revenue$123,585 $115,762 $109,549 
Schedule of Contract Balances
The following table provides information about contract assets and contract liabilities from contracts with customers:
Contract Accounts
Balance Sheet Line Reference
December 31, 2025December 31, 2024
(In thousands)
Contract assets—currentPrepaid expenses and other current assets$5,266 $2,539 
Contract liabilities—currentDeferred revenue, current$(19,385)$(19,240)
v3.25.4
Investments and Fair Value Measurements (Tables)
12 Months Ended
Dec. 31, 2025
Investments, Debt and Equity Securities [Abstract]  
Schedule of Available For Sale Securities
The carrying amount, unrealized gain and loss, and fair value of investments by major security type were as follows:
December 31, 2025
Amortized
Cost
Gross
Unrealized Gain
Fair Value
Fair Value Hierarchy
(In thousands)
Cash equivalents:  
Money market funds$29,639 $— $29,639 Level 1
Total cash equivalents29,639 — 29,639 
Marketable securities:
U.S. treasury and agency securities24,655 84 24,739 Level 2
Total marketable securities
24,655 84 24,739 
Total$54,294 $84 $54,378 

December 31, 2024
Amortized
Cost
Gross
Unrealized Gain
Fair Value
Fair Value Hierarchy
(In thousands)
Cash equivalents: 
 
 
Money market funds$7,112 $— $7,112 Level 1
Commercial paper19,162 — 19,162 Level 2
Total cash equivalents26,274 — 26,274 
Marketable securities:
U.S. treasury and agency securities31,160 92 31,252 Level 2
Commercial paper12,244 — 12,244 Level 2
Debt securities12,643 94 12,737 Level 2
Total marketable securities56,047 186 56,233 
Restricted cash, current:
Money market funds5,023 — 5,023 
Level 1
Total$87,344 $186 $87,530 
The following table summarizes the stated maturities of the Company’s marketable securities and other investments:
December 31, 2025December 31, 2024
(In thousands)
Amortized
Cost
Fair Value
Amortized
Cost
Fair Value
Due within one year$10,446 $10,470 $35,422 $35,477 
Due after one year through two years14,209 14,269 20,625 20,756 
Total marketable securities and other investments
$24,655 $24,739 $56,047 $56,233 
v3.25.4
Significant Balance Sheet Components (Tables)
12 Months Ended
Dec. 31, 2025
Supplemental Balance Sheet Information [Abstract]  
Schedule of Prepaid Expenses and Other Current Assets
Prepaid expenses and other current assets consisted of the following:
December 31, 2025December 31, 2024
(In thousands)
Contract assets$5,266 $2,539 
Deferred contract costs1,812 1,277 
Prepaid software3,985 2,831 
Prepaid insurance1,289 1,291 
Prepaid other1,574 2,229 
Restricted cash
— 5,023 
Other current assets1,195 1,535 
Total prepaid expenses and other current assets$15,121 $16,725 
Schedule of Property and Equipment, Net
Property and equipment are stated at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the assets as follows:
Computer and software3 years
Property and equipment, net, consisted of the following:
December 31, 2025December 31, 2024
(In thousands)
Computer and software$1,367 $783 
Capitalized internal-use software26,059 12,041 
Total property and equipment, gross27,426 12,824 
Accumulated depreciation and amortization(4,429)(1,152)
Total property and equipment, net$22,997 $11,672 
Schedule of Other Non-Current Assets
Other non-current assets consisted of the following:
December 31, 2025December 31, 2024
(In thousands)
Investments in non-marketable equity securities
$30,380 $9,801 
Notes receivable
— 10,500 
Equity method investment9,692 — 
Other non-current assets
1,353 1,605 
Total non-current assets
$41,425 $21,906 
Schedule of Other Current Liabilities
Other current liabilities consisted of the following:
December 31, 2025December 31, 2024
(In thousands)
Accrued expenses$2,835 $2,116 
Accrued professional fees1,5711,392
Accrued connectivity fees3,9513,489
Operating lease liabilities, current portion2542,660
Other
261 83 
Total other current liabilities$8,872 $9,740 
Schedule of Other Non-Current Liabilities
Other non-current liabilities consisted of the following:
December 31, 2025December 31, 2024
(In thousands)
Operating lease liabilities, non-current
$1,223 $— 
Other192278
Total other non-current liabilities
$1,415 $278 
v3.25.4
Leases (Tables)
12 Months Ended
Dec. 31, 2025
Leases [Abstract]  
Schedule of Maturities of Operating Lease Liabilities
As of December 31, 2025, maturities of operating lease liabilities were as follows:
(In thousands)
2026$396 
2027417 
2028437 
2029458 
2030142 
Thereafter— 
Total lease payments1,850 
Less: imputed interest(373)
Total operating lease liabilities$1,477 
v3.25.4
Commitment and Contingencies (Tables)
12 Months Ended
Dec. 31, 2025
Commitments and Contingencies Disclosure [Abstract]  
Schedule of Purchase Obligations
The future non-cancelable purchase obligations, which were not recognized on the Company’s consolidated balance sheet as of December 31, 2025, were as follows:

Year ending December 31,
(In thousands)
2026$2,042 
20271,349 
2028154 
2029— 
2030— 
Total$3,545 
v3.25.4
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Option Activity
A summary of the stock option activity is as follows:
Number of
options
Weighted
average
exercise
price
Weighted
average
remaining
contractual
life
Aggregate
intrinsic
value
(In thousands)(In years)(In thousands)
Balance as of December 31, 202417,300 $4.20 4.69$31,282 
Exercised(1,146)$1.44 
 
$2,309 
Canceled and forfeited(984)$10.17 
 
 
Balance as of December 31, 202515,170 $4.02 3.99$14,414 
Vested and exercisable as of December 31, 202514,427 $4.11 3.99$13,872 
Schedule of RSU and PSU Activity
A summary of the Company’s RSU activity and related information is as follows:
Number of RSUs
Weighted
average
grant date fair value per share
(In thousands)
Balance as of December 31, 202413,770 $1.75 
Granted12,077 $3.44 
Vested(7,430)$2.13 
Forfeited
(5,678)$2.39 
Balance as of December 31, 202512,739 $2.84 
A summary of the Company’s PSU activity and related information is as follows:
Number of PSUs
Weighted
average
grant date fair value per share
(In thousands)
Balance as of December 31, 20243,525 $0.67 
Granted8,260 $1.98 
Vested— $— 
Forfeited
(4,525)$0.81 
Balance as of December 31, 20257,260 $2.06 
Schedule of Valuation Assumptions
The estimated weighted-average grant date fair value of all the awards issued during the first quarter of 2025 was $2.07 per share, which was determined using a Monte Carlo simulation model. The significant assumptions in the Monte Carlo simulation model include the risk-free interest rate, expected volatility of the Company’s stock price, and expected life of the award.

Fair value of common stock
$3.49 - $3.89
Remaining contractual term (years)
4.81 - 4.92
Expected volatility
90%
Risk-free interest rate
4.01% - 4.35%
Expected dividend yield
The remaining tranches were valued using a Monte Carlo simulation model. The weighted average estimated fair value of the remaining tranches was $3.80 per share based on the following assumptions:

Fair value of common stock$18.00
Remaining contractual term (years)14.75
Expected volatility40.00%
Risk-free interest rate1.71%
Expected dividend yield
Schedule of Stock-Based Compensation Expense
The Company’s stock-based compensation expense was as follows:

Year Ended December 31,
202520242023
Cost of revenue$543 $510 $987 
Research and development(1)
6,292 9,870 19,046 
Sales and marketing2,864 3,546 7,035 
General and administrative19,256 14,015 18,489 
Total$28,955$27,941$45,557
____________
(1) Net of $3.2 million and $2.5 million of additions to capitalized internal-use software for the years ended December 31, 2025 and 2024, respectively, and none for the year ended December 31, 2023.
v3.25.4
Restructuring (Tables)
12 Months Ended
Dec. 31, 2025
Restructuring and Related Activities [Abstract]  
Schedule of Reconciliation of the Restructuring Liability Balances
The reconciliation of the restructuring liability balances is as follows:
(In thousands)
Restructuring liability as of December 31, 2023
$31 
January 2024 Plan charge
1,086 
September 2024 Plan charge
1,442 
Settlements(2,484)
Restructuring liability as of December 31, 2024
$75 
2025 Plan charge
871 
Settlements(934)
Restructuring liability as of December 31, 2025
$12 
v3.25.4
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2025
Income Tax Disclosure [Abstract]  
Schedule of Provision For Income Taxes
The total provision for income taxes consisted of the following:

Year Ended December 31,
202520242023
(in thousands)
Current:
Federal$— $— $— 
State79 64 41 
Foreign170 11 87 
Total current249 75 128 
Deferred:
Federal$— $— $— 
State— — — 
Foreign— 34 (34)
Total deferred— 34 (34)
Total provision for income taxes$249 $109 $94 
Schedule of Effective Income Tax Rate Reconciliation
The following table summarizes the differences between the income tax provision recorded by the Company and the amount computed by applying the statutory federal income tax rate of 21% to loss before income tax for the year ended December 31, 2025:
2025
Amount
Rate
(in thousands)
US federal statutory tax rate
$(185)21 %
State and local income taxes, net of federal income tax effect(1)
79 (9)%
Foreign tax effects
India398 (45)%
Tax credits
— — %
Changes in valuation allowances
(2,820)321 %
Nontaxable or nondeductible items
Section 162(m) adjustment
2,657 (302)%
Stock-based compensation
(2,248)256 %
Meals and entertainment45 (5)%
Gifts19 (2)%
Other
(1)%
Other reconciling items
Section 162(m)1,284 (146)%
Stock-based compensation993 (113)%
Other deferred adjustments163 (19)%
Deferred true-up
(142)16 %
Other reconciling items(1)— %
Total Tax Expense$249 (28)%

(1) The only state and local jurisdiction that contributes to the majority (greater than 50%) of the tax effect in this category is Texas.

The following table summarizes the differences between the income tax provision recorded by the Company and the amount computed by applying the statutory federal income tax rate of 21% to loss before income tax for the years ended December 31, 2024 and 2023.

Year Ended December 31
20242023
(in thousands)
Tax benefit at federal statutory rate$(8,957)$(35,151)
State income taxes, net of federal benefit(127)481 
Research and other credits(2,771)(3,774)
Change in valuation allowance8,898 26,519 
Section 162(m) adjustment 4,830 2,836 
Stock-based compensation(2,009)9,380 
Other245 (197)
Total provision for income taxes$109 $94 
Schedule of Deferred Tax Assets and Liabilities Significant components of the Company’s deferred tax assets and liabilities are as follows:
December 31, 2025December 31, 2024
(in thousands)
Deferred tax assets:
Net operating loss carryforwards$156,822 $152,665 
Lease liabilities— 642 
Research and other credits25,808 25,296 
Accruals and reserves1,150 265 
Interest expense limitation14,497 15,023 
Stock-based compensation6,665 6,513 
Fixed assets1,195 1,469 
Capitalized research and development costs25,782 37,428 
Other deferred tax assets28 100 
Gross deferred tax assets231,947 239,401 
Less: valuation allowance(223,684)(235,540)
Total deferred tax assets$8,263 $3,861 
Deferred tax liabilities:
Right-of-use assets$— $(75)
Deferred contract costs(1,303)(1,016)
ASC 606 adjustments(3)(3)
Investments(5,936)(1,782)
Other deferred tax liabilities(383)(240)
Amortization(638)(745)
Gross deferred tax liabilities(8,263)(3,861)
Total net deferred tax assets$— $— 
Schedule of Unrecognized Tax Benefits
The following table reflects the changes in the Company’s unrecognized tax benefits:

Year Ended December 31,
202520242023
(in thousands)
Beginning Balance$11,677 $10,040 $8,228 
Gross increases—tax positions in prior periods35 275 191 
Gross increases—tax positions in current periods240 1,362 1,621 
Ending balance$11,952 $11,677 $10,040 
v3.25.4
Net Income (Loss) Per Share (Tables)
12 Months Ended
Dec. 31, 2025
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share
The following table presents the calculation of basic and diluted net loss per share for Class A and Class B common stock. No shares of Class C common stock were issued and outstanding during the periods presented.
Year Ended December 31,
202520242023
Class A
Common
Class B
Common
Class A
Common
Class B
Common
Class A
Common
Class B
Common
(In thousands, except per share data)
Numerator:
Loss from continuing operations
$(1,111)$(16)$(41,686)$(1,074)$(160,519)$(6,961)
Less: Accretion of Series A Preferred Stock to redemption value(17,583)(249)(10,606)(273)— — 
Net loss attributable to Blend Labs, Inc common stockholders from continuing operations(18,694)(265)(52,292)(1,347)(160,519)(6,961)
Net loss from discontinued operations(5,774)(82)(642)(17)(11,884)(515)
Less: Accretion of RNCI to redemption value from discontinued operations
(1,236)(18)(6,102)(157)(6,352)(275)
Less: Net loss attributable to noncontrolling interest included in discontinued operations
179 72 1,137 49 
Net loss attributable to Blend Labs, Inc common stockholders from discontinued operations(6,831)(97)(6,672)(172)(17,099)(741)
Net loss attributable to Blend Labs, Inc common stockholders$(25,525)$(362)$(58,964)$(1,519)$(177,618)$(7,702)
Denominator:
Weighted average common stock outstanding, basic and diluted255,330 3,619 247,546 6,375 235,015 10,191 
Net loss per share from continuing operations
Basic and diluted$(0.07)$(0.07)$(0.21)$(0.21)$(0.69)$(0.69)
Net loss per share from discontinued operations
Basic and diluted$(0.03)$(0.03)$(0.03)$(0.03)$(0.07)$(0.07)
Net loss per share attributable to Blend Labs, Inc.:
Basic and diluted$(0.10)$(0.10)$(0.24)$(0.24)$(0.76)$(0.76)
Schedule of Antidilutive Securities
The following potential shares of common stock were excluded from the computation of diluted net earnings per share for the years ended December 31, 2025, 2024 and 2023 because including them would have been antidilutive as the Company has reported net loss for each of the periods:

As of December 31,
202520242023
(In thousands)
Outstanding stock options15,170 17,300 19,946 
Early exercised options subject to repurchase— — 124 
Non-plan Co-Founder and Head of Blend options20,194 26,057 26,057 
Unvested restricted stock units12,739 13,770 20,137 
Unvested performance stock awards(1)
7,260 3,525 5,500 
Series G Warrant598 598 598 
Haveli Warrant11,111 11,111 — 
Series A redeemable convertible preferred stock46,154 46,154 — 
Total anti-dilutive securities113,226 118,515 72,362 
____________
(1) Performance conditions were not satisfied for the unvested performance stock awards as of December 31, 2025.
v3.25.4
Segment Information (Tables)
12 Months Ended
Dec. 31, 2025
Segment Reporting [Abstract]  
Schedule of Segment Profit or Loss
The Company’s reported measure of segment profit or loss is as follows:
Year Ended December 31,
202520242023
(In thousands)
Loss from continuing operations$(1,127)$(42,760)$(167,480)
Schedule of Long-Lived Assets by Geographic Areas The Company’s long-lived assets, which consist of property and equipment, net and operating lease right-of-use assets, by geographic location are as follows:
As of December 31,
20252024
(in thousands)
Long-lived assets:
United States$22,595 $11,924 
India1,746 — 
Mexico
50 87 
Total$24,391 $12,011 
v3.25.4
Assets Held for Sale and Discontinued Operations (Tables)
12 Months Ended
Dec. 31, 2025
Discontinued Operations and Disposal Groups [Abstract]  
Schedule of Assets and Liabilities Held for Sale from Discontinued Operations and Operating Results From Disposal Group
The following table is a summary of the assets and liabilities held for sale from discontinued operations:
December 31, 2025December 31, 2024
(In thousands)
Cash and cash equivalents$1,483 $4,232 
Trade and other receivables, net of allowance for credit losses
3,346 2,782 
Prepaid expenses and other current assets811 2,604 
Current assets held for sale from discontinued operations$5,640 $9,618 
Property and equipment, net$652 $649 
Operating lease right-of-use assets349 1,130 
Intangible assets, net— 2,000 
Other non-current assets(1)
1,939 2,278 
Non-current assets held for sale from discontinued operations$2,940 $6,057 
Accounts payable$343 $797 
Accrued compensation438 661 
Other current liabilities4,035 3,649 
Current liabilities held for sale from discontinued operations$4,816 $5,107 
Operating lease liabilities, non-current$— $801 
Other non-current liabilities154 302 
Non-current liabilities held for sale from discontinued operations$154 $1,103 
____________
(1) Other non-current assets includes $1.9 million of restricted cash related to collateral for surety bonds.
Operating results from the disposal group for the years ended December 31, 2025, 2024 and 2023 are reported as Loss from discontinued operations, on the consolidated statements of operations and comprehensive income (loss), as follows:
Year Ended December 31,
202520242023
(in thousands)
Revenue$33,396 $46,257 $47,297 
Cost of revenue29,643 38,934 42,621 
Operating expenses:
Research and development
— — 334 
Sales and marketing1,365 1,639 2,660 
General and administrative5,402 4,870 9,404 
Impairment of intangible asset2,000 — — 
Restructuring1,205 1,589 4,892 
Loss from operations
(6,219)(775)(12,614)
Other income (expense), net363 116 215 
Loss before income taxes
(5,856)(659)(12,399)
Income tax benefit
— — — 
Loss from discontinued operations
$(5,856)$(659)$(12,399)
v3.25.4
Revision of Previously Issued Quarterly Information (Unaudited) (Tables)
12 Months Ended
Dec. 31, 2025
Accounting Changes and Error Corrections [Abstract]  
Schedule of Revision of Previously Issued Quarterly Information
The following tables present selected unaudited condensed consolidated statements of operations and comprehensive income (loss), condensed consolidated statements of cash flows, and condensed consolidated balance sheets for the periods indicated, as well as information about the impact of the revision adjustments on the previously reported amounts for those periods (in thousands, except per share data). The below revisions to the 2025 interim periods will be reflected as applicable in the Company’s 2026 quarterly reports to be filed on Form 10-Q.
Blend Labs, Inc.
Condensed Consolidated Balance Sheets
(In thousands, except per share amounts)
(Unaudited)

As of March 31, 2025
As Reported
Adjustments
As Revised
Assets
Current assets:
Cash and cash equivalents$56,244 $— $56,244 
Marketable securities and other investments48,574 — 48,574 
Trade and other receivables10,692 10,696 
Prepaid expenses and other current assets15,916 (475)15,441 
Current assets held for sale from discontinued operations8,518 — 8,518 
Total current assets139,944 (471)139,473 
Property and equipment, net16,993 (322)16,671 
Operating lease right-of-use assets262 — 262 
Intangible assets, net77 — 77 
Deferred contract costs3,221 — 3,221 
Other non-current assets21,930 — 21,930 
Non-current assets held for sale from discontinued operations5,839 — 5,839 
Total assets$188,266 $(793)$187,473 
Liabilities, redeemable equity and stockholders’ equity
Current liabilities:
Accounts payable$2,666 $— $2,666 
Deferred revenue33,266 (346)32,920 
Accrued compensation3,901 — 3,901 
Other current liabilities11,467 (160)11,307 
Current liabilities held for sale from discontinued operations6,793 — 6,793 
Total current liabilities58,093 (506)57,587 
Other non-current liabilities291 — 291 
Non-current liabilities held for sale from discontinued operations903 — 903 
Total liabilities59,287 (506)58,781 
Commitments and contingencies
Series A redeemable convertible preferred stock145,865 — 145,865 
Stockholders’ equity:
Common Stock— 
Additional paid-in capital1,376,752 — 1,376,752 
Accumulated other comprehensive income565 — 565 
Accumulated deficit(1,394,205)(287)(1,394,492)
Total stockholders’ equity(16,886)(287)(17,173)
Total liabilities, redeemable equity and stockholders’ equity$188,266 $(793)$187,473 
Blend Labs, Inc.
Condensed Consolidated Balance Sheets
(In thousands, except per share amounts)
(Unaudited)

As of June 30, 2025
As Reported
AdjustmentsAs Revised
Assets
Current assets:
Cash and cash equivalents$36,499 $— $36,499 
Marketable securities and other investments51,801 — 51,801 
Trade and other receivables14,962 142 15,104 
Prepaid expenses and other current assets17,128 (543)16,585 
Current assets held for sale from discontinued operations6,440 — 6,440 
Total current assets126,830 (401)126,429 
Property and equipment, net21,179 (476)20,703 
Operating lease right-of-use assets1,780 — 1,780 
Intangible assets, net73 — 73 
Deferred contract costs3,399 — 3,399 
Other non-current assets25,938 — 25,938 
Non-current assets held for sale from discontinued operations3,873 — 3,873 
Total assets$183,072 $(877)$182,195 
Liabilities, redeemable equity and stockholders’ equity
Current liabilities:
Accounts payable$1,201 $— $1,201 
Deferred revenue32,746 (382)32,364 
Accrued compensation2,854 — 2,854 
Other current liabilities10,152 (6)10,146 
Current liabilities held for sale from discontinued operations5,790 — 5,790 
Total current liabilities52,743 (388)52,355 
Other non-current liabilities1,795 — 1,795 
Non-current liabilities held for sale from discontinued operations858 — 858 
Total liabilities55,396 (388)55,008 
Commitments and contingencies
Series A redeemable convertible preferred stock150,241 — 150,241 
Stockholders’ equity:
Common Stock— 
Additional paid-in capital1,377,769 — 1,377,769 
Accumulated other comprehensive income514 — 514 
Accumulated deficit(1,400,850)(489)(1,401,339)
Total stockholders’ equity(22,565)(489)(23,054)
Total liabilities, redeemable equity and stockholders’ equity$183,072 $(877)$182,195 
Blend Labs, Inc.
Consolidated Balance Sheets
(In thousands, except per share amounts)
(Unaudited)

As of September 30, 2025
As Reported
AdjustmentsAs Revised
Assets
Current assets:
Cash and cash equivalents$55,021 $— $55,021 
Marketable securities and other investments22,234 — 22,234 
Trade and other receivables12,201 120 12,321 
Prepaid expenses and other current assets20,105 (418)19,687 
Current assets held for sale from discontinued operations6,427 — 6,427 
Total current assets115,988 (298)115,690 
Property and equipment, net22,978 (659)22,319 
Operating lease right-of-use assets1,573 — 1,573 
Intangible assets, net69 — 69 
Deferred contract costs3,136 — 3,136 
Other non-current assets42,559 — 42,559 
Non-current assets held for sale from discontinued operations3,263 — 3,263 
Total assets$189,566 $(957)$188,609 
Liabilities, redeemable equity and stockholders’ equity
Current liabilities:
Accounts payable$772 $— $772 
Deferred revenue25,325 (119)25,206 
Accrued compensation4,596 — 4,596 
Other current liabilities9,235 87 9,322 
Current liabilities held for sale from discontinued operations5,744 — 5,744 
Total current liabilities45,672 (32)45,640 
Operating lease liabilities, non-current— — — 
Other non-current liabilities1,420 — 1,420 
Debt, non-current, net— — — 
Non-current liabilities held for sale from discontinued operations160 — 160 
Total liabilities47,252 (32)47,220 
Commitments and contingencies
Series A redeemable convertible preferred stock154,799 — 154,799 
Stockholders’ equity:
Common Stock— 
Additional paid-in capital1,375,276 — 1,375,276 
Accumulated other comprehensive income555 — 555 
Accumulated deficit(1,388,318)(925)(1,389,243)
Total stockholders’ equity(12,485)(925)(13,410)
Total liabilities, redeemable equity and stockholders’ equity$189,566 $(957)$188,609 
Blend Labs, Inc.
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)
(In thousands, except per share amounts)
(Unaudited)

Three months ended March 31, 2025
As Reported
AdjustmentsAs Revised
Revenue
Software platform$24,260 $42 $24,302 
Professional services2,510 33 2,543 
Total revenue26,770 75 26,845 
Cost of revenue
Software platform5,865 33 5,898 
Professional services1,947 — 1,947 
Total cost of revenue7,812 33 7,845 
Gross profit18,958 42 19,000 
Operating expenses:
Research and development7,520 322 7,842 
Sales and marketing7,188 — 7,188 
General and administrative11,224 11,231 
Restructuring719 — 719 
Total operating expenses26,651 329 26,980 
Loss from operations(7,693)(287)(7,980)
Other income (expense), net1,114 — 1,114 
Loss before income taxes(6,579)(287)(6,866)
Income tax expense(30)— (30)
Loss from continuing operations(6,609)(287)(6,896)
Loss from discontinued operations (Note 16)(2,803)— (2,803)
Net loss
(9,412)(287)(9,699)
Less: Net loss attributable to noncontrolling interest included in discontinued operations182 — 182 
Net loss attributable to Blend Labs, Inc.(9,230)(287)(9,517)
Less: Accretion of redeemable noncontrolling interest to redemption value from discontinued operations(1,254)— (1,254)
Less: Accretion of Series A redeemable convertible preferred stock to redemption value(4,202)— (4,202)
Net loss attributable to Blend Labs, Inc. common stockholders$(14,686)$(287)$(14,973)
Net loss per share attributable to Blend Labs, Inc. common stockholders - basic and diluted:
Continuing operations$(0.04)$— $(0.04)
Discontinued operations$(0.01)$— $(0.01)
Weighted average shares used in calculating net loss per share:
Basic and diluted258,832 — $258,832 
Comprehensive loss:
Net loss$(9,412)$(287)$(9,699)
Unrealized gain on marketable securities
— 
Foreign currency translation loss
(43)— (43)
Comprehensive loss(9,449)(287)(9,736)
Less: Comprehensive loss attributable to noncontrolling interest182 — 182 
Comprehensive loss attributable to Blend Labs, Inc.$(9,267)$(287)$(9,554)
Blend Labs, Inc.
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)
(In thousands, except per share amounts)
(Unaudited)

Three months ended June 30, 2025
As ReportedAdjustmentsAs Revised
Revenue
Software platform$29,391 $74 $29,465 
Professional services2,132 32 2,164 
Total revenue31,523 106 31,629 
Cost of revenue
Software platform6,505 55 6,560 
Professional services1,713 — 1,713 
Total cost of revenue8,218 55 8,273 
Gross profit23,305 51 23,356 
Operating expenses:
Research and development7,332 154 7,486 
Sales and marketing6,950 — 6,950 
General and administrative13,619 99 13,718 
Restructuring28 — 28 
Total operating expenses27,929 253 28,182 
Loss from operations(4,624)(202)(4,826)
Other income (expense), net1,018 — 1,018 
Loss before income taxes(3,606)(202)(3,808)
Income tax expense(41)— (41)
Loss from continuing operations(3,647)(202)(3,849)
Loss from discontinued operations (Note 16)(2,998)— (2,998)
Net loss(6,645)(202)(6,847)
Less: Net loss attributable to noncontrolling interest included in discontinued operations— — — 
Net loss attributable to Blend Labs, Inc.(6,645)(202)(6,847)
Less: Accretion of redeemable noncontrolling interest to redemption value from discontinued operations— — — 
Less: Accretion of Series A redeemable convertible preferred stock to redemption value(4,376)— (4,376)
Net loss attributable to Blend Labs, Inc. common stockholders$(11,021)$(202)$(11,223)
Net loss per share attributable to Blend Labs, Inc. common stockholders - basic and diluted:
Continuing operations$(0.03)$— $(0.03)
Discontinued operations$(0.01)$— $(0.01)
Weighted average shares used in calculating net loss per share:
Basic and diluted259,211 — 259,211 
Comprehensive loss:
Net loss$(6,645)$(202)$(6,847)
Unrealized loss on marketable securities(44)— (44)
Foreign currency translation loss(7)— (7)
Comprehensive loss(6,696)(202)(6,898)
Less: Comprehensive loss attributable to noncontrolling interest— — — 
Comprehensive loss attributable to Blend Labs, Inc.$(6,696)$(202)$(6,898)
Blend Labs, Inc.
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)
(In thousands, except per share amounts)
(Unaudited)

Three months ended September 30, 2025
As ReportedAdjustmentsAs Revised
Revenue
Software platform$30,459 $(97)$30,362 
Professional services2,401 (68)2,333 
Total revenue32,860 (165)32,695 
Cost of revenue
Software platform6,624 13 6,637 
Professional services1,780 — 1,780 
Total cost of revenue8,404 13 8,417 
Gross profit24,456 (178)24,278 
Operating expenses:
Research and development8,522 183 8,705 
Sales and marketing7,873 — 7,873 
General and administrative12,879 75 12,954 
Restructuring93 — 93 
Total operating expenses29,367 258 29,625 
Loss from operations(4,911)(436)(5,347)
Other income (expense), net17,348 — 17,348 
Income before income taxes12,437 (436)12,001 
Income tax expense(27)— (27)
Income from continuing operations12,410 (436)11,974 
Income from discontinued operations (Note 16)122 — 122 
Net income12,532 (436)12,096 
Less: Net income attributable to noncontrolling interest included in discontinued operations— — — 
Net income attributable to Blend Labs, Inc.12,532 (436)12,096 
Less: Accretion of redeemable noncontrolling interest to redemption value from discontinued operations— — — 
Less: Accretion of Series A redeemable convertible preferred stock to redemption value(4,558)— (4,558)
Net income attributable to Blend Labs, Inc. common stockholders$7,974 $(436)$7,538 
Net income per share attributable to Blend Labs, Inc. common stockholders - basic and diluted:
Basic
Continuing operations$0.03 $(0.01)$0.02 
Discontinued operations$— $— $— 
Net income per share attributable to Blend Labs, Inc. common stockholders$0.03 $(0.01)$0.02 
Diluted
Continuing operations$0.02 $— $0.02 
Discontinued operations$— $— $— 
Net income per share attributable to Blend Labs, Inc. common stockholders$0.02 $— $0.02 
Weighted average shares used in calculating net income per share:
Basic259,631 — 259,631 
Diluted268,719 — 268,719 
Comprehensive income:
Net income$12,532 $(436)$12,096 
Unrealized loss on marketable securities(62)— (62)
Foreign currency translation gain103 — 103 
Comprehensive income12,573 (436)12,137 
Less: Comprehensive loss attributable to noncontrolling interest— — — 
Comprehensive income attributable to Blend Labs, Inc.$12,573 $(436)$12,137 
Blend Labs, Inc.
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)
(In thousands, except per share amounts)
(Unaudited)

Six months ended June 30, 2025
As ReportedAdjustmentsAs Revised
Revenue
Software platform$53,651 $116 $53,767 
Professional services4,642 65 4,707 
Total revenue58,293 181 58,474 
Cost of revenue
Software platform12,369 88 12,457 
Professional services3,660 — 3,660 
Total cost of revenue16,029 88 16,117 
Gross profit42,264 93 42,357 
Operating expenses:
Research and development14,853 476 15,329 
Sales and marketing14,137 — 14,137 
General and administrative24,844 106 24,950 
Restructuring747 — 747 
Total operating expenses54,581 582 55,163 
Loss from operations(12,317)(489)(12,806)
Other income (expense), net2,132 — 2,132 
Loss before income taxes(10,185)(489)(10,674)
Income tax expense(71)— (71)
Loss from continuing operations(10,256)(489)(10,745)
Loss from discontinued operations (Note 16)(5,801)— (5,801)
Net loss(16,057)(489)(16,546)
Less: Net loss attributable to noncontrolling interest included in discontinued operations182 — 182 
Net loss attributable to Blend Labs, Inc.(15,875)(489)(16,364)
Less: Accretion of redeemable noncontrolling interest to redemption value from discontinued operations(1,254)— (1,254)
Less: Accretion of Series A redeemable convertible preferred stock to redemption value(8,578)— (8,578)
Net loss attributable to Blend Labs, Inc. common stockholders$(25,707)$(489)$(26,196)
Net loss per share attributable to Blend Labs, Inc. common stockholders - basic and diluted:
Continuing operations$(0.07)$— $(0.07)
Discontinued operations$(0.03)$— $(0.03)
Weighted average shares used in calculating net income (loss) per share:
Basic and diluted259,004 — 259,004 
Comprehensive loss:
Net loss$(16,057)$(489)$(16,546)
Unrealized loss on marketable securities(38)— (38)
Foreign currency translation loss(50)— (50)
Comprehensive loss(16,145)(489)(16,634)
Less: Comprehensive loss attributable to noncontrolling interest182 — 182 
Comprehensive loss attributable to Blend Labs, Inc.$(15,963)$(489)$(16,452)
Blend Labs, Inc.
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)
(In thousands, except per share amounts)
(Unaudited)

Nine months ended September 30, 2025
As ReportedAdjustmentsAs Revised
Revenue
Software platform$84,110 $19 $84,129 
Professional services7,043 (3)7,040 
Total revenue91,153 16 91,169 
Cost of revenue
Software platform18,993 101 19,094 
Professional services5,440 — 5,440 
Total cost of revenue24,433 101 24,534 
Gross profit66,720 (85)66,635 
Operating expenses:
Research and development23,375 659 24,034 
Sales and marketing22,010 — 22,010 
General and administrative37,723 181 37,904 
Restructuring840 — 840 
Total operating expenses83,948 840 84,788 
Loss from operations(17,228)(925)(18,153)
Other income (expense), net19,480 — 19,480 
Income before income taxes2,252 (925)1,327 
Income tax expense(98)— (98)
Income from continuing operations2,154 (925)1,229 
Loss from discontinued operations (Note 16)(5,679)— (5,679)
Net loss(3,525)(925)(4,450)
Less: Net loss attributable to noncontrolling interest included in discontinued operations182 — 182 
Net loss attributable to Blend Labs, Inc.(3,343)(925)(4,268)
Less: Accretion of redeemable noncontrolling interest to redemption value from discontinued operations(1,254)— (1,254)
Less: Accretion of Series A redeemable convertible preferred stock to redemption value(13,136)— (13,136)
Net loss attributable to Blend Labs, Inc. common stockholders$(17,733)$(925)$(18,658)
Net loss per share attributable to Blend Labs, Inc. common stockholders - basic and diluted:
Basic:
Continuing operations$(0.04)$— $(0.04)
Discontinued operations$(0.03)$— $(0.03)
Weighted average shares used in calculating net loss per share:
Basic and diluted
259,228 — 259,228 
Comprehensive loss:
Net loss$(3,525)$(925)$(4,450)
Unrealized loss on marketable securities(100)— (100)
Foreign currency translation gain53 — 53 
Comprehensive loss(3,572)(925)(4,497)
Less: Comprehensive loss attributable to noncontrolling interest182 — 182 
Comprehensive loss attributable to Blend Labs, Inc.$(3,390)$(925)$(4,315)
Blend Labs, Inc.
Condensed Consolidated Statements of Cash Flows
(In thousands)
(Unaudited)

Three months ended March 31, 2025
As ReportedAdjustmentsAs Revised
Operating activities
Net loss$(9,412)$(287)$(9,699)
Net loss from continuing operations(6,609)(287)(6,896)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation6,048 48 6,096 
Changes in operating assets and liabilities:
Trade and other receivables3,906 (4)3,902 
Prepaid expenses and other assets, current and non-current389 475 864 
Deferred revenue13,254 (346)12,908 
Other liabilities, current and non-current2,179 (160)2,019 
Net cash provided by operating activities - continuing operations20,085 (274)19,811 
Net cash provided by operating activities20,390 (274)20,116 
Additions to property, equipment and internal-use software development costs(4,587)274 (4,313)
Net cash provided by investing activities - continuing operations3,312 274 3,586 
Net cash provided by investing activities3,228 274 3,502 
Blend Labs, Inc.
Condensed Consolidated Statements of Cash Flows
(In thousands)
(Unaudited)

Six months ended June 30, 2025
As ReportedAdjustmentsAs Revised
Operating activities
Net loss$(16,057)$(489)$(16,546)
Net loss from continuing operations(10,256)(489)(10,745)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation13,610 68 13,678 
Changes in operating assets and liabilities:
Trade and other receivables(364)(142)(506)
Prepaid expenses and other assets, current and non-current(1,262)543 (719)
Deferred revenue12,734 (382)12,352 
Other liabilities, current and non-current2,210 (6)2,204 
Net cash provided by operating activities - continuing operations
14,793 (408)14,385 
Net cash provided by operating activities
14,022 (408)13,614 
Additions to property, equipment and internal-use software development costs(8,320)408 (7,912)
Net cash used in investing activities - continuing operations(7,483)408 (7,075)
Net cash used in investing activities(7,603)408 (7,195)
Blend Labs, Inc.
Condensed Consolidated Statements of Cash Flows
(In thousands)
(Unaudited)

Nine months ended September 30, 2025
As ReportedAdjustmentsAs Revised
Operating activities
Net loss$(3,525)$(925)$(4,450)
Net income from continuing operations2,154 (925)1,229 
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation21,376 101 21,477 
Changes in operating assets and liabilities:
Trade and other receivables2,345 (120)2,225 
Prepaid expenses and other assets, current and non-current(4,709)418 (4,291)
Deferred revenue5,313 (119)5,194 
Other liabilities, current and non-current1,686 87 1,773 
Net cash provided by operating activities - continuing operations
12,060 (558)11,502 
Net cash provided by operating activities
10,532 (558)9,974 
Additions to property, equipment and internal-use software development costs(10,592)558 (10,034)
Net cash provided by investing activities - continuing operations19,972 558 20,530 
Net cash provided by investing activities19,790 558 20,348 
v3.25.4
Description of Business and Basis of Presentation (Details) - Series A Redeemable Convertible Preferred Stock
Apr. 29, 2024
$ / shares
shares
Description of Business and Basis of Presentation [Line Items]  
Exercise price of warrants (in dollars per share) | $ / shares $ 4.50
Number shares warrants can purchase (in shares) | shares 11,111,112
v3.25.4
Summary of Significant Accounting Policies - Narrative (Details)
12 Months Ended
Feb. 26, 2025
USD ($)
Apr. 29, 2024
USD ($)
shares
Dec. 31, 2025
USD ($)
segment
tranche
Dec. 31, 2024
USD ($)
shares
Dec. 31, 2023
USD ($)
Sep. 30, 2025
USD ($)
Jun. 30, 2025
USD ($)
Mar. 31, 2025
USD ($)
Noncontrolling Interest [Line Items]                
Restricted cash     $ 0 $ 5,023,000        
Restricted Cash, Current, Statement of Financial Position [Extensible Enumeration]     Total prepaid expenses and other current assets Total prepaid expenses and other current assets        
Reserve for credit loss     $ 0 $ 0        
Credit loss, writeoff     0 0        
Gain on investment in equity securities     16,580,000 4,417,000 $ 0      
Redemption amount $ 59,200,000     58,700,000        
Reclassification of redeemable noncontrolling interest related to discontinued operations to equity     $ 52,675,000 $ 0 0      
Issuance of Series A redeemable convertible preferred stock, net of issuance costs (in shares) | shares       150,000        
Number of operating segment | segment     1          
Number of reportable segment | segment     1          
Operating lease right-of-use assets     $ 1,394,000 $ 339,000   $ 1,573,000 $ 1,780,000 $ 262,000
Total operating lease liabilities     $ 1,477,000          
Amortization period (in years)     5 years          
Advertising expense     $ 3,500,000 1,800,000 3,900,000      
Gain on sale of insurance business     0 9,213,000 0      
Investment portfolio income     3,700,000 5,400,000 11,400,000      
Loss on extinguishment of debt     0 5,476,000 3,970,000      
Loss on transfer of the subsidiary       600,000        
Contribution expense     1,400,000 1,600,000 2,600,000      
Cash and cash equivalents     $ 43,578,000 38,011,000 23,503,000 $ 55,021,000 $ 36,499,000 $ 56,244,000
Incorporated Investee                
Noncontrolling Interest [Line Items]                
Equity method investment, ownership (as a percent)     20.00%          
Unincorporated Investee | Minimum                
Noncontrolling Interest [Line Items]                
Equity method investment, ownership (as a percent)     3.00%          
Unincorporated Investee | Maximum                
Noncontrolling Interest [Line Items]                
Equity method investment, ownership (as a percent)     5.00%          
Foreign Jurisdiction                
Noncontrolling Interest [Line Items]                
Cash and cash equivalents     $ 2,000,000.0 2,200,000        
Unvested performance stock awards                
Noncontrolling Interest [Line Items]                
Number of tranches | tranche     4          
Discontinued Operations, Held-for-Sale | Title Business                
Noncontrolling Interest [Line Items]                
Impairment of intangible asset     $ 2,000,000 0 $ 0      
No impairment loss recognized     0          
Variable Interest Entity, Primary Beneficiary                
Noncontrolling Interest [Line Items]                
Operating lease right-of-use assets     1,600,000          
Total operating lease liabilities     $ 1,500,000          
Term Loan | Line of Credit                
Noncontrolling Interest [Line Items]                
Repayments of credit facility   $ 146,100,000            
Fee amount   $ 4,500,000            
Loss on extinguishment of debt       5,500,000        
Series A Redeemable Convertible Preferred Stock                
Noncontrolling Interest [Line Items]                
Issuance of Series A redeemable convertible preferred stock, net of issuance costs (in shares) | shares   150,000            
Redemption term (in years)     7 years          
Redeemable noncontrolling interest - held for sale from discontinued operations                
Noncontrolling Interest [Line Items]                
Reclassification of redeemable noncontrolling interest related to discontinued operations to equity     $ (53,447,000)          
Additional Paid-In Capital                
Noncontrolling Interest [Line Items]                
Reclassification of redeemable noncontrolling interest related to discontinued operations to equity 52,700,000   $ 52,675,000          
Put Option | Redeemable noncontrolling interest - held for sale from discontinued operations                
Noncontrolling Interest [Line Items]                
Reclassification of redeemable noncontrolling interest related to discontinued operations to equity $ (53,500,000)              
Title365                
Noncontrolling Interest [Line Items]                
Ownership percentage (as a percent) 9.90%   9.90%          
Purchase price     $ 49,500,000          
Interest rate (as a percent)     5.00%          
EBITDA ratio     4.4          
EBITDA period (in months)     12 months          
Title365 | Put Option                
Noncontrolling Interest [Line Items]                
Exercisable period (in years)     5 years          
Title365                
Noncontrolling Interest [Line Items]                
Interest acquired (as a percent)     90.10%          
Title365 | Put Option | Deferred Revenue                
Noncontrolling Interest [Line Items]                
Reclassification of redeemable noncontrolling interest related to discontinued operations to equity $ 800,000              
Investment In Series Growth 1a Preferred Stock, Privately Held                
Noncontrolling Interest [Line Items]                
Gain on investment in equity securities     $ 16,600,000 $ 4,400,000        
v3.25.4
Summary of Significant Accounting Policies - Schedule of Property and Equipment (Details)
Dec. 31, 2025
Computer and software  
Property, Plant and Equipment [Line Items]  
Property and equipment, useful life (in years) 3 years
v3.25.4
Summary of Significant Accounting Policies - Schedule of Capitalized Internal-Use (Details)
Dec. 31, 2025
Application  
Intangible Asset, Acquired, Finite-Lived [Line Items]  
Estimated useful life of the software (in years) 3 years
Integration  
Intangible Asset, Acquired, Finite-Lived [Line Items]  
Estimated useful life of the software (in years) 4 years
Platform  
Intangible Asset, Acquired, Finite-Lived [Line Items]  
Estimated useful life of the software (in years) 5 years
v3.25.4
Summary of Significant Accounting Policies - Schedule of Concentration of Credit Risk (Details) - Customer Concentration Risk
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Revenue | A      
Concentration Risk [Line Items]      
Concentration risk (as a percent) 14.00% 10.00% 6.00%
Accounts Receivable | B      
Concentration Risk [Line Items]      
Concentration risk (as a percent) 11.00% 8.00%  
Accounts Receivable | C      
Concentration Risk [Line Items]      
Concentration risk (as a percent) 1.00% 11.00%  
v3.25.4
Revenue Recognition and Contract Costs - Schedule of Disaggregation of Revenue (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2025
Sep. 30, 2025
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Disaggregation of Revenue [Line Items]                
Total revenue $ 32,695 $ 31,629 $ 26,845 $ 58,474 $ 91,169 $ 123,585 $ 115,762 $ 109,549
Total software platform                
Disaggregation of Revenue [Line Items]                
Total revenue 30,362 29,465 24,302 53,767 84,129 114,446 106,914 101,204
Mortgage Suite                
Disaggregation of Revenue [Line Items]                
Total revenue           69,223 73,257 77,574
Consumer Banking Suite                
Disaggregation of Revenue [Line Items]                
Total revenue           45,223 33,657 23,630
Professional services                
Disaggregation of Revenue [Line Items]                
Total revenue $ 2,333 $ 2,164 $ 2,543 $ 4,707 $ 7,040 $ 9,139 $ 8,848 $ 8,345
v3.25.4
Revenue Recognition and Contract Costs - Schedule of Contract Balances (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Dec. 31, 2024
Revenue from Contract with Customer [Abstract]          
Contract assets—current $ 5,266       $ 2,539
Contract liabilities—current $ (19,385) $ (25,206) $ (32,364) $ (32,920) $ (19,240)
v3.25.4
Revenue Recognition and Contract Costs - Narrative (Details) - USD ($)
12 Months Ended
Sep. 30, 2024
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Capitalized Contract Cost [Line Items]              
Contract assets, noncurrent   $ 0 $ 0        
Contract liabilities, noncurrent   0 0        
Revenue recognized   15,400,000 7,300,000        
Revenue from performance obligations satisfied (reversed) in previous periods   500,000 300,000        
Remaining performance obligations   189,400,000          
Unamortized deferred contract costs   5,200,000 4,200,000        
Unamortized deferred contract costs, current   1,812,000 1,277,000        
Unamortized deferred contract costs, noncurrent   3,425,000 2,868,000   $ 3,136,000 $ 3,399,000 $ 3,221,000
Amortization of deferred contract costs   $ 1,626,000 1,068,000 $ 2,979,000      
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-01-01              
Capitalized Contract Cost [Line Items]              
Remaining performance obligation (as a percent)   50.00%          
Remaining performance obligations (in months)   12 months          
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2027-01-01 | Minimum              
Capitalized Contract Cost [Line Items]              
Remaining performance obligations (in months)   13 months          
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2027-01-01 | Maximum              
Capitalized Contract Cost [Line Items]              
Remaining performance obligations (in months)   24 months          
Covered Insurance Solutions, LLC | Strategic Partnership Agreement              
Capitalized Contract Cost [Line Items]              
Number of license agreement granted (in years) 5 years            
Prepaid Expenses and Other Current Assets              
Capitalized Contract Cost [Line Items]              
Unamortized deferred contract costs, current   $ 1,800,000 $ 1,300,000        
v3.25.4
Investments and Fair Value Measurements - Schedule of Available For Sale Securities (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Debt Securities, Available-for-sale [Line Items]            
Cash and cash equivalents $ 43,578 $ 55,021 $ 36,499 $ 56,244 $ 38,011 $ 23,503
Gross
Unrealized
Gain 84       186  
Marketable securities and other investments, fair value 24,739 $ 22,234 $ 51,801 $ 48,574 56,233  
Restricted cash 0       5,023  
Cash, Cash Equivalents, Restricted Cash And Short Term Investments, Amortized Cost 54,294       87,344  
Cash, Cash Equivalents, Restricted Cash And Short Term Investments, Fair Value 54,378       87,530  
Total cash equivalents            
Debt Securities, Available-for-sale [Line Items]            
Cash and cash equivalents 29,639       26,274  
Total marketable securities            
Debt Securities, Available-for-sale [Line Items]            
Gross
Unrealized
Gain 84       186  
Marketable securities and other investments, amortized cost 24,655       56,047  
Marketable securities and other investments, fair value 24,739       56,233  
Level 2 | U.S. treasury and agency securities            
Debt Securities, Available-for-sale [Line Items]            
Amortized
Cost 24,655       31,160  
Gross
Unrealized
Gain 84       92  
Fair Value 24,739       31,252  
Level 2 | Commercial paper            
Debt Securities, Available-for-sale [Line Items]            
Amortized
Cost         12,244  
Gross
Unrealized
Gain         0  
Fair Value         12,244  
Level 2 | Debt securities            
Debt Securities, Available-for-sale [Line Items]            
Amortized
Cost         12,643  
Gross
Unrealized
Gain         94  
Fair Value         12,737  
Money market funds | Level 1            
Debt Securities, Available-for-sale [Line Items]            
Cash and cash equivalents $ 29,639       7,112  
Restricted cash         5,023  
Commercial paper | Level 2            
Debt Securities, Available-for-sale [Line Items]            
Cash and cash equivalents         $ 19,162  
v3.25.4
Investments and Fair Value Measurements - Narrative (Details) - USD ($)
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Investments, Debt and Equity Securities [Abstract]      
Restricted cash related to lease obligations   $ 5,000,000.0  
Fair value that are in an unrealized loss position $ 0 0  
Fair value that are in an unrealized loss position, twelve months or greater 0 0  
Interest income 3,700,000 5,300,000 $ 11,400,000
Interest receivable $ 300,000 $ 400,000  
v3.25.4
Investments and Fair Value Measurements - Schedule of Debt Maturities (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Dec. 31, 2024
Amortized
Cost          
Due within one year $ 10,446       $ 35,422
Due after one year through two years 14,209       20,625
Total marketable securities and other investments 24,655       56,047
Fair Value          
Due within one year 10,470       35,477
Due after one year through two years 14,269       20,756
Marketable securities and other investments $ 24,739 $ 22,234 $ 51,801 $ 48,574 $ 56,233
v3.25.4
Significant Balance Sheet Components - Schedule of Prepaid Expenses and Other Current Assets (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Dec. 31, 2024
Supplemental Balance Sheet Information [Abstract]          
Contract assets $ 5,266       $ 2,539
Deferred contract costs 1,812       1,277
Prepaid software 3,985       2,831
Prepaid insurance 1,289       1,291
Prepaid other 1,574       2,229
Restricted cash 0       5,023
Other current assets 1,195       1,535
Total prepaid expenses and other current assets $ 15,121 $ 19,687 $ 16,585 $ 15,441 $ 16,725
v3.25.4
Significant Balance Sheet Components - Schedule of Property and Equipment, Net (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Dec. 31, 2024
Property, Plant and Equipment [Line Items]          
Total property and equipment, gross $ 27,426       $ 12,824
Accumulated depreciation and amortization (4,429)       (1,152)
Total property and equipment, net 22,997 $ 22,319 $ 20,703 $ 16,671 11,672
Computer and software          
Property, Plant and Equipment [Line Items]          
Total property and equipment, gross 1,367       783
Capitalized internal-use software          
Property, Plant and Equipment [Line Items]          
Total property and equipment, gross $ 26,059       $ 12,041
v3.25.4
Significant Balance Sheet Components - Property and Equipment, Net (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Text Block [Abstract]      
Depreciation expense $ 200 $ 800 $ 1,500
Capitalized internal-use software development costs included in accrued compensation 3,100 500 0
Impairment $ 0 $ 0 $ 0
v3.25.4
Significant Balance Sheet Components - Schedule of Other Non-Current Assets (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Dec. 31, 2024
Supplemental Balance Sheet Information [Abstract]          
Investments in non-marketable equity securities $ 30,380       $ 9,801
Notes receivable 0       10,500
Equity method investment 9,692       0
Other non-current assets 1,353       1,605
Total non-current assets $ 41,425 $ 42,559 $ 25,938 $ 21,930 $ 21,906
v3.25.4
Significant Balance Sheet Components - Investments in Non-Marketable Equity Securities (Details) - USD ($)
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Marketable Securities [Line Items]      
Investments in non-marketable equity securities $ 30,380,000 $ 9,801,000  
Gain on investment in equity securities 16,580,000 4,417,000 $ 0
Impairments $ 0 0 $ 0
Investment In Series Growth 1a Preferred Stock, Privately Held      
Marketable Securities [Line Items]      
Investment shares (in shares) 103,611    
Investments in non-marketable equity securities $ 26,400,000 9,800,000  
Cumulative upward adjustment 23,900,000 7,300,000  
Gain on investment in equity securities 16,600,000 $ 4,400,000  
Investment In Series A Preferred Units, Privately Held      
Marketable Securities [Line Items]      
Investments in non-marketable equity securities $ 4,000,000.0    
v3.25.4
Significant Balance Sheet Components - Notes Receivable and Equity Method Investments (Details)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2025
USD ($)
shares
Dec. 31, 2025
USD ($)
vote
shares
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2021
USD ($)
Accounts, Notes, Loans and Financing Receivable [Line Items]          
Potential merger consideration $ 1,000,000 $ 1,000,000      
Number of times issuers gross revenue exercised | vote   11      
Potential merger consideration period (in months)   12 months      
Proceeds from sale of equity method investments 2,300        
Equity method investment 9,692 $ 9,692 $ 0    
Gain on investments $ 800        
Privately Held Company          
Accounts, Notes, Loans and Financing Receivable [Line Items]          
Equity method investment, ownership (as a percent) 19.00% 19.00%      
Carrying value of equity method investment $ 6,700 $ 6,700      
Series Seed Preferred Stock          
Accounts, Notes, Loans and Financing Receivable [Line Items]          
Shares issuable in debt conversion (in shares) | shares   4,500,000      
Series A Preferred Stock          
Accounts, Notes, Loans and Financing Receivable [Line Items]          
Shares issuable in debt conversion (in shares) | shares   2,192,308      
Series B Preferred Stock          
Accounts, Notes, Loans and Financing Receivable [Line Items]          
Shares issuable in debt conversion (in shares) | shares   4,384,615      
Class A Common Stock          
Accounts, Notes, Loans and Financing Receivable [Line Items]          
Shares issuable in debt conversion (in shares) | shares 1,846,153        
Class B Common Stock          
Accounts, Notes, Loans and Financing Receivable [Line Items]          
Shares issuable in debt conversion (in shares) | shares 9,230,770        
Notes Receivable          
Accounts, Notes, Loans and Financing Receivable [Line Items]          
Account receivable     $ 5,000 $ 2,500 $ 3,000
Interest rate (as a percent)     4.00% 2.00% 2.00%
Term of receivable (in months)   60 months      
v3.25.4
Significant Balance Sheet Components - Cloud Computing Arrangements (Details) - USD ($)
$ in Millions
Dec. 31, 2025
Dec. 31, 2024
Property, Plant and Equipment [Line Items]    
Costs incurred, development costs $ 0.2 $ 0.2
Prepaid Expenses and Other Current Assets    
Property, Plant and Equipment [Line Items]    
Costs incurred, development costs 0.1 0.1
Other Noncurrent Assets    
Property, Plant and Equipment [Line Items]    
Costs incurred, development costs $ 0.1 $ 0.1
v3.25.4
Significant Balance Sheet Components - Schedule of Other Current Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Dec. 31, 2024
Supplemental Balance Sheet Information [Abstract]          
Accrued expenses $ 2,835       $ 2,116
Accrued professional fees 1,571       1,392
Accrued connectivity fees 3,951       3,489
Operating lease liabilities, current portion 254       2,660
Other 261       83
Total other current liabilities $ 8,872 $ 9,322 $ 10,146 $ 11,307 $ 9,740
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Total other current liabilities       Total other current liabilities
v3.25.4
Significant Balance Sheet Components - Schedule of Other Non-Current Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Dec. 31, 2024
Supplemental Balance Sheet Information [Abstract]          
Operating lease liabilities, non-current $ 1,223 $ 0     $ 0
Other 192       278
Other non-current liabilities $ 1,415 $ 1,420 $ 1,795 $ 291 $ 278
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Other non-current liabilities       Other non-current liabilities
v3.25.4
Leases - Narrative (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2024
Jan. 31, 2024
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2025
Sep. 30, 2025
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Lessee, Lease, Description [Line Items]                    
Operating lease costs               $ 2,000 $ 4,900 $ 5,400
Restructuring     $ 93 $ 28 $ 719 $ 747 $ 840 871 5,882 20,056
Variable lease costs               1,300 2,100 1,900
Short-term lease, cost               $ 800 $ 100 200
Weighted average remaining operating lease term (in years)               4 years 3 months 18 days 9 months 18 days  
Weighted average discount rate (as a percent)               10.80% 6.80%  
Cash paid               $ 3,300 $ 4,200 4,300
Workforce Reduction Plans                    
Lessee, Lease, Description [Line Items]                    
Restructuring $ 1,442 $ 1,086           871 2,500 $ 18,900
Cash payment for restructuring               $ 934 2,484  
Early Lease Termination                    
Lessee, Lease, Description [Line Items]                    
Restructuring                 1,200  
Early Lease Termination | Workforce Reduction Plans                    
Lessee, Lease, Description [Line Items]                    
Restructuring                 1,200  
Cash payment for restructuring                 $ 1,400  
v3.25.4
Leases - Schedule of Maturities of Operating Lease Liabilities (Details)
$ in Thousands
Dec. 31, 2025
USD ($)
Leases [Abstract]  
2026 $ 396
2027 417
2028 437
2029 458
2030 142
Thereafter 0
Total lease payments 1,850
Less: imputed interest (373)
Total operating lease liabilities $ 1,477
v3.25.4
Commitment and Contingencies - Schedule of Purchase Obligations (Details)
$ in Thousands
Dec. 31, 2025
USD ($)
Commitments and Contingencies Disclosure [Abstract]  
2026 $ 2,042
2027 1,349
2028 154
2029 0
2030 0
Total $ 3,545
v3.25.4
Commitments and Contingencies - Narrative (Details) - USD ($)
$ in Millions
Dec. 31, 2025
Dec. 31, 2024
Other Current Liabilities    
Loss Contingencies [Line Items]    
Accrued litigation contingencies $ 0.0 $ 0.3
v3.25.4
Debt (Details) - USD ($)
12 Months Ended
Apr. 29, 2024
Nov. 27, 2023
Jun. 30, 2021
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Sep. 30, 2025
Debt Instrument [Line Items]              
Long-term debt outstanding       $ 0 $ 0   $ 0
Loss on extinguishment of debt       $ 0 $ 5,476,000 $ 3,970,000  
Series G Preferred Stock              
Debt Instrument [Line Items]              
Number shares warrants can purchase (in shares)     598,431        
Exercise price of warrants (in dollars per share)     $ 13.827822        
Expiration period (in years)       10 years 10 years    
Line of Credit | SOFR              
Debt Instrument [Line Items]              
Variable rate (as a percent)     7.50%        
Floor rate (as a percent)     1.00%        
Line of Credit | Base Rate              
Debt Instrument [Line Items]              
Variable rate (as a percent)     6.50%        
Floor rate (as a percent)     2.00%        
Unused commitment fee (as a percent)     0.50%        
Line of Credit | Federal Funds Effective Rate              
Debt Instrument [Line Items]              
Variable rate (as a percent)     0.50%        
Term Loan | Line of Credit              
Debt Instrument [Line Items]              
Maximum borrowing capacity     $ 225,000,000.0        
Debt issuance costs           $ 5,700,000  
Debt discount       $ 6,800,000 $ 6,800,000    
Debt repaid   $ 85,000,000.0          
Loss on extinguishment of debt         $ 5,500,000    
Repayments of credit facility $ 146,100,000            
Fee amount $ 4,500,000            
Effective percentage (as a percent) 14.55%            
Revolving Credit Facility | Line of Credit              
Debt Instrument [Line Items]              
Maximum borrowing capacity     25,000,000.0        
Revolving Credit Facility | Line of Credit | Letter of Credit Sublimit              
Debt Instrument [Line Items]              
Maximum borrowing capacity     10,000,000.0        
Revolving Credit Facility | Line of Credit | Swingline Sub-Facility              
Debt Instrument [Line Items]              
Maximum borrowing capacity     $ 5,000,000.0        
v3.25.4
Redeemable Preferred Stock (Details)
$ / shares in Units, $ in Thousands
12 Months Ended
Apr. 29, 2024
USD ($)
$ / shares
shares
Dec. 31, 2025
USD ($)
$ / shares
Dec. 31, 2024
USD ($)
shares
Dec. 31, 2023
USD ($)
Temporary Equity [Line Items]        
Issuance of Series A redeemable convertible preferred stock, net of issuance costs (in shares) | shares     150,000  
Issuance of Series A redeemable convertible preferred stock, net of issuance costs     $ 130,784  
Stock issuance costs   $ 0 $ 9,480 $ 0
Proceeds from issuance of convertible stock   130,800    
Issuance of warrants   $ 9,100    
Series A Redeemable Convertible Preferred Stock        
Temporary Equity [Line Items]        
Issuance of Series A redeemable convertible preferred stock, net of issuance costs (in shares) | shares 150,000      
Issuance of Series A redeemable convertible preferred stock, net of issuance costs $ 150,000      
Stock issuance costs 10,100      
Proceeds from issuance of convertible stock $ 139,900      
Conversion ratio 307.6923      
Conversion price (in dollars per share) | $ / shares $ 3.25      
Liquidation preference per share (in dollars per share) | $ / shares   $ 1,000    
Liquidation preference share value   $ 150,000    
Liquidation preference anniversary term (in years)   5 years    
Redemption value   $ 300,000    
Redemption term (in years)   7 years    
Warrants outstanding (in shares) | shares 11,111,112      
Exercise price of warrants (in dollars per share) | $ / shares $ 4.50      
Warrants and rights outstanding term (in months) 24 months      
Series A Redeemable Convertible Preferred Stock | Haveli        
Temporary Equity [Line Items]        
Investment owned (as a percent)   33.00%    
Series A Redeemable Convertible Preferred Stock | Scenario One        
Temporary Equity [Line Items]        
Redemption (as a percent) 150.00%      
Series A Redeemable Convertible Preferred Stock | Scenario Two        
Temporary Equity [Line Items]        
Redemption (as a percent) 175.00%      
Series A Redeemable Convertible Preferred Stock | Scenario Three        
Temporary Equity [Line Items]        
Redemption (as a percent) 200.00%      
Series A Redeemable Convertible Preferred Stock | Scenario Four        
Temporary Equity [Line Items]        
Redemption (as a percent) 200.00%      
Series A Redeemable Convertible Preferred Stock | Scenario Five        
Temporary Equity [Line Items]        
Redemption (as a percent) 200.00%      
v3.25.4
Stockholders’ Equity (Details)
$ in Millions
12 Months Ended
Dec. 31, 2025
USD ($)
class
vote
shares
Dec. 31, 2024
USD ($)
shares
Aug. 31, 2024
USD ($)
Dec. 31, 2023
shares
Class of Stock [Line Items]        
Number of classes of stock | class 3      
Temporary equity, shares outstanding (in shares) 150,000 150,000   0
Authorized amount | $     $ 25.0  
Class A Common Stock        
Class of Stock [Line Items]        
Number of votes | vote 1      
Stock repurchased and retired (in shares) 7,979,247      
Stock repurchased and retired | $ $ 25.0 $ 0.0    
Class B Common Stock        
Class of Stock [Line Items]        
Number of votes | vote 40      
Shares converted (in shares) 1      
Series A Redeemable Convertible Preferred Stock        
Class of Stock [Line Items]        
Temporary equity, shares authorized (in shares) 200,000,000 200,000,000    
Temporary equity, shares issued (in shares) 150,000 150,000    
Temporary equity, shares outstanding (in shares) 150,000 150,000    
v3.25.4
Stock-Based Compensation - 2012 Stock Option Plan (Details) - 2012 Stock Plan
12 Months Ended
Dec. 31, 2025
Outstanding stock options  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Common stock value at grant date (as a percent) 100.00%
Vesting period (in years) 4 years
Incentive Stock Options | Minimum  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Common stock value at grant date (as a percent) 110.00%
Stockholder (as a percent) 10.00%
v3.25.4
Stock-Based Compensation - 2021 Equity Incentive Plan (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 12 Months Ended
Jan. 01, 2022
Jul. 31, 2021
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Vesting of early exercised stock options       $ 363 $ 1,446
Unrecognized compensation expense     $ 800    
Stock Options          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Unrecognized compensation expense, period of recognition (in years)     1 year    
2021 Equity Incentive Plan          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Number of shares authorized (in shares)   23,000,000      
Additional shares authorized (in shares) 34,500,000        
Additional shares authorized as a percentage of outstanding common stock (as a percent) 5.00%        
Granted (in shares)     0 0 0
Number of options unvested (in shares)     742,000 1,552,000  
Weighted average grant-date fair value of options unvested (in dollars per share)     $ 1.18 $ 1.58  
Vesting of early exercised stock options     $ 1,500 $ 4,500 $ 11,400
Aggregate intrinsic value of options exercised     $ 2,300 $ 1,800 $ 200
2021 Equity Incentive Plan | Minimum          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Vesting period (in years)   1 year      
2021 Equity Incentive Plan | Maximum          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Vesting period (in years)   4 years      
2012 Stock Plan          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Number of shares authorized (in shares)   36,101,718      
2012 Stock Plan | Stock Options          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Vesting period (in years)     4 years    
v3.25.4
Stock-Based Compensation - Schedule of Stock Option Activity (Details) - 2021 Equity Incentive Plan - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Number of
options    
Beginning balance (in shares) 17,300,000  
Exercised (in shares) (1,146,000)  
Canceled and forfeited (in shares) (984,000)  
Ending balance (in shares) 15,170,000 17,300,000
Vested and exercisable (in shares) 14,427,000  
Weighted
average
exercise
price    
Beginning balance (in dollars per share) $ 4.20  
Exercised (in dollars per share) 1.44  
Cancelled and forfeited (in dollars per share) 10.17  
Ending balance (in dollars per share) 4.02 $ 4.20
Vested and exercisable (in dollars per share) $ 4.11  
Weighted
average
remaining
contractual
life and Aggregate
intrinsic
value    
Weighted average remaining contractual life (in years) 3 years 11 months 26 days 4 years 8 months 8 days
Weighted average remaining contractual life, vested and exercisable (in years) 3 years 11 months 26 days  
Aggregate intrinsic value $ 14,414 $ 31,282
Exercised 2,309  
Aggregate intrinsic value, vested and exercisable $ 13,872  
v3.25.4
Stock-Based Compensation - Schedule of RSU Activity (Details) - Restricted Stock Units (RSUs)
shares in Thousands
12 Months Ended
Dec. 31, 2025
$ / shares
shares
Number of RSUs  
Beginning balance (in shares) | shares 13,770
Granted (in shares) | shares 12,077
Vested (in shares) | shares (7,430)
Forfeited (in shares) | shares (5,678)
Ending balance (in shares) | shares 12,739
Weighted
average
grant date fair value per share  
Beginning balance (in dollars per share) | $ / shares $ 1.75
Granted (in dollars per share) | $ / shares 3.44
Vested (in dollars per share) | $ / shares 2.13
Forfeited (in dollars per share) | $ / shares 2.39
Ending balance (in dollars per share) | $ / shares $ 2.84
v3.25.4
Stock-Based Compensation - Restricted Stock Units (Details) - Restricted Stock Units (RSUs) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Unrecognized compensation expense $ 32.4    
Unrecognized compensation expense, period of recognition (in years) 2 years 6 months    
Vesting of early exercised stock options $ 15.8 $ 17.5 $ 33.6
Number of shares forfeited (in shares) 5,678,000    
Incremental cost $ 0.3    
Minimum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vesting period (in years) 2 years    
Maximum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vesting period (in years) 4 years    
Legacy Senior Executive      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of shares forfeited (in shares) 1,093,750,000    
Shares modified (in shares) 218,750,000    
v3.25.4
Stock-Based Compensation - Schedule of PSU Activity (Details) - PSU
shares in Thousands
12 Months Ended
Dec. 31, 2025
$ / shares
shares
Number of RSUs  
Beginning balance (in shares) | shares 3,525
Granted (in shares) | shares 8,260
Vested (in shares) | shares 0
Forfeited (in shares) | shares (4,525)
Ending balance (in shares) | shares 7,260
Weighted
average
grant date fair value per share  
Beginning balance (in dollars per share) | $ / shares $ 0.67
Granted (in dollars per share) | $ / shares 1.98
Vested (in dollars per share) | $ / shares 0
Forfeited (in dollars per share) | $ / shares 0.81
Ending balance (in dollars per share) | $ / shares $ 2.06
v3.25.4
Stock-Based Compensation - Performance Stock Units (Details)
$ in Thousands
1 Months Ended 12 Months Ended
Mar. 13, 2025
USD ($)
tranche
shares
Dec. 31, 2024
Dec. 31, 2025
USD ($)
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
tranche
executive
shares
Mar. 31, 2025
tranche
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Stock based compensation expense | $     $ 28,955 $ 27,941 $ 45,557  
Unrecognized compensation expense | $     800      
PSU            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Number of shares authorized (in shares)           1,300,000,000
Number of vesting tranches | tranche           4
PSU | Non-employee            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Stock based compensation expense | $     8,000 $ 1,800 $ 600  
Unrecognized compensation expense | $     $ 5,800      
Unrecognized compensation expense, period of recognition (in years)     1 year 6 months      
PSU | Co-Founder and Head            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Number of shares authorized (in shares)           4,200,000
PSU | Senior Executive            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Number of shares authorized (in shares)           250,000
PSU | 2023 Awards            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Number of vesting tranches | tranche         4  
Number of legacy senior executives | executive         2  
Award vesting rights (as a percent)   25.00%        
PSU | 2023 Awards | Legacy Senior Executive One            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Number of shares authorized (in shares)         1,200,000  
PSU | 2023 Awards | Legacy Senior Executive Two            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Number of shares authorized (in shares)         800,000  
PSU | New PSUs | Senior Executive            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Number of vesting tranches | tranche 4          
Incremental cost | $ $ 2,800          
Unrecognized compensation expense | $ $ 200          
PSU | New PSUs | Legacy Senior Executive One            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Number of shares authorized (in shares) 1,300,000          
PSU | New PSUs | Legacy Senior Executive Two            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Number of shares authorized (in shares) 800,000          
v3.25.4
Stock-Based Compensation - Schedule of Valuation Assumptions of PSU (Details) - PSU - $ / shares
3 Months Ended 12 Months Ended
Mar. 31, 2025
Dec. 31, 2025
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Granted (in dollars per share)   $ 1.98
New PSUs    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Granted (in dollars per share) $ 2.07  
Tranche Two | Non-employee    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Expected volatility   90.00%
Risk free interest rate, minimum   4.01%
Risk free interest rate, maximum   4.35%
Expected dividend yield   0.00%
Minimum | Tranche Two | Non-employee    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Fair value of common stock (in dollars per share)   $ 3.49
Remaining contractual term (years)   4 years 9 months 21 days
Maximum | Tranche Two | Non-employee    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Fair value of common stock (in dollars per share)   $ 3.89
Remaining contractual term (years)   4 years 11 months 1 day
v3.25.4
Stock-Based Compensation - Non-Plan Co-Founder and Head of Blend Options (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 12 Months Ended
Mar. 31, 2021
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock based compensation expense   $ 28,955 $ 27,941 $ 45,557
Unrecognized compensation expense   $ 800    
Stock Options        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Unrecognized compensation expense, period of recognition (in years)   1 year    
Non-employee | Stock Options        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Option forfeitures in period (in shares)   5,862,866    
Stock based compensation expense   $ 3,400 $ 5,800 $ 12,300
Unrecognized compensation expense   $ 4,800    
Unrecognized compensation expense, period of recognition (in years)   2 years 7 months 6 days    
Non-employee | Class B Common Stock        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Granted (in shares) 26,057,181      
Granted (in dollars per share) $ 8.58      
Non-employee | Class B Common Stock | Tranche One        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Expected to vest (in shares) 1,954,289      
Non-employee | Class B Common Stock | Stock Options        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Vesting period (in years) 15 years      
Performance period (in months) 15 months      
v3.25.4
Stock-Based Compensation - Schedule of Valuation Assumptions of Non-Plan Co-Founder and Head of Blend Options (Details) - Stock Options - Tranche Two - Non-employee
1 Months Ended
Mar. 31, 2021
$ / shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Vested and exercisable (in dollars per share) $ 3.80
Fair value of common stock (in dollars per share) $ 18.00
Remaining contractual term (years) 14 years 9 months
Expected volatility 40.00%
Risk-free interest rate 1.71%
Expected dividend yield 0.00%
v3.25.4
Stock-Based Compensation - Schedule of Stock-Based Compensation Expense (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]      
Total $ 28,955 $ 27,941 $ 45,557
Amount capitalized 3,162 2,450 0
Cost of revenue      
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]      
Total 543 510 987
Research and development      
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]      
Total 6,292 9,870 19,046
Sales and marketing      
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]      
Total 2,864 3,546 7,035
General and administrative      
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]      
Total $ 19,256 $ 14,015 $ 18,489
v3.25.4
Restructuring - Narrative (Details)
$ in Thousands
1 Months Ended 3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2024
USD ($)
Jan. 31, 2024
USD ($)
Sep. 30, 2025
USD ($)
Jun. 30, 2025
USD ($)
Mar. 31, 2025
USD ($)
Jun. 30, 2025
USD ($)
Jun. 30, 2023
USD ($)
Sep. 30, 2025
USD ($)
Dec. 31, 2025
USD ($)
position
Dec. 31, 2024
USD ($)
Agreement
Dec. 31, 2023
USD ($)
Schedule of Restructuring and Related Costs [Line Items]                      
Restructuring     $ 93 $ 28 $ 719 $ 747   $ 840 $ 871 $ 5,882 $ 20,056
Accelerated expense             $ 2,100        
Number of lease agreement termination | Agreement                   1  
Total operating lease liabilities                 1,477    
Early Lease Termination                      
Schedule of Restructuring and Related Costs [Line Items]                      
Restructuring                   $ 1,200  
Lease Abandonment                      
Schedule of Restructuring and Related Costs [Line Items]                      
Restructuring                   3,300  
Total operating lease liabilities                 0 2,600  
Discontinued Operations, Held-for-Sale | Title Business                      
Schedule of Restructuring and Related Costs [Line Items]                      
Restructuring                 $ 1,205 1,589 4,892
Workforce Reduction Plans                      
Schedule of Restructuring and Related Costs [Line Items]                      
Number of positions eliminated | position                 24    
Restructuring $ 1,442 $ 1,086             $ 871 2,500 18,900
Workforce Reduction Plans | Early Lease Termination                      
Schedule of Restructuring and Related Costs [Line Items]                      
Restructuring                   1,200  
Workforce Reduction Plans | Discontinued Operations, Held-for-Sale | Title Business                      
Schedule of Restructuring and Related Costs [Line Items]                      
Restructuring                 1,200 400 4,900
Executive Transition Costs                      
Schedule of Restructuring and Related Costs [Line Items]                      
Executive transaction costs                 $ 700 $ 0 $ 1,100
v3.25.4
Restructuring - Schedule of Reconciliation of the Restructuring Liability Balances (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2024
Jan. 31, 2024
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2025
Sep. 30, 2025
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Restructuring Reserve [Roll Forward]                    
Restructuring charges     $ 93 $ 28 $ 719 $ 747 $ 840 $ 871 $ 5,882 $ 20,056
Workforce Reduction Plans                    
Restructuring Reserve [Roll Forward]                    
Restructuring liability, beginning balance   $ 31     $ 75 $ 75 $ 75 75 31  
Restructuring charges $ 1,442 $ 1,086           871 2,500 18,900
Settlements               (934) (2,484)  
Restructuring liability, ending balance               $ 12 $ 75 $ 31
v3.25.4
Income Taxes - Schedule of Provision For Income Taxes (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2025
Sep. 30, 2025
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Current:                
Federal           $ 0 $ 0 $ 0
State           79 64 41
Foreign           170 11 87
Total current           249 75 128
Deferred:                
Federal           0 0 0
State           0 0 0
Foreign           0 34 (34)
Total deferred           0 34 (34)
Total provision for income taxes $ 27 $ 41 $ 30 $ 71 $ 98 $ 249 $ 109 $ 94
v3.25.4
Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2025
Sep. 30, 2025
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Amount                
US federal statutory tax rate           $ (185) $ (8,957) $ (35,151)
State and local income taxes, net of federal income tax effect           79 (127) 481
Tax credits           0    
Research and other credits             (2,771) (3,774)
Changes in valuation allowances           (2,820) 8,898 26,519
Nontaxable or nondeductible items                
Section 162(m) adjustment           2,657 4,830 2,836
Stock-based compensation           (2,248) (2,009) 9,380
Meals and entertainment           45    
Gifts           19    
Other           7    
Other reconciling items                
Section 162(m)           1,284    
Stock-based compensation           993    
Deferred true-up           (142)    
Other           163 245 (197)
Other reconciling items           (1)    
Total provision for income taxes $ 27 $ 41 $ 30 $ 71 $ 98 $ 249 $ 109 $ 94
Rate                
US federal statutory tax rate           21.00% 21.00% 21.00%
State and local income taxes, net of federal income tax effect           (9.00%)    
Tax credits           0.00%    
Changes in valuation allowances           321.00%    
Nontaxable or nondeductible items                
Section 162(m) adjustment           (302.00%)    
Stock-based compensation           256.00%    
Meals and entertainment           (5.00%)    
Gifts           (2.00%)    
Other           (1.00%)    
Other reconciling items                
Section 162(m)           (146.00%)    
Stock-based compensation           (113.00%)    
Other deferred adjustments           (19.00%)    
Deferred true-up           16.00%    
Other reconciling items           0.00%    
Total Tax Expense           (28.00%)    
India                
Amount                
Foreign tax effects           $ 398    
Rate                
Foreign tax effects           (45.00%)    
v3.25.4
Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Deferred tax assets:    
Net operating loss carryforwards $ 156,822 $ 152,665
Lease liabilities 0 642
Research and other credits 25,808 25,296
Accruals and reserves 1,150 265
Interest expense limitation 14,497 15,023
Stock-based compensation 6,665 6,513
Fixed assets 1,195 1,469
Capitalized research and development costs 25,782 37,428
Other deferred tax assets 28 100
Gross deferred tax assets 231,947 239,401
Less: valuation allowance (223,684) (235,540)
Total deferred tax assets 8,263 3,861
Deferred tax liabilities:    
Right-of-use assets 0 (75)
Deferred contract costs (1,303) (1,016)
ASC 606 adjustments (3) (3)
Investments (5,936) (1,782)
Other deferred tax liabilities (383) (240)
Amortization (638) (745)
Gross deferred tax liabilities (8,263) (3,861)
Total net deferred tax assets $ 0 $ 0
v3.25.4
Income Taxes - Narrative (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Income Tax Contingency [Line Items]        
Deferred tax assets, valuation allowance $ 223,684 $ 235,540    
Increase in valuation allowance 11,800      
Unrecognized tax benefits 11,952 $ 11,677 $ 10,040 $ 8,228
Federal        
Income Tax Contingency [Line Items]        
Operating loss carryforwards 636,300      
Federal | Research Tax Credit Carryforward        
Income Tax Contingency [Line Items]        
Tax credit carryforward 25,700      
State        
Income Tax Contingency [Line Items]        
Operating loss carryforwards 434,500      
State | Research Tax Credit Carryforward        
Income Tax Contingency [Line Items]        
Tax credit carryforward $ 14,100      
v3.25.4
Income Taxes - Schedule of Unrecognized Tax Benefits (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]      
Beginning Balance $ 11,677 $ 10,040 $ 8,228
Gross increases—tax positions in prior periods 35 275 191
Gross increases—tax positions in current periods 240 1,362 1,621
Ending balance $ 11,952 $ 11,677 $ 10,040
v3.25.4
Net Income (Loss) Per Share - Narrative (Details)
Dec. 31, 2025
class
Earnings Per Share [Abstract]  
Number of classes of stock 3
v3.25.4
Net Income (Loss) Per Share - Schedule of Earnings Per Share (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2025
Sep. 30, 2025
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]                
Shares issued (in shares)           256,043,000 258,173,000  
Shares outstanding (in shares)           256,043,000 258,173,000  
Numerator:                
Loss from continuing operations $ 11,974 $ (3,849) $ (6,896) $ (10,745) $ 1,229 $ (1,127) $ (42,760) $ (167,480)
Less: Accretion of Series A Preferred Stock to redemption value (4,558) (4,376) (4,202) (8,578) (13,136) (17,832) (10,879) 0
Net loss from discontinued operations 122 (2,998) (2,803) (5,801) (5,679) (5,856) (659) (12,399)
Less: Accretion of RNCI to redemption value from discontinued operations 0 0 (1,254) (1,254) (1,254) (1,254) (6,259) (6,627)
Net loss attributable to Blend Labs, Inc. common stockholders, basic 7,538 (11,223) (14,973) (26,196) (18,658) (25,887) (60,483) (185,320)
Net income (loss) attributable to Blend Labs, Inc. common stockholders, diluted $ 7,538 $ (11,223) $ (14,973) $ (26,196) $ (18,658) $ (25,887) $ (60,483) $ (185,320)
Denominator:                
Weighted average common stock outstanding, basic (in shares) 259,631,000 259,211,000 258,832,000 259,004,000 259,228,000 258,949,000 253,921,000 245,206,000
Weighted average common stock outstanding, diluted (in shares) 268,719,000 259,211,000 258,832,000 259,004,000 259,228,000 258,949,000 253,921,000 245,206,000
Net loss per share from continuing operations                
Basic (in dollars per share) $ 0.02 $ (0.03) $ (0.04) $ (0.07) $ (0.04) $ (0.07) $ (0.21) $ (0.69)
Diluted (in dollars per share) 0.02 (0.03) (0.04) (0.07) (0.04) (0.07) (0.21) (0.69)
Net loss per share from discontinued operations                
Basic (in dollars per share) 0 (0.01) (0.01) (0.03) (0.03) (0.03) (0.03) (0.07)
Diluted (in dollars per share) 0 $ (0.01) $ (0.01) $ (0.03) $ (0.03) (0.03) (0.03) (0.07)
Net loss per share attributable to Blend Labs, Inc.:                
Basic (in dollars per share) 0.02         (0.10) (0.24) (0.76)
Diluted (in dollars per share) $ 0.02         $ (0.10) $ (0.24) $ (0.76)
Class C Common Stock                
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]                
Shares issued (in shares)           0 0 0
Shares outstanding (in shares)           0 0 0
Class A
Common                
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]                
Shares issued (in shares)           252,787,000 254,426,000  
Shares outstanding (in shares)           252,787,000 254,426,000  
Numerator:                
Loss from continuing operations           $ (1,111) $ (41,686) $ (160,519)
Less: Accretion of Series A Preferred Stock to redemption value           (17,583) (10,606) 0
Net loss attributable to Blend Labs, Inc common stockholders from continuing operations, basic           (18,694) (52,292) (160,519)
Net loss attributable to Blend Labs, Inc common stockholders from continuing operations, diluted           (18,694) (52,292) (160,519)
Net loss from discontinued operations           (5,774) (642) (11,884)
Less: Accretion of RNCI to redemption value from discontinued operations           (1,236) (6,102) (6,352)
Less: Net loss attributable to noncontrolling interest included in discontinued operations           179 72 1,137
Net loss attributable to Blend Labs, Inc common stockholders from discontinued operations, basic           (6,831) (6,672) (17,099)
Net loss attributable to Blend Labs, Inc common stockholders from discontinued operations, diluted           (6,831) (6,672) (17,099)
Net loss attributable to Blend Labs, Inc. common stockholders, basic           (25,525) (58,964) (177,618)
Net income (loss) attributable to Blend Labs, Inc. common stockholders, diluted           $ (25,525) $ (58,964) $ (177,618)
Denominator:                
Weighted average common stock outstanding, basic (in shares)           255,330,000 247,546,000 235,015,000
Weighted average common stock outstanding, diluted (in shares)           255,330,000 247,546,000 235,015,000
Net loss per share from continuing operations                
Basic (in dollars per share)           $ (0.07) $ (0.21) $ (0.69)
Diluted (in dollars per share)           (0.07) (0.21) (0.69)
Net loss per share from discontinued operations                
Basic (in dollars per share)           (0.03) (0.03) (0.07)
Diluted (in dollars per share)           (0.03) (0.03) (0.07)
Net loss per share attributable to Blend Labs, Inc.:                
Basic (in dollars per share)           (0.10) (0.24) (0.76)
Diluted (in dollars per share)           $ (0.10) $ (0.24) $ (0.76)
Class B
Common                
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]                
Shares issued (in shares)           3,256,000 3,747,000  
Shares outstanding (in shares)           3,256,000 3,747,000  
Numerator:                
Loss from continuing operations           $ (16) $ (1,074) $ (6,961)
Less: Accretion of Series A Preferred Stock to redemption value           (249) (273) 0
Net loss attributable to Blend Labs, Inc common stockholders from continuing operations, basic           (265) (1,347) (6,961)
Net loss attributable to Blend Labs, Inc common stockholders from continuing operations, diluted           (265) (1,347) (6,961)
Net loss from discontinued operations           (82) (17) (515)
Less: Accretion of RNCI to redemption value from discontinued operations           (18) (157) (275)
Less: Net loss attributable to noncontrolling interest included in discontinued operations           3 2 49
Net loss attributable to Blend Labs, Inc common stockholders from discontinued operations, basic           (97) (172) (741)
Net loss attributable to Blend Labs, Inc common stockholders from discontinued operations, diluted           (97) (172) (741)
Net loss attributable to Blend Labs, Inc. common stockholders, basic           (362) (1,519) (7,702)
Net income (loss) attributable to Blend Labs, Inc. common stockholders, diluted           $ (362) $ (1,519) $ (7,702)
Denominator:                
Weighted average common stock outstanding, basic (in shares)           3,619,000 6,375,000 10,191,000
Weighted average common stock outstanding, diluted (in shares)           3,619,000 6,375,000 10,191,000
Net loss per share from continuing operations                
Basic (in dollars per share)           $ (0.07) $ (0.21) $ (0.69)
Diluted (in dollars per share)           (0.07) (0.21) (0.69)
Net loss per share from discontinued operations                
Basic (in dollars per share)           (0.03) (0.03) (0.07)
Diluted (in dollars per share)           (0.03) (0.03) (0.07)
Net loss per share attributable to Blend Labs, Inc.:                
Basic (in dollars per share)           (0.10) (0.24) (0.76)
Diluted (in dollars per share)           $ (0.10) $ (0.24) $ (0.76)
v3.25.4
Net Income (Loss) Per Share - Schedule of Antidilutive Securities (Details) - shares
shares in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Total antidilutive securities (in shares) 113,226 118,515 72,362
Outstanding stock options      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Total antidilutive securities (in shares) 15,170 17,300 19,946
Early exercised options subject to repurchase      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Total antidilutive securities (in shares) 0 0 124
Non-plan Co-Founder and Head of Blend options      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Total antidilutive securities (in shares) 20,194 26,057 26,057
Unvested restricted stock units      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Total antidilutive securities (in shares) 12,739 13,770 20,137
Unvested performance stock awards      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Total antidilutive securities (in shares) 7,260 3,525 5,500
Series G Warrant      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Total antidilutive securities (in shares) 598 598 598
Haveli Warrant      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Total antidilutive securities (in shares) 11,111 11,111 0
Series A Redeemable Convertible Preferred Stock      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Total antidilutive securities (in shares) 46,154 46,154 0
v3.25.4
Segment Information - Narrative (Details)
12 Months Ended
Dec. 31, 2025
segment
Segment Reporting [Abstract]  
Number of operating segment 1
Number of reportable segment 1
v3.25.4
Segment Information - Schedule of Segment Profit or Loss (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2025
Sep. 30, 2025
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Segment Reporting [Abstract]                
Loss from continuing operations $ 11,974 $ (3,849) $ (6,896) $ (10,745) $ 1,229 $ (1,127) $ (42,760) $ (167,480)
v3.25.4
Segment Information - Schedule of Long-Lived Assets by Geographic Areas (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Revenues from External Customers and Long-Lived Assets [Line Items]    
Long-lived assets $ 24,391 $ 12,011
United States    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Long-lived assets 22,595 11,924
India    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Long-lived assets 1,746 0
Mexico    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Long-lived assets $ 50 $ 87
v3.25.4
Assets Held for Sale and Discontinued Operations - Narrative (Details) - Discontinued Operations, Held-for-Sale - Title Business - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Impairment of intangible asset $ 2,000 $ 0 $ 0
No impairment loss recognized $ 0    
v3.25.4
Assets Held for Sale and Discontinued Operations - Schedule of Assets and Liabilities Held for Sale from Discontinued Operations (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Current assets held for sale from discontinued operations            
Cash and cash equivalents $ 3,420       $ 6,503 $ 9,727
Current assets held for sale from discontinued operations 5,640 $ 6,427 $ 6,440 $ 8,518 9,618  
Non-current assets held for sale from discontinued operations            
Non-current assets held for sale from discontinued operations 2,940 3,263 3,873 5,839 6,057  
Current liabilities held for sale from discontinued operations            
Current liabilities held for sale from discontinued operations 4,816 5,744 5,790 6,793 5,107  
Non-current liabilities held for sale from discontinued operations            
Non-current liabilities held for sale from discontinued operations 154 $ 160 $ 858 $ 903 1,103  
Discontinued Operations, Held-for-Sale | Title Business            
Current assets held for sale from discontinued operations            
Cash and cash equivalents 1,483       4,232  
Trade and other receivables, net of allowance for credit losses 3,346       2,782  
Prepaid expenses and other current assets 811       2,604  
Current assets held for sale from discontinued operations 5,640       9,618  
Non-current assets held for sale from discontinued operations            
Property and equipment, net 652       649  
Operating lease right-of-use assets 349       1,130  
Intangible assets, net 0       2,000  
Other non-current assets 1,939       2,278  
Non-current assets held for sale from discontinued operations 2,940       6,057  
Current liabilities held for sale from discontinued operations            
Accounts payable 343       797  
Accrued compensation 438       661  
Other current liabilities 4,035       3,649  
Current liabilities held for sale from discontinued operations 4,816       5,107  
Non-current liabilities held for sale from discontinued operations            
Operating lease liabilities, non-current 0       801  
Other non-current liabilities 154       302  
Non-current liabilities held for sale from discontinued operations 154       1,103  
Restricted cash $ 1,900       $ 1,900  
v3.25.4
Assets Held for Sale and Discontinued Operations - Schedule of Operating Results From Disposal Group (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2025
Sep. 30, 2025
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Operating expenses:                
Loss from discontinued operations $ 122 $ (2,998) $ (2,803) $ (5,801) $ (5,679) $ (5,856) $ (659) $ (12,399)
Discontinued Operations, Held-for-Sale | Title Business                
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                
Revenue           33,396 46,257 47,297
Cost of revenue           29,643 38,934 42,621
Operating expenses:                
Research and development           0 0 334
Sales and marketing           1,365 1,639 2,660
General and administrative           5,402 4,870 9,404
Impairment of intangible asset           2,000 0 0
Restructuring           1,205 1,589 4,892
Loss from operations           (6,219) (775) (12,614)
Other income (expense), net           363 116 215
Loss before income taxes           (5,856) (659) (12,399)
Income tax benefit           0 0 0
Loss from discontinued operations           $ (5,856) $ (659) $ (12,399)
v3.25.4
Revision of Previously Issued Quarterly Information (Unaudited) - Schedule of Condensed Consolidated Balance Sheets (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Current assets:              
Cash and cash equivalents $ 43,578 $ 55,021 $ 36,499 $ 56,244 $ 38,011 $ 23,503  
Marketable securities and other investments 24,739 22,234 51,801 48,574 56,233    
Trade and other receivables 8,786 12,321 15,104 10,696 14,656    
Total prepaid expenses and other current assets 15,121 19,687 16,585 15,441 16,725    
Current assets held for sale from discontinued operations 5,640 6,427 6,440 8,518 9,618    
Total current assets 97,864 115,690 126,429 139,473 135,243    
Property and equipment, net 22,997 22,319 20,703 16,671 11,672    
Operating lease right-of-use assets 1,394 1,573 1,780 262 339    
Intangible assets, net   69 73 77      
Deferred contract costs 3,425 3,136 3,399 3,221 2,868    
Other non-current assets 41,425 42,559 25,938 21,930 21,906    
Non-current assets held for sale from discontinued operations 2,940 3,263 3,873 5,839 6,057    
Total assets 170,045 188,609 182,195 187,473 178,085    
Current liabilities:              
Accounts payable 1,826 772 1,201 2,666 1,620    
Deferred revenue 19,385 25,206 32,364 32,920 19,240    
Accrued compensation 4,555 4,596 2,854 3,901 3,315    
Other current liabilities 8,872 9,322 10,146 11,307 9,740    
Current liabilities held for sale from discontinued operations 4,816 5,744 5,790 6,793 5,107    
Total current liabilities 39,454 45,640 52,355 57,587 39,022    
Operating lease liabilities, non-current 1,223 0     0    
Other non-current liabilities 1,415 1,420 1,795 291 278    
Debt, non-current, net 0 0     0    
Non-current liabilities held for sale from discontinued operations 154 160 858 903 1,103    
Total liabilities 41,023 47,220 55,008 58,781 40,403    
Commitments and contingencies (Note 7)    
Series A redeemable convertible preferred stock 159,495       141,663 0  
Stockholders’ equity:              
Common Stock 2 2 2 2 2    
Additional paid-in capital 1,360,704 1,375,276 1,377,769 1,376,752 1,328,015    
Accumulated other comprehensive income 597 555 514 565 602    
Accumulated deficit (1,391,776) (1,389,243) (1,401,339) (1,394,492) (1,384,975)    
Total stockholders’ equity (30,473) (13,410) (23,054) (17,173) (56,356) $ (19,243) $ 123,172
Total liabilities, redeemable equity and stockholders’ equity 170,045 188,609 182,195 187,473 178,085    
Series A Redeemable Convertible Preferred Stock              
Current liabilities:              
Series A redeemable convertible preferred stock $ 159,495 154,799 150,241 145,865 $ 141,663    
As Reported              
Current assets:              
Cash and cash equivalents   55,021 36,499 56,244      
Marketable securities and other investments   22,234 51,801 48,574      
Trade and other receivables   12,201 14,962 10,692      
Total prepaid expenses and other current assets   20,105 17,128 15,916      
Current assets held for sale from discontinued operations   6,427 6,440 8,518      
Total current assets   115,988 126,830 139,944      
Property and equipment, net   22,978 21,179 16,993      
Operating lease right-of-use assets   1,573 1,780 262      
Intangible assets, net   69 73 77      
Deferred contract costs   3,136 3,399 3,221      
Other non-current assets   42,559 25,938 21,930      
Non-current assets held for sale from discontinued operations   3,263 3,873 5,839      
Total assets   189,566 183,072 188,266      
Current liabilities:              
Accounts payable   772 1,201 2,666      
Deferred revenue   25,325 32,746 33,266      
Accrued compensation   4,596 2,854 3,901      
Other current liabilities   9,235 10,152 11,467      
Current liabilities held for sale from discontinued operations   5,744 5,790 6,793      
Total current liabilities   45,672 52,743 58,093      
Operating lease liabilities, non-current   0          
Other non-current liabilities   1,420 1,795 291      
Debt, non-current, net   0          
Non-current liabilities held for sale from discontinued operations   160 858 903      
Total liabilities   47,252 55,396 59,287      
Commitments and contingencies (Note 7)        
Stockholders’ equity:              
Common Stock   2 2 2      
Additional paid-in capital   1,375,276 1,377,769 1,376,752      
Accumulated other comprehensive income   555 514 565      
Accumulated deficit   (1,388,318) (1,400,850) (1,394,205)      
Total stockholders’ equity   (12,485) (22,565) (16,886)      
Total liabilities, redeemable equity and stockholders’ equity   189,566 183,072 188,266      
As Reported | Series A Redeemable Convertible Preferred Stock              
Current liabilities:              
Series A redeemable convertible preferred stock   154,799 150,241 145,865      
Adjustments              
Current assets:              
Cash and cash equivalents   0 0 0      
Marketable securities and other investments   0 0 0      
Trade and other receivables   120 142 4      
Total prepaid expenses and other current assets   (418) (543) (475)      
Current assets held for sale from discontinued operations   0 0 0      
Total current assets   (298) (401) (471)      
Property and equipment, net   (659) (476) (322)      
Operating lease right-of-use assets   0 0 0      
Intangible assets, net   0 0 0      
Deferred contract costs   0 0 0      
Other non-current assets   0 0 0      
Non-current assets held for sale from discontinued operations   0 0 0      
Total assets   (957) (877) (793)      
Current liabilities:              
Accounts payable   0 0 0      
Deferred revenue   (119) (382) (346)      
Accrued compensation   0 0 0      
Other current liabilities   87 (6) (160)      
Current liabilities held for sale from discontinued operations   0 0 0      
Total current liabilities   (32) (388) (506)      
Operating lease liabilities, non-current   0          
Other non-current liabilities   0 0 0      
Debt, non-current, net   0          
Non-current liabilities held for sale from discontinued operations   0 0 0      
Total liabilities   (32) (388) (506)      
Commitments and contingencies (Note 7)        
Stockholders’ equity:              
Common Stock   0 0 0      
Additional paid-in capital   0 0 0      
Accumulated other comprehensive income   0 0 0      
Accumulated deficit   (925) (489) (287)      
Total stockholders’ equity   (925) (489) (287)      
Total liabilities, redeemable equity and stockholders’ equity   (957) (877) (793)      
Adjustments | Series A Redeemable Convertible Preferred Stock              
Current liabilities:              
Series A redeemable convertible preferred stock   $ 0 $ 0 $ 0      
v3.25.4
Revision of Previously Issued Quarterly Information (Unaudited) - Schedule of Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2025
Sep. 30, 2025
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Revenue                
Total revenue $ 32,695 $ 31,629 $ 26,845 $ 58,474 $ 91,169 $ 123,585 $ 115,762 $ 109,549
Cost of revenue                
Total cost of revenue 8,417 8,273 7,845 16,117 24,534 32,418 32,541 33,090
Gross profit 24,278 23,356 19,000 42,357 66,635 91,167 83,221 76,459
Operating expenses:                
Research and development 8,705 7,486 7,842 15,329 24,034 32,843 46,087 81,257
Sales and marketing 7,873 6,950 7,188 14,137 22,010 29,073 34,410 57,470
General and administrative 12,954 13,718 11,231 24,950 37,904 50,115 45,687 61,284
Restructuring 93 28 719 747 840 871 5,882 20,056
Total operating expenses 29,625 28,182 26,980 55,163 84,788 112,902 132,066 220,067
Loss from operations (5,347) (4,826) (7,980) (12,806) (18,153) (21,735) (48,845) (143,608)
Other income (expense), net 17,348 1,018 1,114 2,132 19,480 20,857 12,941 7,033
Loss before income taxes 12,001 (3,808) (6,866) (10,674) 1,327 (878) (42,651) (167,386)
Income tax expense (27) (41) (30) (71) (98) (249) (109) (94)
Loss from continuing operations 11,974 (3,849) (6,896) (10,745) 1,229 (1,127) (42,760) (167,480)
Loss from discontinued operations (Note 16) 122 (2,998) (2,803) (5,801) (5,679) (5,856) (659) (12,399)
Net loss 12,096 (6,847) (9,699) (16,546) (4,450) (6,983) (43,419) (179,879)
Less: Net loss attributable to noncontrolling interest included in discontinued operations 0 0 182 182 182 182 74 1,186
Net loss attributable to Blend Labs, Inc. 12,096 (6,847) (9,517) (16,364) (4,268) (6,801) (43,345) (178,693)
Less: Accretion of redeemable noncontrolling interest to redemption value from discontinued operations 0 0 (1,254) (1,254) (1,254) (1,254) (6,259) (6,627)
Less: Accretion of Series A redeemable convertible preferred stock to redemption value (4,558) (4,376) (4,202) (8,578) (13,136) (17,832) (10,879) 0
Net loss attributable to Blend Labs, Inc. common stockholders, basic 7,538 (11,223) (14,973) (26,196) (18,658) (25,887) (60,483) (185,320)
Net loss attributable to Blend Labs, Inc. common stockholders, diluted $ 7,538 $ (11,223) $ (14,973) $ (26,196) $ (18,658) $ (25,887) $ (60,483) $ (185,320)
Net loss per share attributable to Blend Labs, Inc. common stockholders - basic and diluted:                
Continuing operations, basic (in dollars per share) $ 0.02 $ (0.03) $ (0.04) $ (0.07) $ (0.04) $ (0.07) $ (0.21) $ (0.69)
Discontinuing operations, basic (in dollars per share) 0 (0.01) (0.01) (0.03) (0.03) (0.03) (0.03) (0.07)
Net loss per share attributable to Blend Labs, Inc. common stockholders, basic (in dollars per share) 0.02         (0.10) (0.24) (0.76)
Continuing operations, diluted (in dollars per share) 0.02 (0.03) (0.04) (0.07) (0.04) (0.07) (0.21) (0.69)
Discontinuing operations, diluted (in dollars per share) 0 $ (0.01) $ (0.01) $ (0.03) $ (0.03) (0.03) (0.03) (0.07)
Net loss per share attributable to Blend Labs, Inc. common stockholders, diluted (in dollars per share) $ 0.02         $ (0.10) $ (0.24) $ (0.76)
Weighted average shares used in calculating net loss per share:                
Basic (in shares) 259,631 259,211 258,832 259,004 259,228 258,949 253,921 245,206
Diluted (in shares) 268,719 259,211 258,832 259,004 259,228 258,949 253,921 245,206
Comprehensive loss:                
Net loss $ 12,096 $ (6,847) $ (9,699) $ (16,546) $ (4,450) $ (6,983) $ (43,419) $ (179,879)
Unrealized (loss) gain on marketable securities (62) (44) 6 (38) (100) (100) 87 1,030
Foreign currency translation gain 103 (7) (43) (50) 53 95 74 119
Comprehensive loss 12,137 (6,898) (9,736) (16,634) (4,497) (6,988) (43,258) (178,730)
Less: Comprehensive loss attributable to noncontrolling interest included in discontinued operations 0 0 182 182 182 182 74 1,186
Comprehensive loss attributable to Blend Labs, Inc. 12,137 (6,898) (9,554) (16,452) (4,315) (6,806) (43,184) (177,544)
As Reported                
Revenue                
Total revenue 32,860 31,523 26,770 58,293 91,153      
Cost of revenue                
Total cost of revenue 8,404 8,218 7,812 16,029 24,433      
Gross profit 24,456 23,305 18,958 42,264 66,720      
Operating expenses:                
Research and development 8,522 7,332 7,520 14,853 23,375      
Sales and marketing 7,873 6,950 7,188 14,137 22,010      
General and administrative 12,879 13,619 11,224 24,844 37,723      
Restructuring 93 28 719 747 840      
Total operating expenses 29,367 27,929 26,651 54,581 83,948      
Loss from operations (4,911) (4,624) (7,693) (12,317) (17,228)      
Other income (expense), net 17,348 1,018 1,114 2,132 19,480      
Loss before income taxes 12,437 (3,606) (6,579) (10,185) 2,252      
Income tax expense (27) (41) (30) (71) (98)      
Loss from continuing operations 12,410 (3,647) (6,609) (10,256) 2,154      
Loss from discontinued operations (Note 16) 122 (2,998) (2,803) (5,801) (5,679)      
Net loss 12,532 (6,645) (9,412) (16,057) (3,525)      
Less: Net loss attributable to noncontrolling interest included in discontinued operations 0 0 182 182 182      
Net loss attributable to Blend Labs, Inc. 12,532 (6,645) (9,230) (15,875) (3,343)      
Less: Accretion of redeemable noncontrolling interest to redemption value from discontinued operations 0 0 (1,254) (1,254) (1,254)      
Less: Accretion of Series A redeemable convertible preferred stock to redemption value (4,558) (4,376) (4,202) (8,578) (13,136)      
Net loss attributable to Blend Labs, Inc. common stockholders, basic 7,974 (11,021) (14,686) (25,707) (17,733)      
Net loss attributable to Blend Labs, Inc. common stockholders, diluted $ 7,974 $ (11,021) $ (14,686) $ (25,707) $ (17,733)      
Net loss per share attributable to Blend Labs, Inc. common stockholders - basic and diluted:                
Continuing operations, basic (in dollars per share) $ 0.03 $ (0.03) $ (0.04) $ (0.07) $ (0.04)      
Discontinuing operations, basic (in dollars per share) 0 (0.01) (0.01) (0.03) (0.03)      
Net loss per share attributable to Blend Labs, Inc. common stockholders, basic (in dollars per share) 0.03              
Continuing operations, diluted (in dollars per share) 0.02 (0.03) (0.04) (0.07) (0.04)      
Discontinuing operations, diluted (in dollars per share) 0 $ (0.01) $ (0.01) $ (0.03) $ (0.03)      
Net loss per share attributable to Blend Labs, Inc. common stockholders, diluted (in dollars per share) $ 0.02              
Weighted average shares used in calculating net loss per share:                
Basic (in shares) 259,631 259,211 258,832 259,004 259,228      
Diluted (in shares) 268,719 259,211 258,832 259,004 259,228      
Comprehensive loss:                
Net loss $ 12,532 $ (6,645) $ (9,412) $ (16,057) $ (3,525)      
Unrealized (loss) gain on marketable securities (62) (44) 6 (38) (100)      
Foreign currency translation gain 103 (7) (43) (50) 53      
Comprehensive loss 12,573 (6,696) (9,449) (16,145) (3,572)      
Less: Comprehensive loss attributable to noncontrolling interest included in discontinued operations 0 0 182 182 182      
Comprehensive loss attributable to Blend Labs, Inc. 12,573 (6,696) (9,267) (15,963) (3,390)      
Adjustments                
Revenue                
Total revenue (165) 106 75 181 16      
Cost of revenue                
Total cost of revenue 13 55 33 88 101      
Gross profit (178) 51 42 93 (85)      
Operating expenses:                
Research and development 183 154 322 476 659      
Sales and marketing 0 0 0 0 0      
General and administrative 75 99 7 106 181      
Restructuring 0 0 0 0 0      
Total operating expenses 258 253 329 582 840      
Loss from operations (436) (202) (287) (489) (925)      
Other income (expense), net 0 0 0 0 0      
Loss before income taxes (436) (202) (287) (489) (925)      
Income tax expense 0 0 0 0 0      
Loss from continuing operations (436) (202) (287) (489) (925)      
Loss from discontinued operations (Note 16) 0 0 0 0 0      
Net loss (436) (202) (287) (489) (925)      
Less: Net loss attributable to noncontrolling interest included in discontinued operations 0 0 0 0 0      
Net loss attributable to Blend Labs, Inc. (436) (202) (287) (489) (925)      
Less: Accretion of redeemable noncontrolling interest to redemption value from discontinued operations 0 0 0 0 0      
Less: Accretion of Series A redeemable convertible preferred stock to redemption value 0 0 0 0 0      
Net loss attributable to Blend Labs, Inc. common stockholders, basic (436) (202) (287) (489) (925)      
Net loss attributable to Blend Labs, Inc. common stockholders, diluted $ (436) $ (202) $ (287) $ (489) $ (925)      
Net loss per share attributable to Blend Labs, Inc. common stockholders - basic and diluted:                
Continuing operations, basic (in dollars per share) $ (0.01) $ 0 $ 0 $ 0 $ 0      
Discontinuing operations, basic (in dollars per share) 0 0 0 0 0      
Net loss per share attributable to Blend Labs, Inc. common stockholders, basic (in dollars per share) (0.01)              
Continuing operations, diluted (in dollars per share) 0 0 0 0 0      
Discontinuing operations, diluted (in dollars per share) 0 $ 0 $ 0 $ 0 $ 0      
Net loss per share attributable to Blend Labs, Inc. common stockholders, diluted (in dollars per share) $ 0              
Weighted average shares used in calculating net loss per share:                
Basic (in shares) 0 0 0 0 0      
Diluted (in shares) 0 0 0 0 0      
Comprehensive loss:                
Net loss $ (436) $ (202) $ (287) $ (489) $ (925)      
Unrealized (loss) gain on marketable securities 0 0 0 0 0      
Foreign currency translation gain 0 0 0 0 0      
Comprehensive loss (436) (202) (287) (489) (925)      
Less: Comprehensive loss attributable to noncontrolling interest included in discontinued operations 0 0 0 0 0      
Comprehensive loss attributable to Blend Labs, Inc. (436) (202) (287) (489) (925)      
Software platform                
Revenue                
Total revenue 30,362 29,465 24,302 53,767 84,129 114,446 106,914 101,204
Cost of revenue                
Total cost of revenue 6,637 6,560 5,898 12,457 19,094 25,312 23,107 22,025
Software platform | As Reported                
Revenue                
Total revenue 30,459 29,391 24,260 53,651 84,110      
Cost of revenue                
Total cost of revenue 6,624 6,505 5,865 12,369 18,993      
Software platform | Adjustments                
Revenue                
Total revenue (97) 74 42 116 19      
Cost of revenue                
Total cost of revenue 13 55 33 88 101      
Professional services                
Revenue                
Total revenue 2,333 2,164 2,543 4,707 7,040 9,139 8,848 8,345
Cost of revenue                
Total cost of revenue 1,780 1,713 1,947 3,660 5,440 $ 7,106 $ 9,434 $ 11,065
Professional services | As Reported                
Revenue                
Total revenue 2,401 2,132 2,510 4,642 7,043      
Cost of revenue                
Total cost of revenue 1,780 1,713 1,947 3,660 5,440      
Professional services | Adjustments                
Revenue                
Total revenue (68) 32 33 65 (3)      
Cost of revenue                
Total cost of revenue $ 0 $ 0 $ 0 $ 0 $ 0      
v3.25.4
Revision of Previously Issued Quarterly Information (Unaudited) - Schedule of Condensed Consolidated Statements of Cash Flows (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2025
Sep. 30, 2025
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Operating activities                
Net loss $ 12,096 $ (6,847) $ (9,699) $ (16,546) $ (4,450) $ (6,983) $ (43,419) $ (179,879)
Net loss from continuing operations 11,974 (3,849) (6,896) (10,745) 1,229 (1,127) (42,760) (167,480)
Adjustments to reconcile net loss to net cash used in operating activities:                
Stock-based compensation     6,096 13,678 21,477 28,955 27,941 45,557
Changes in operating assets and liabilities:                
Trade and other receivables     3,902 (506) 2,225 5,760 4,765 765
Prepaid expenses and other assets, current and non-current     864 (719) (4,291) (5,430) (432) 1,883
Deferred revenue     12,908 12,352 5,194 (627) 10,256 289
Other liabilities, current and non-current     2,019 2,204 1,773 1,452 (303) (1,948)
Net cash provided by (used in) operating activities - continuing operations     19,811 14,385 11,502 14,398 (8,200) (116,818)
Net cash provided by (used in) operating activities     20,116 13,614 9,974 11,512 (13,044) (127,621)
Additions to property, equipment and internal-use software development costs     (4,313) (7,912) (10,034) (11,593) (9,741) (35)
Net cash provided by investing activities - continuing operations     3,586 (7,075) 20,530 18,731 45,498 127,858
Net cash provided by investing activities     3,502 (7,195) 20,348 $ 18,536 $ 45,395 $ 127,306
As Reported                
Operating activities                
Net loss 12,532 (6,645) (9,412) (16,057) (3,525)      
Net loss from continuing operations 12,410 (3,647) (6,609) (10,256) 2,154      
Adjustments to reconcile net loss to net cash used in operating activities:                
Stock-based compensation     6,048 13,610 21,376      
Changes in operating assets and liabilities:                
Trade and other receivables     3,906 (364) 2,345      
Prepaid expenses and other assets, current and non-current     389 (1,262) (4,709)      
Deferred revenue     13,254 12,734 5,313      
Other liabilities, current and non-current     2,179 2,210 1,686      
Net cash provided by (used in) operating activities - continuing operations     20,085 14,793 12,060      
Net cash provided by (used in) operating activities     20,390 14,022 10,532      
Additions to property, equipment and internal-use software development costs     (4,587) (8,320) (10,592)      
Net cash provided by investing activities - continuing operations     3,312 (7,483) 19,972      
Net cash provided by investing activities     3,228 (7,603) 19,790      
Adjustments                
Operating activities                
Net loss (436) (202) (287) (489) (925)      
Net loss from continuing operations $ (436) $ (202) (287) (489) (925)      
Adjustments to reconcile net loss to net cash used in operating activities:                
Stock-based compensation     48 68 101      
Changes in operating assets and liabilities:                
Trade and other receivables     (4) (142) (120)      
Prepaid expenses and other assets, current and non-current     475 543 418      
Deferred revenue     (346) (382) (119)      
Other liabilities, current and non-current     (160) (6) 87      
Net cash provided by (used in) operating activities - continuing operations     (274) (408) (558)      
Net cash provided by (used in) operating activities     (274) (408) (558)      
Additions to property, equipment and internal-use software development costs     274 408 558      
Net cash provided by investing activities - continuing operations     274 408 558      
Net cash provided by investing activities     $ 274 $ 408 $ 558      
v3.25.4
Subsequent Events (Details) - USD ($)
$ in Millions
Mar. 10, 2026
Aug. 31, 2024
Subsequent Event [Line Items]    
Authorized amount   $ 25.0
Subsequent Event | Class A Common Stock    
Subsequent Event [Line Items]    
Authorized amount $ 50.0